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ABSTRACT
With emergence of biomedical informatics, Web intelligence, and E-business, new
challenges are coming for knowledge discovery and data mining modeling problems.
In this dissertation work, a framework named Granular Support Vector Machines
(GSVM) is proposed to systematically and formally combine statistical learning theory,
granular computing theory and soft computing theory to address challenging predictive
data modeling problems effectively and/or efficiently, with specific focus on binary
classification problems. In general, GSVM works in 3 steps. Step 1 is granulation to build
a sequence of information granules from the original dataset or from the original feature
space. Step 2 is modeling Support Vector Machines (SVM) in some of these information
granules when necessary. Finally, step 3 is aggregation to consolidate information in
these granules at suitable abstract level. A good granulation method to find suitable
granules is crucial for modeling a good GSVM.
Under this framework, many different granulation algorithms including the GSVMCMW (cumulative margin width) algorithm, the GSVM-AR (association rule mining)
algorithm, a family of GSVM-RFE (recursive feature elimination) algorithms, the
GSVM-DC (data cleaning) algorithm and the GSVM-RU (repetitive undersampling)
algorithm are designed for binary classification problems with different characteristics.

The empirical studies in biomedical domain and many other application domains
demonstrate that the framework is promising.
As a preliminary step, this dissertation work will be extended in the future to build a
Granular Computing based Predictive Data Modeling framework (GrC-PDM) with which
we can create hybrid adaptive intelligent data mining systems for high quality prediction.

INDEX WORDS:
Data Mining, Machine Learning, Statistical Learning, Computational Intelligence,
Granular Computing, Granular Support Vector Machines, Bioinformatics

GRANULAR SUPPORT VECTOR MACHINES BASED ON GRANULAR
COMPUTING, SOFT COMPUTING AND STATISTICAL LEARNING

by

YUCHUN TANG

A Dissertation Submitted in Partial Fulfillment of Requirements for the Degree of
Doctor of Philosophy
in the College of Arts and Sciences
Georgia Stage University

2006

Copyright by
Yuchun Tang
2006

GRANULAR SUPPORT VECTOR MACHINES BASED ON GRANULAR
COMPUTING, SOFT COMPUTING AND STATISTICAL LEARNING

by
YUCHUN TANG

Major Professor: Yan-Qing Zhang
Committee:
Rajshekhar Sunderraman
Robert Harrison
Yichuan Zhao

Electronic Version Approved:

Office of Graduate Studies
College of Arts and Sciences
Georgia State University
May 2006

iv

Acknowledgments
Firstly, my specific thanks go to my advisor, Dr. Yan-Qing Zhang, for his kind
guidance and precise advisement during the process of my PhD dissertation. The
dissertation would not have been possible without his helps.
Secondly, I would like to thank Dr. Rajshekhar Sunderraman, Dr. Robert Harrison,
Dr. Yichuan Zhao, Dr. Zhen Huang and Dr. Xiaohua Hu for their well-appreciated
support and assistance.
Finally, I want to thank my family and friends for their support and beliefs.

v

TABLE OF CONTENTS
LIST OF FIGURES ........................................................................................................... xi
LIST OF TABLES............................................................................................................ xv
LIST OF ACRONYMS .................................................................................................... xx
Chapter 1 Introduction ........................................................................................................ 1
1.1 Problem definitions................................................................................................... 2
1.1.1 Binary classification........................................................................................... 2
1.1.2 Binary ranking ................................................................................................... 5
1.1.3 Feature selection ................................................................................................ 5
1.2 Challenges................................................................................................................. 6
1.3 Organizations ............................................................................................................ 6
Chapter 2 Related Works .................................................................................................... 7
2.1 Linear classifiers ....................................................................................................... 7
2.2 Support Vector Machines ......................................................................................... 9
2.2.1 Linear SVM ....................................................................................................... 9
2.2.2 Kernel methods ................................................................................................ 10
2.3 Granular computing ................................................................................................ 11
2.4 Soft computing........................................................................................................ 12
Chapter 3 Granular Support Vector Machines.................................................................. 13
3.1 Motivation............................................................................................................... 13
3.2 GSVM Modeling .................................................................................................... 15
3.3 Comparison with SVM ........................................................................................... 16

vi

Chapter 4 GSVM-CMW ................................................................................................... 20
4.1 GSVM-CMW algorithm ......................................................................................... 20
4.2 GSVM-CMW simulation........................................................................................ 22
4.2.1 Environment..................................................................................................... 22
4.2.2 Data Sets .......................................................................................................... 22
4.2.3 Data Preprocessing........................................................................................... 24
4.2.4 Modeling .......................................................................................................... 25
4.2.5 Result ............................................................................................................... 25
4.3 GSVM-CMW-PCA algorithm ................................................................................ 27
4.4 GSVM-CMW-PCA simulation............................................................................... 28
4.4.1 Data Preprocessing........................................................................................... 28
4.4.2 Modeling .......................................................................................................... 28
4.4.3 Result ............................................................................................................... 29
4.5 Discussion ............................................................................................................... 34
Chapter 5 GSVM-AR ....................................................................................................... 36
5.1 Association rules..................................................................................................... 36
5.2 Algorithm................................................................................................................ 37
5.3 Simulation ............................................................................................................... 38
5.3.1 Data description ............................................................................................... 38
5.3.2 Data preprocessing........................................................................................... 41
5.3.3 Modeling .......................................................................................................... 41
5.3.4 Result ............................................................................................................... 44

vii

5.4 Discussion ............................................................................................................... 49
Chapter 6 GSVM-RFEs .................................................................................................... 50
6.1 Gene selection and cancer classification on Microarray expression data............... 50
6.1.1 Biological background ..................................................................................... 50
6.1.2 Challenges for bioinformatics scientists .......................................................... 51
6.1.3 SVM for cancer classification.......................................................................... 52
6.1.4 Correlation-based feature ranking algorithms for gene selection .................... 53
6.1.5 SVM-RFE algorithm for gene selection .......................................................... 54
6.1.6 Gene Categories ............................................................................................... 57
6.1.7 New Metrics for Gene Selection Algorithms Evaluation ................................ 58
6.2 Two-stage SVM-RFE algorithm............................................................................. 60
6.2.1 Instability of SVM-RFE................................................................................... 61
6.2.2 Two-stage SVM-RFE algorithm: Different granules with different f values .. 64
6.3 Two-stage SVM-RFE simulation ........................................................................... 67
6.3.1 Data description ............................................................................................... 67
6.3.2 Data preprocessing........................................................................................... 68
6.3.3 Modeling .......................................................................................................... 68
6.3.4 Statistical Analysis on the AML/ALL dataset ................................................. 71
6.3.5 Biological Analysis on the AML/ALL dataset ................................................ 75
6.3.6 Statistical Analysis on the colon cancer dataset .............................................. 78
6.3.7 Biological Analysis on the colon cancer dataset.............................................. 80
6.3.8 Summary on two-stage SVM-RFE simulation ................................................ 82

viii

6.4 GSVM-RFE algorithm............................................................................................ 85
6.4.1 Inflexibility of current algorithms.................................................................... 85
6.4.2 Relevance Index............................................................................................... 85
6.4.3 Fuzzy C-Means clustering ............................................................................... 87
6.4.4 GSVM-RFE algorithm..................................................................................... 88
6.5 GSVM-RFE simulation .......................................................................................... 91
6.5.1 Modeling .......................................................................................................... 91
6.5.2 Data description on the prostate cancer dataset ............................................... 92
6.5.3 Statistical Analysis on the prostate cancer dataset........................................... 93
6.5.4 Biological Analysis on the prostate cancer dataset.......................................... 95
6.5.5 Statistical Analysis on the AML/ALL dataset ................................................. 95
6.5.6 Biological Analysis on the AML/ALL dataset ................................................ 97
6.6 Discussion ............................................................................................................... 98
6.6.1 Natural training/testing partition...................................................................... 98
6.6.2 Size of the final gene subsets ......................................................................... 100
6.6.3 RI pre-filtering ............................................................................................... 100
6.6.4 Number of clusters and membership of clusters............................................ 100
6.6.5 Extract gene subsets in balance...................................................................... 101
6.6.6 Selection bias ................................................................................................. 102
6.6.7 Time Complexity ........................................................................................... 103
6.7 Summary on GSVM-RFE simulation................................................................... 103
Chapter 7 GSVM-DC ..................................................................................................... 105

ix

7.1 Algorithm.............................................................................................................. 105
7.2 Simulation ............................................................................................................. 108
7.2.1 Datasets .......................................................................................................... 108
7.2.2 Metrics ........................................................................................................... 109
7.2.3 Modeling ........................................................................................................ 109
7.2.4 Results analysis on balanced datasets ............................................................ 110
7.2.5 Results analysis on imbalanced datasets........................................................ 112
7.3 Discussion ............................................................................................................. 114
Chapter 8 GSVM-RU ..................................................................................................... 115
8.1 Introduction........................................................................................................... 115
8.1.1 Class Imbalance Problem............................................................................... 115
8.1.2 Traditional Algorithms................................................................................... 116
8.1.3 SVM for Imbalanced Classification............................................................... 116
8.1.4 GSVM-RU for Imbalanced Classification..................................................... 118
8.2 GSVM-RU algorithm............................................................................................ 119
8.2.1 GSVM-RU ..................................................................................................... 119
8.2.2 Time Complexity Analysis ............................................................................ 124
8.3 Simulations on the First Group of Datasets .......................................................... 124
8.3.1 Evaluation Metric and Datasets ..................................................................... 124
8.3.2 Data Modeling ............................................................................................... 125
8.3.3 Result Analysis .............................................................................................. 126
8.4 Simulations on the KDDCUP 2004 Protein Homology Prediction Dataset ......... 132

x

8.4.1 Granular Computing and GSVM Dataset and Evaluation Metrics................ 132
8.4.2 Data Modeling ............................................................................................... 134
8.4.3 Result Analysis .............................................................................................. 135
8.4 Summary ............................................................................................................... 136
Chapter 9 Conclusions and future works ........................................................................ 138
9.1 Conclusion ............................................................................................................ 138
9.2 Long vision ........................................................................................................... 139
Bibliography ................................................................................................................... 141

xi

LIST OF FIGURES
Figure 1.1. confusion matrix

3

Figure 1.2. the area under the ROC curve

4

Figure 2.1. The perceptron discriminates the classes with a linear boundary

8

Figure 2.2. SVM with maximal margin

10

Figure 3.1. XOR classification problem

13

Figure 3.2. increase one more dimension z=xy to transfer XOR problem
to be linear separable

14

Figure 3.3. partition the whole space to two granules to transfer XOR
problem to be two smaller problems which are linear separable

14

Figure 3.4. GSVM can get better generalization by splitting the whole feature
space with x=2 and x=4. As a result, there are three SVMs for the
three information granules
Figure 5.1. GSVM-AR modeling algorithm

17
40

Figure 5.2. Performance comparison on TOP1 metric averaged on 5 trials.
The larger TOP1 is, the better the performance is. The results
are grouped by different data/kernel pairs. In each group, the
left bar shows the result of SVM, while the right GSVM-AR.
The mean and standard deviation statistics are given in the above
table. In each cell, the 1st number is the result of SVM, while the
2nd GSVM-AR.

47

xii

Figure 5.3. Performance comparison on RKL metric averaged on 5 trials.
The smaller RKL is, the better the performance is. The results
are grouped by different data/kernel pairs. In each group, the left
bar shows the result of SVM, while the right GSVM-AR. The
mean and standard deviation statistics are given in the above table.
In each cell, the 1st number is the result of SVM, while the 2nd
GSVM-AR.

47

Figure 5.4. Performance comparison on RMS metric averaged on 5 trials.
The smaller RMS is, the better the performance is. The results
are grouped by different data/kernel pairs. In each group, the
left bar shows the result of SVM, while the right GSVM-AR.
The mean and standard deviation statistics are given in the
above table. In each cell, the 1st number is the result of SVM,
while the 2nd GSVM-AR.

48

Figure 5.5. Performance comparison on APR metric averaged on 5 trials.
The larger APR is, the better the performance is. The results are
grouped by different data/kernel pairs. In each group, the left bar
shows the result of SVM, while the right GSVM-AR. The mean
and standard deviation statistics are given in the above table.
In each cell, the 1st number is the result of SVM, while the 2nd
GSVM-AR.
Figure 6.1. XOR relationship between two genes can not be grasped by a

48

xiii

correlation metric

55

Figure 6.2. the SVM-RFE algorithm

56

Figure 6.3. the two-stage SVM-RFE algorithm

65

Figure 6.4. One example to show the two-stage SVM-RFE will result
in more accurate and more stable
Figure 6.5. pseudocode of the two-stage SVM-RFE algorithm

66
69

Figure 6.6. two-stage SVM-RFE extracts most reliable gene subsets
on the AML/ALL dataset (The prediction accuracy is 100%
from 47 genes to 58 genes)

74

Figure 6.7. gene X1 is positive-related; gene X2 is negative-related;
gene X3 is both positive-related and negative-related;
gene X4 is irrelevant

86

Figure 6.8. GSVM-RFE algorithm

89

Figure 6.9. average performance comparison on the prostate cancer dataset

94

Figure 6.10. average performance comparison on the AML/ALL dataset

96

Figure 7.1. A SVM with maximal margin. Except Support Vectors, the
other samples can be safely removed
Figure 7.2. GSVM-DC algorithm

106
108

Figure 8.1. GSVM-RU can still give good cues on the orientation of the
ideal boundary while make the distance close to the ideal one.

121

Figure 8.2. GSVM-RU algorithm

121

Figure 8.3. the confusion matrix

128

xiv

Figure 8.4. a larger C value results in more Support Vectors
on the yeast dataset

129

Figure 8.5. a larger C value results in more Support Vectors
on the abalone dataset

129

Figure 8.6. a larger C value results in less Support Vectors
on the mammography dataset

129

Figure 8.7. results of different granules for the yeast dataset
with the “discard” operation averaged on the 7 runs

130

Figure 8.8. results of different granules for the abalone dataset
with the “combine” operation averaged on the 7 runs
Figure 9.1. GrC-PDM

130
139

xv

LIST OF TABLES
TABLE 4.1. characteristics of datasets used for experiments

22

TABLE 4.2. testing accuracy comparison on Wisconsin Breast Cancer
dataset without kernel mapping

23

TABLE 4.3. testing accuracy comparison on Cleveland heart-disease
dataset without kernel mapping

23

TABLE 4.4. testing accuracy comparison on BUPA Liver Disorders
dataset without kernel mapping

23

TABLE 4.5. testing accuracy comparison on Wisconsin Breast Cancer
dataset with RBF kernel mapping

24

TABLE 4.6. testing accuracy comparison on Cleveland heart-disease
dataset with RBF kernel mapping

24

TABLE 4.7. testing accuracy comparison on BUPA Liver Disorders
dataset with RBF kernel mapping

24

TABLE 4.8. testing accuracy comparison on Wisconsin Breast Cancer dataset

30

TABLE 4.9. testing accuracy comparison on Cleveland heart-disease dataset

30

TABLE 4.10. modeling time comparison on Wisconsin Breast Cancer dataset

31

TABLE 4.11. modeling time comparison on Cleveland heart-disease dataset

31

TABLE 4.12. standard deviation of testing accuracy on Wisconsin Breast
Cancer dataset with different model parameters
TABLE 4.13. standard deviation of testing accuracy on Cleveland

32

xvi

heart-disease dataset with different model parameters

32

TABLE 4.14. relationship between validation accuracy and testing accuracy
of RBF-SVM on Wisconsin Breast Cancer dataset

33

TABLE 4.15. relationship between validation accuracy and testing accuracy
of RBF-SVM on Cleveland heart-disease dataset

33

TABLE 5.1. characteristics of Kddcup04 protein homology prediction datasets

39

TABLE 5.2. 1-feature association rules on original training data
with confidence/support in 5 trials

42

TABLE 5.3. top1 on validation/test set in 5 trials (mean ± standard deviation
from best 5 blocks)

45

TABLE 5.4. rkl on validation/test set in 5 trials (mean ± standard deviation
from best 5 blocks)

46

TABLE 5.5. rms on validation/test set in 5 trials (mean ± standard deviation
from best 5 blocks)

46

TABLE 5.6. apr on validation/test set in 5 trials (mean ± standard deviation
from best 5 blocks)

46

TABLE 6.1. SVM-RFE performance on AML/ALL data by training on
38 samples and testing on 34 samples
TABLE 6.2. characteristics of datasets used for simulations

62
68

TABLE 6.3. accuracy comparison on the 7 different algorithms on the aml/all
dataset by training on 38 samples and testing on 34 samples
TABLE 6.4. area under roc curve comparison on the 7 different algorithms

71

xvii

on the aml/all dataset by training on 38 samples and testing on
34 samples

71

TABLE 6.5. accuracy of two-stage svm-rfes with different “filter-out” factors
at the second stage on the aml/all dataset by training on 38 samples
and testing on 34 samples

73

TABLE 6.6. area under roc curve of two-stage svm-rfes with different
“filter-out” factors at the second stage on the aml/all dataset
by training on 38 samples and testing on 34 samples

74

TABLE 6.7. performance of two-stage svm-rfe on aml/all dataset by
training on 38 samples and testing on 34 samples

75

TABLE 6.8. most important genes selected by two-stage svm-rfe on
aml/all data by training on 38 samples and testing on 34 samples

76

TABLE 6.9. accuracy comparison on the 7 different algorithms on the
colon cancer dataset by leave-one-out validation

79

TABLE 6.10. area under roc curve comparison on the 7 different algorithms on
the colon cancer dataset by leave-one-out validation

79

TABLE 6.11. accuracy comparison on the 7 different algorithms on
the colon cancer dataset by 100 times bootstrapping

80

TABLE 6.12. area under roc curve comparison on the 7 different algorithms
on the colon cancer dataset by 100 times bootstrapping

80

TABLE 6.13. performance of two-stage svm-rfe on colon dataset by
leave-one-out validation

81

xviii

TABLE 6.14. performance of two-stage svm-rfe on the colon cancer dataset
by 100 times bootstrapping

81

TABLE 6.15. most important genes selected by two-stage svm-rfe on colon
cancer data by leave-one-out validation

81

TABLE 6.16. testing accuracy on the prostate cancer dataset

93

TABLE 6.17. testing auc on the prostate cancer dataset

93

TABLE 6.18. testing sensitivity on the prostate cancer dataset

93

TABLE 6.19. testing specificity on the prostate cancer dataset

93

TABLE 6.20. a perfect gene subset on the prostate cancer dataset

95

TABLE 6.21. testing accuracy on the aml/all dataset

96

TABLE 6.22. testing auc on the aml/all dataset

96

TABLE 6.23. testing sensitivity on the aml/all dataset

96

TABLE 6.24. testing specificity on the aml/all dataset

96

TABLE 6.25. a perfect gene subset on the aml/all dataset

97

TABLE 6.26. unbiased performance comparison on the prostate cancer dataset

101

TABLE 6.27. unbiased performance comparison on aml/all dataset

101

TABLE 7.1. characteristics of datasets used for experiments

109

TABLE 7.2. validation/test Errors on Pima Indians Diabetes Dataset

111

TABLE 7.3. validation/test Errors on Wisconsin Breast Cancer Dataset

111

TABLE 7.4. validation/test Errors on Cleveland heart-disease Dataset

111

TABLE 7.5. validation/test Errors on Postoperative Patient Dataset

112

TABLE 7.6. validation/test g-Means on Abalone Dataset

113

xix

TABLE 7.7. time(s)/avgtrainsize g-Means on Abalone Dataset

113

TABLE 7.8. validation/test g-Means on Protein Localization Sites Dataset

113

TABLE 7.9. time(s)/avgtrainsize g-Means on Protein Localization Sites Dataset

113

TABLE 8.1. characteristics of datasets used for simulations

128

TABLE 8.2. validation/test g-means on yeast dataset
(the 7th granule, 7-6-folds double CV)

131

TABLE 8.3. validation/test g-means on abalone dataset
(the first 5 granules, 7-6-folds double CV)

131

TABLE 8.4. validation/test g-means on mammography dataset
(the first granule, 10-9-folds double CV)

131

TABLE 8.5. modeling time comparison averaged on 7 runs
between SVM and GSVM-RU
TABLE 8.6. characteristics of kddcup04 protein homology prediction datasets

134
135

TABLE 8.7. validation/test performance on kddcup04 protein homology
prediction task (153-folds CV) as of 07/19/2005

135

xx

LIST OF ACRONYMS

Granular Computing-based Predictive Data Modeling

GrC-PDM

Granular Support Vector Machines

GSVM

Granular Support Vector Machines – Association Rule

GSVM-AR

Granular Support Vector Machines – Cumulative margin Width

GSVM-CMW

Granular Support Vector Machines – Data Cleaning

GSVM-DC

Granular Support Vector Machines – Recursive Feature Elimination

GSVM-RFE

Granular Support Vector Machines – Repetitive Undersampling

GSVM-RU

1
CHAPTER 1
INTRODUCTION
Knowledge discovery and data mining is known as the science of extracting useful information
from large and complex datasets or databases. Specifically, predictive/supervised data mining is
targeted at predicting the unknown value of a variable of interest given known values of other
variables. There are two important distinct kinds of problems in predictive data mining:
classification if the unknown variable is categorical; and regression if the unknown variable is
real-valued [44]. For a classification problem, samples of different classes are accumulated, on
which a classifier is modeled to predict future samples.
How to build effective and efficient models for supervised classification problems has been a hot
research topic for a long time in data mining community and machine learning community.
Effectiveness is targeted at evaluating a model in terms of accuracy (or other metrics in different
contexts), while efficiency means to evaluate a model in terms of running time (or other metrics
in different contexts). Usually efficiency is in inverse ratio with effectiveness: To get a more
accurate classifier, a longer time is required for modeling. In many real-world applications,
effectiveness is the key to evaluate if a classifier is good or not. However, in some other
applications, due to real time requirement or due to very large size of the available dataset, a
classifier with high efficiency is usually more preferable, at the prerequisite of not deteriorating
effectiveness too much. That means a more desirable classifier in this context should run faster
but still remain high accuracy. With the emergence of life science, including bioinformatics and
computational biology, computational chemistry, medical informatics, the efficiency requirement
is even necessary.
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Besides accuracy, interpretability is another important metric to evaluate the effectiveness of a
predictive data model. With good interpretability, a predictive data model (a classifier for
classification problems) can be extended to build a decision support system to help humans to
make decisions more reliably.

1.1 Problem definitions
In this dissertation, we focus on binary classification modeling. Although binary classification is
the simplest classification problem, many works show that binary classification algorithms can
be naturally extended to solve multiple classification or regression problems. (This extension
itself is an interesting research topic and will not be covered in this dissertation.)
1.1.1 Binary classification
A general binary classification problem is defined as follows:
•

Given

l

i.i.d.

sample:

( x1 , y1 ), ( x2 , y2 ), K, ( xl , yl )

where xi ∈ R d , for i = 1,2,L, l is a feature vector of length d and yi = {+1,−1} is the class

label (+1 for the positive class, and -1 for the negative class) for data point x i ,
•

Assume the classes are mutually exclusive and exhaustive, which means every sample
has one and only one class label,

•

Find a classifier with the decision function f ( x,θ ) such that y = f ( x,θ ) , where y is the
class label for x, θ is a vector of unknown parameters in the function. These l samples are
called “training data”.

The performance of the classifier is usually measured in terms of misclassification error on
unseen “testing data” which is defined in Eq. (1.1).
⎧ 0 if y = f ( x,θ ),
E ( y, f ( x,θ )) = ⎨
otherwise
⎩ 1

(1.1)
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Based on the confusion matrix in Fig. 1.1, three metrics, named accuracy, sensitivity and
specificity, are calculated to evaluate the performance:
•

Accuracy is the fraction of correctly classified samples.

•

Sensitivity is the fraction of the real positives that actually are correctly predicted as
positives.

•

Specificity is the fraction of the samples predicted as positives that really are positives.

accuracy =

TN + TP
.
TN + FN + FP + TP

(1.2)

sensitivity =

TP
.
TP + FN

(1.3)

specificity =

TP
.
TP + FP

(1.4)

By the definitions, the combination of sensitivity and specificity can be used to evaluate a
model’s balance ability so that we know if a model is biased to a special class. Notice that the
sum of FP and FN is the number of misclassification errors on the unseen testing dataset.

real negatives

real positives

predicted
negatives

(TN) true
negatives

(FN) false
negatives

predicted
positives

(FP) false
positives

(TP) true
positives

Figure. 1.1. confusion matrix
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Recently, Area under ROC curve (AUC) has been well accepted as a better metric to evaluate a
classifier’s generalization capability [14]. AUC can indicate a model’s balance ability between
TP rate and FP rate (See Fig. 1.2) as a function of varying a classification threshold. As a result,
we know if a model is biased to a special class. An area of 1 represents a perfect classification,
while an area of 0.5 represents a worthless model.

Figure. 1.2. the area under the ROC curve

TP − rate =

TP
.
TP + FN

(1.5)

FP − rate =

FP
.
FP + TN

(1.6)

There is a traditional academic point system to roughly guide the performance evaluation on the
AUC metric:
0.9 ≤ auc ≤ 1
0.8 ≤ auc < 0.9
0.7 ≤ auc < 0.8
0.6 ≤ auc < 0.7
0.5 ≤ auc < 0.6

=
=
=
=
=

excellent
good
fair
poor
fail

(A)
(B)
(C)
(D)
(F)
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1.1.2 Binary ranking

Some binary classification problem is more natural to be modeled as a binary ranking modeling.
Protein homology prediction task is a good example. The target is to predict if a protein sequence
is homologous to another pre-specified natural protein sequence. Because of biological
complexity, it is difficult and arbitrary to say two protein sequences are absolutely homologous
or not (1 or -1 is output); an output with "confidence" may be more helpful. In this way, many
protein sequences could be ranked by their confidence to be homologous to the pre-specified
protein sequence. As a result, biologists could quickly prioritize a list of protein sequences for
further study and thus their working efficiencies can be enhanced.
A binary ranking problem is similar to a binary classification problem. The differences are
•

the output is a real number in the field of [-1,1], and

•

the absolute value of the output is useless. Intuitively, a good model should rank the
unseen positive samples (in case of protein homology prediction, they are homologous
protein sequences) close to the top and rank unseen negative samples (in case of protein
homology prediction, they are non-homologous protein sequences) close to the bottom of
the list.

1.1.3 Feature selection

Feature selection is closely related to binary classification. For a dataset with many input
features, some features may be useless or even harmful for classification. A feature may be noisy
itself, or worse, it may correlate with other features to hide real data distribution to induce
overfitting.
Suppose there are d input features in the original dataset, the target of feature selection is to
select d i informative features while removing d n non-informative features. d i > 0 , d n >= 0 ,
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d i + d n = d . The expectation is that the classifier modeled in the d i feature space has better

performance than the classifier modeled in the original feature space.

1.2 Challenges

With emergence of biomedical informatics, Web-based information retrieval, Internet
Information Security and E-business, some new challenges are coming. Among them, noise, non
i.i.d., sparseness and imbalance are four especially interesting ones and are abstract noticeable
increase of interest from more and more researchers recently due to their pervasiveness in
datasets from these application domains.
•

Non i.i.d. (independent and identically distributed). The datasets accumulated under
different contexts or even same contexts but at different time are significantly different.

•

Noise. The dataset may have many noisy samples or noisy features.

•

High dimensionality. The dataset may have a few samples but a huge number of features,
which is known as “curse of dimensionality” in the data mining community.

•

Imbalance. The dataset may have highly skewed sample distribution or highly skewed
feature distribution. That means the samples/features for one class is significantly more
than the samples/features for another class.

1.3 Organizations

The rest of this dissertation is organized as follows: In chapter 2, we discuss related works. After
that, the general idea and framework of GSVM is presented in Chapter 3. Chapters 4-8 report
five GSVM modeling algorithms, named GSVM-CMW, GSVM-AR, GSVM-RFE, GSVM-DC
and GSVM-RU, respectively, for binary classification with different characteristics. Finally, we
conclude this dissertation and direct the future work in Chapter 9.
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CHAPTER 2
RELATED WORKS

Before introducing the GSVM framework, some related works are briefly reviewed in this
chapter.
2.1 Linear classifiers

Finding the decision function f ( x,θ ) is equivalent to finding a decision boundary that
maximally discriminate two classes in the feature space. The simplest form of a boundary is just
a linear combination of the input features. This kind of classifiers is called linear classifiers. Let
us imagine a simple example with only two input features, a decision boundary of a linear
classifier is just a straight line. The boundary is generalized to be a hyperplane for higher
dimensional feature space.
The perceptron is one of the earliest examples of a linear classifier [44]. A boundary is defined
in Eq. 2.1.
d

h( x) = ∑ wi xi + b = 0 .
i =1

(2.1)

where wi , 1 ≤ i ≤ d are unknown parameters called weights; b is an unknown parameters called
bias.
If h( x) > 0 , then x is assigned class label + 1 . If h( x) < 0 , then x is assigned class label − 1 . That
means the decision function

f ( x,θ ) = sign(h( x)) .

(2.2)

where θ is ( w1 , w2 L, wd , b) .
The values of unknown parameters are estimated by examining samples in the training dataset
one by one in a way similar to gradient descent techniques. Usually the values with (possibly
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locally) minimized misclassification error on the training dataset are selected as the “optimal”
values.
Fisher presented one of the earliest forms of linear discriminant analysis for binary classification
problems [35].
C=

1
(n+1C+1 + n−1C −1) ,
n+1 + n−1

S ( w) =

w' µ +1 − w' µ −1
.
w' Cw

(2.3)

(2.4)

where n i is the number of samples which pertains to class i in the training dataset; C i is
d × d covariance matrix for class i estimated from the training dataset; µi is d × 1 mean vector

of class i estimated in the training dataset; i = {+1,−1} ; w is a 1 × d weight vector which decides
the direction of a linear classifier.
The w with largest S(w) defined in Equations 2.3-2.4 is taken as the weights of the classifier.
The b is decided by prior probabilities of two classes or by minimizing the misclassification
error. The same decision procedure as the perceptron showed in Equations 2.1-2.2 is adopted to
decide a sample’s class label.

Figure. 2.1. The perceptron discriminates the classes with a linear boundary
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2.2 Support Vector Machines

SVM is a superior classifier in that SVM embodies the Structural Risk Minimization (SRM)
principle to minimize an upper bound on the expected risk [102,30,19,28,42].
R (α ) ≤ Remp (α ) +

h(log(2l / h) + 1) − log(η / 4)
,
l

(2.5)

where
Remp (α ) =

1 l
∑ yi − f ( xi ,α ) is empirical risk,
2l i =1

(2.6)

h is non-negative integer called the Vapnik Chervonenkis (VC) dimension, η ∈ [0,1] and the

bound holds with probability 1 − η . α is the vector of unknown parameters.
Because structural risk is a reasonable trade-off between the error on the training dataset (the 1st
factor of Eq. 2.5) and the complication of modeling (the 2nd factor of Eq. 2.5), SVM has a great
ability to avoid overfitting and thus could be confidently generalized to predict new data that are
not included in the training dataset.
2.2.1 Linear SVM

Geometrically, SVM modeling algorithm works for a binary classification problem by
constructing a linear separating hyperplane with maximal margin as showed in Fig. 2.2. Finding
the optimal separating hyperplane of SVM requires the solution to a convex quadratic
programming problem, the Wolfe dual formulation of which is showed in Equations 2.7-2.9 [19].
maximize
1
LD = ∑ α i − ∑ α iα j yi y j K ( xi , x j )
i
2 i, j

subject to

(2.7)

10
0 ≤ αi ≤ C,

(2.8)

∑ α i yi = 0

(2.9)

i

Figure. 2.2. SVM with maximal margin

For a linear separable classification problem, K ( xi , x j ) = xi • x j (the inner production of two

samples). The geometry explanation is that the margin between classes could be maximized by
maximizing LD in Eq. 2.7. For linear SVM, the margin width can be calculated by the Equations
2.10-2.11.
Ns

w = ∑ α i y i xi

(2.10)

margin width = 2 / w

(2.11)

i =1

where N s is the number of support vectors.
2.2.2 Kernel methods

Kernel functions are known to be a kind of elegant dimension-increasing-based methods [19] to
transfer a linear non-separable problem into a linear separable problem. Nonlinear kernel
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functions are introduced to implicitly map input sample from input feature space into a higher
dimensional feature space, where a linear classification decision could be made. The following
are some most common nonlinear kernel functions.
Polynomial kernel

r r
r r
K ( x , y ) = (γ * ( x • y ) + θ ) d

(2.12)

RBF kernel

r r
r r
K ( x , y ) = exp(−γ || x − y ||2 )

(2.13)

Sigmoid kernel

r r
r r
K ( x , y ) = tanh(γ * ( x • y ) + θ )

(2.14)

2.3 Granular computing

Granular computing represents information in the form of some aggregates (called "information
granules") such as subsets, classes, and clusters of a universe and then solves the targeted
problem in each information granule [8,109,108]. On one hand, for a huge and complicated task,
it embodies Divide-and-Conquer principle to split the original problem into a sequence of more
manageable and smaller subtasks. On the other side, for a sequence of similar little tasks, it
comprehends the problem at hand without getting buried in all unnecessary details. As opposed
to traditional data-oriented numeric computing, granular computing is knowledge-oriented [108].
For a specific data mining task, we can embed prior knowledge or prior assumptions into the
granular computing based data modeling process to improve performance both in terms of
accuracy, efficiency and interpretability. Some formal models of information granules are:
•

Set theory and interval analysis

•

Fuzzy sets

•

Rough sets

•

Probabilistic sets

•

Decision Trees

•

Clusters
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•

Association rules

2.4 Soft computing

The basic ideas underlying soft computing in its current incarnation have links to many earlier
influences, among them Prof. Zadeh’s 1965 paper on fuzzy sets [114]; the 1973 paper on the
analysis of complex systems and decision processes [115].
The principal constituents of soft computing (SC) are fuzzy logic (FL), neural network theory
(NN) and probabilistic reasoning (PR), with the latter subsuming belief networks, evolutionary
computing including DNA computing, chaos theory and parts of learning theory. For more
detailed information and latest news on the soft computing, please refer to The Berkeley
Initiative in Soft Computing (BISC) program (http://www-bisc.cs.berkeley.edu/).
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CHAPTER 3
GRANULAR SUPPORT VECTOR MACHINES

GSVM is a hybrid model by systematically combining principles from statistical learning theory
and granular computing theory [93-100].
3.1 Motivation

Figure. 3.1. XOR classification problem

For linear non-separable classification problems, two different ideas are usually adopted to
transfer them into linear separable ones: dimension-increasing-based or partition-based
(granular-computing-based). Fig. 3.1 shows the well-known XOR problem, which is a linear
non-separable because there is not a line discriminating the two classes perfectly. Fig. 3.2 shows
that how increasing dimensionality works to address the problem: We can add the 3rd dimension
z=xy to transfer the problem to be linear separable;

The dimension-increasing idea is the foundation of kernel methods. There are two problems:
Firstly, up to now no one kernel method can guarantee to transfer a linear non-separable problem
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into a linear separable problem, even the dimensionality is increased to be infinite. Secondly, it
takes longer time to model a classifier because of increased dimensionality.

Figure. 3.2. increase one more dimension z=xy to transfer XOR problem to be linear separable

Figure. 3.3. partition the whole space to two granules to transfer XOR problem to be two
smaller problems which are linear separable
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Now let us see how to use the idea of granular computing to solve the XOR problem: If we can
somehow split the whole space by x=0 into two subspaces (granules), the resulted classification
subproblem in each granule is linear separable! And hence we can build two linear SVMs in
these two granules. This process is showed in Fig. 3.3.
This simple XOR example stimulates us to design a novel classification model named Granular
Support Vector Machines (GSVM).
3.2 GSVM Modeling

There are mainly three steps for GSVM modeling.
The first step is granulation. Many algorithms, such as Decision Trees, Association Rules, and
Clustering algorithms, can be used to split the original feature space into a sequence of
subspaces. Some other data mining techniques, including sampling, bagging, and boosting, can
be used to build a sequence of subsets from the original dataset. Besides these generic
algorithms, for a specific classification task, we even can design new granulation methods to
embed prior knowledge or prior assumptions into the granulation process. Notice that some
information granules may overlap so that some samples may appear in multiple information
granules. Also notice that one granule (the original dataset or the original feature space) is
already the optimal so that we even don’t need granulation in this special case.
In general, multiple information granules are created at the first step. After that, some classifiers
are modeled to solve sub classification problems in these granules. Here any classification
algorithms can be used. However, we adopt SVM due to its strong statistical background and
superior performance on many real world classification applications.
After that, in each information granule, we have raw data, we have a SVM classifier, and we
even can extract knowledge in the form of a few critical rules or cases. So the final step is to
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aggregate these information to build a single GSVM model. The aggregation can be executed in
different abstract levels such as data fusion, decision fusion, knowledge fusion, or hybrid
information fusion.
3.3 Comparison with SVM

SVM is inherently a contiguous model in that it uses a single contiguous hyperplane to halve the
whole feature space. Is it reasonable to always assume that the classification boundary is
contiguous? Here we argue that the boundary maybe discrete for many classification problems.
So if we can somehow correctly split the whole feature space into a set of subspaces (information
granules) and then build a SVM for some mixed ones of the subspaces, the resulting model is
expected to capture the inherent data distribution of the classification problem at hand more
accurately. Even for a contiguous classification boundary, the boundaries from suitably built
subspaces could approximate it with enough accuracy. Currently, for the discrete or other linear
non-separable classification problems, the only method is to use some kernel function to map the
data to a new feature space in which the data is expected to be linear separable. But up to now no
kernel function can guarantee the "linear separability".
SVM tries to find the optimal decision boundary by extracting important samples called Support
Vectors (SVs). However, by extracting SVs in just one granule (the whole feature space,
actually), it is prone to be affected by noisy samples or noisy features. Furthermore, whether a
sample is extracted to be a SV is highly sensitive to parameters of the SVM. As a result, some
important samples may be lost. If we can split the whole feature space into several overlapping
granules, in each of which important samples are extracted as SVs, each sample can achieve
more than one opportunity to be extracted. This way, information loss is decreased.
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GSVM is a model which systematically and formally combines the principles from statistical
learning theory, granular computing theory and soft computing theory. It works by building a
sequence of information granules and then building SVM in some of information granules on
demand.

Figure. 3.4. GSVM can get better generalization by splitting the whole feature space with
x=2 and x=4. As a result, there are three SVMs for the three information granules

Some potential advantages of GSVM are
•

GSVM can get better generalization in a linear separable classification problem.
Compared to Fig. 2.2, Fig. 3.4 shows that GSVM may improve the generalization
capability by enlarging the margin width.

•

GSVM can increase a linear non-separable problem’s "linear separability", or even
transfer a linear non-separable problem to totally linear separable as the XOR example
demonstrates. That means GSVM could be a potential alternative to kernel functions by
transferring a linear non-separable classification problem to a set of linear separable
subproblems. In fact, these two methods are not contradictory so we can combine granule
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functions and kernel functions in a GSVM to achieve better separability. One way is
mapping the data to a new feature space with some kernel function at first, and then a
GSVM is modeled in the new feature space; Another way is splitting the original feature
space into a set of information granules at first, and then using different kernel functions
to map the data in these information granules to different new feature spaces separately.
•

In many real world data mining applications, what people expect is not only to get a
model with small prediction error, but also to explain the reason why it works so well. As
we know, SVM is almost unable to provide this kind of information. However, a few
critical rules or cases can be extracted from information granules so that GSVM decision
process is similar to human understandable Rule-Based Reasoning (RBR) or Case-Based
Reasoning (CBR).

•

Compared to SVM, GSVM is more possible to grasp inherent data distribution by tradeoff between local significance of a subset of data and global correlation among different
subsets of data. And hence, GSVM is expected to be effective to improve classification
performance.

•

GSVM may speed up the modeling process by eliminating redundant data locally.
Moreover, GSVM is easy to be parallelized so that it is more efficient to be applied to
huge data classification problems, which are common in biomedical application domain.

•

Like SVM, GSVM could also be applied to multiple classification or regression problems
without or with small modifications.

However, building suitable information granules is far from a trivial task. The key is to build the
information granules somehow reasonably and effectively. Many questions need to be answered
during modeling a GSVM:
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•

Top-down or bottom-up? Begin from the whole feature space and then gradually split it
into smaller spaces (top-down)? Or begin from creating many tiny information granules
and then gradually combine them into larger spaces?

•

What is the stop condition? What time should we stop splitting or combining? How do
we know a splitting or combining will result in overfitting? From the granular computing
viewpoint, how do we know we already get optimal information granules? Notice here
maybe the original whole feature space is itself an optimal granule so we even don’t need
to split it.

•

If top-down, how to find the feature(s) the splitting hyperplane should be based on? Is it
reasonable to split a space by a hyperplane orthogonal to a single feature? Or select a
splitting hyperplane based on a group of features?

•

After selecting the splitting feature (or features), how to decide the direction and the bias
parameters of the splitting hyperplane wx + b ?

Obviously, GSVM modeling is knowledge oriented and data dependent. There are no general
answers for these questions. And hence, many different GSVM modeling algorithms are
designed for binary classification with different characteristics.
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CHAPTER 4
GSVM-CMW

This chapter proposes GSVM-CMW (cumulative margin width) algorithm for general binary
classification problems.
4.1 GSVM-CMW algorithm

GSVM-CMW is a simple but efficient modeling method for building a linear GSVM in the topdown way. The hyperplane used to split the feature space is selected by extending statistical
margin maximization principle as showed at section 2.2.1.
The margin between classes could be maximized by maximizing L D in Eq. 2.7. For linear SVM,
the margin width can be calculated by the Eq. 2.10-2.11.
Here we will find granules splitting hyperplane by extending this principle. Suppose we split the
whole feature space by the hyperplane x k = c , where x k is the kth input feature, and c ∈ R is a
constant value, and then we build two SVMs, named SVM1 and SVM2, for 2 subspaces, named
subspace1 and subspace2, respectively. For comparison, we also build a SVM called SVM0 in
the whole feature space. We define a “cumulative margin width” (CMW) as follows.
For linear SVMs, we define CMW in Eq. 4.1. The geometrical explanation is straightforward: the
hyperplane with the smallest cumulative weight is selected to be the splitting hyperplane.
CMW =

1
w1 + w2

(4.1)

where w 1 , w2 are weights calculated by Eq. 2.10 for SVM1,SVM2, respectively.
Unfortunately, for SVMs with nonlinear kernels, the margin width could not be directly
calculated in this simple way because the separating hyperplane resides in an implicit high-
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dimension feature space. Here we will define CMW in Eq. 4.2 to get sub-maximized margins
because the margin between classes could be maximized by maximizing L D in Eq. 2.7.
CMW =

l1
l
( LD1 − LD 01 ) + 2 ( LD 2 − LD 02 )
l
l

(4.2)

where l = l1 + l2 ,
l1 is the number of training data in subspace1,
l2 is the number of training data in subspace2,
LD1 is LD of SVM1 calculated by Eq. 2.7,
LD2 is LD of SVM2,

LD01 is LD of SVM0 by only counting SVs in subspace1,
LD02 is LD of SVM0 by only counting SVs in subspace2.

Now the problem to find the optimal splitting hyperplane is transformed to find the hyperplane
with largest CMW value in Eq. 4.1 for linear kernel or Eq. 4.2 for non-linear kernel. Here many
search algorithms can be candidates, for example, genetic algorithms. But for fairness of
comparison, we use grid search heuristic to find a suboptimal solution [46]. Notice here we only
search the hyperplane orthogonal to a single feature to simplify the searching process. We
equally select m constants
c1 , c2 ,L, cm ∈ ( x k _ min , x k _ max ) for each feature x k

where x k _ min is the minimum value of x k in the training

(4.3)

dataset, while x k _ max is the maximum

value.
As a result, there are altogether dm hyperplane candidates. The hyperplane with largest CMW
value will be selected as the splitting hyperplane. If there are many hyperplanes with the largest
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CMW value, the hyperplane with the largest training accuracy is selected because we can expect

the better accuracy could be generalized to new unseen data.
The above process can recursively applied to subspace1 and subspace2. Here once again for
simplicity, we apply the above process only once to halve the original whole feature space and
build one SVM for each subspace.
4.2 GSVM-CMW simulation
4.2.1 Environment

The hardware we used is a PC with P4-2.8MHz CPU and 256M memory. The software we used
is OSU SVM Classifier Matlab Toolbox [67] which implements a Matlab interface to LIBSVM
[23]. All simulations in this dissertation work are under this environment, so we will not repeat it
in the following chapters.
4.2.2 Data Sets

TABLE 4.1
CHARACTERISTICS OF DATASETS USED FOR EXPERIMENTS

Dataset
Wisconsin Breast Cancer
Cleveland heart-disease
BUPA Liver Disorders

Size
683
297
345

Attr
9
13
5

Ratio
239:444
160:137
169:176

Note 1:
Size = # of cases after removing cases with missing data, Attr =
# of input features, Ratio = # of positive cases : # of negative cases.
Note 2:
16 cases in Wisconsin Breast Cancer and 6 cases in Cleveland
heart-disease with missing values are removed.

Three public medical binary classification data from UCI data mining repository [68] are used
for comparison:
•

Wisconsin Breast Cancer dataset

•

Cleveland heart-disease dataset
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•

BUPA Liver Disorders dataset

The detailed characteristics of datasets are listed in Table 4.1.

TABLE 4.2
TESTING ACCURACY COMPARISON ON WISCONSIN BREAST CANCER
DATASET WITHOUT KERNEL MAPPING
Splitting
Testing accuracy
Testing accuracy
Trial
hyperplane of
of linear SVM
of linear GSVM
linear GSVM
1
0.9559
pc1= 0.2083
0.9780
2
0.9649
pc1= 0.2161
0.9649
3
0.9649
pc1= 0.2083
0.9868
4
0.9778
pc1= -0.2083
0.9822
5
0.9565
pc1= -0.2083
0.9739
Mean
0.9640
0.9772
Std
0.0089
0.0084

TABLE 4.3
TESTING ACCURACY COMPARISON ON CLEVELAND HEART-DISEASE
DATASET WITHOUT KERNEL MAPPING

Trial
1
2
3
4
5
Mean
Std

Testing accuracy
of linear SVM
0.8776
0.8100
0.8586
0.7959
0.8500
0.8384
0.0342

Splitting
hyperplane of
linear GSVM
pc10= -0.7093
pc1= -0.3349
pc4= -1.4573
pc10= -0.7602
pc10= -0.6992

Testing accuracy
of linear GSVM
0.8776
0.7900
0.8889
0.7857
0.8600
0.8404
0.0491

TABLE 4.4
TESTING ACCURACY COMPARISON ON BUPA LIVER DISORDERS DATASET
WITHOUT KERNEL MAPPING

Trial
1

Testing accuracy
of linear SVM
0.4897

Splitting
hyperplane of
linear GSVM
pc5= 0.0938

Testing accuracy
of linear GSVM
0.4966
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TABLE 4.5
TESTING ACCURACY COMPARISON ON WISCONSIN BREAST CANCER
DATASET WITH RBF KERNEL MAPPING
Splitting
Testing accuracy
Testing accuracy
Trial
hyperplane of
of RBF SVM
of RBF GSVM
RBF GSVM
1
0.9692
pc1= -1.1570
0.9604
2
0.9737
pc1= -1.1396
0.9605
3
0.9781
pc1= -1.1570
0.9693
4
0.9733
pc1= -1.1570
0.9733
5
0.9565
pc1= 1.1570
0.9652
Mean
0.9702
0.9657
Std
0.0083
0.0056

TABLE 4.6
TESTING ACCURACY COMPARISON ON CLEVELAND HEART-DISEASE
DATASET WITH RBF KERNEL MAPPING
Splitting
Testing accuracy
Testing accuracy
Trial
hyperplane of
of RBF SVM
of RBF GSVM
RBF GSVM
1
0.7959
pc1= -0.5223
0.8265
2
0.8200
pc1= -0.3349
0.8000
3
0.7273
pc1= -0.5277
0.8687
4
0.7551
pc1= -0.3349
0.7857
5
0.8600
pc1= -0.3411
0.8900
Mean
0.7917
0.8342
Std
0.0524
0.0444

TABLE 4.7
TESTING ACCURACY COMPARISON ON BUPA LIVER DISORDERS DATASET
WITH RBF KERNEL MAPPING
Splitting
Testing accuracy
Testing accuracy
Trial
hyperplane of
of RBF SVM
of RBF GSVM
RBF GSVM
1
pc5= -0.0353
0.6690
0.6828

4.2.3 Data Preprocessing

Firstly, we scale and normalize the input features to [-0.9, 0.9]. Out results show that the scaling
does not deteriorate the performance of classifiers but speed up the training and testing process
significantly.
Secondly, we split each dataset into training dataset and testing dataset. BUPA Liver Disorder
dataset is already split into training data and testing data, so we make just one trial on it. For
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other two datasets, we randomly split the data into training data and testing data with the
conditions in Eq. 4.4-4.6. We make five trials on each of the two datasets.
S (training ) : S (testing ) = 2 : 1 ,

(4.4)

S ( positive _ training ) : S ( positive _ testing ) = 2 : 1 ,

(4.5)

S (negative _ training ) : S (negative _ testing ) = 2 : 1 ,

(4.6)

where S ( x) means the size of the dataset x.
4.2.4 Modeling

Two models are created for performance comparison. The first one is a general SVM in the
whole space. For linear SVM, regulation parameter C ≡ 1 ; for RBF SVM, kernel parameter γ ≡ 1
and regulation parameter C ≡ 1 .
The second model is GSVM-CMW. Here we only split the whole space to two information
granules. The splitting hyperplane has the format x k = c , where x k is the 4th feature. It means we
only search the hyperplanes orthogonal to a single feature. And then two SVMs with the same
parameters as the general SVM above are built for both information granules.
4.2.5 Result

For Wisconsin Breast Cancer dataset, Table 4.2 shows that the performance of linear GSVMCMW (97.72%) is better than linear SVM (96.40%) averaged on 5 trials. And Table 4.5 shows
that the performance of RBF GSVM-CMW (96.57%) is a little worse than RBF SVM (97.02%).
The best model is linear GSVM-CMW (97.72%).
For Cleveland Heart-disease dataset, Table 4.3 shows that the performance of linear GSVMCMW (84.04%) is a little better than linear SVM (83.84%) averaged on 5 trials. And Table 4.6
shows that the performance of RBF GSVM-CMW (83.42%) is significantly better than RBF
SVM (79.17%). Once again, the best model is linear GSVM-CMW (84.04%).

26
For BUPA Liver Disorders dataset, Table 4.4 shows that the performance of linear GSVMCMW (49.66%) is a little better than linear SVM (48.97%). And Table 4.7 shows that the
performance of RBF GSVM-CMW (68.28%) is better than RBF SVM (66.90%). The best model
is RBF GSVM-CMW (68.28%).
The experiment results demonstrate, although the splitting hyperplane is limited to be orthogonal
to a single feature and the number of information granules is fixed to be two, that our GSVM
shows superior generalization capability. Except BUPA Liver Disorder dataset, standard
deviations of other two datasets show that experiment results are stable and conceivable.
However, Table 4.5 also shows that, sometimes GSVM performs a little worse than SVM. (More
specifically, Table 4.5 shows that RBF GSVM for Wisconsin Breast Cancer dataset is a little
worse than RBF SVM). One possible reason is that the modeling method proposed here is too
simplified. If we can find more appropriate criteria to search splitting hyperplanes which are not
necessary to be orthogonal to a single feature, the performance of GSVM is expected to be
improved further. Another possible reason is that two information granules may be not the
optimal ones, maybe recursively splitting the space and thus building more information granules
could improve the performance of GSVM, maybe the whole feature space is itself the optimal
one so it is even unnecessary to split it. It means the result on Table 4.5 is not contradictory to
our general GSVM idea, because it shows that just one information granule is more suitable than
two information granules in this special case. The open problem is how to get the optimal or
suboptimal information granules effectively so that the utility of GSVM modeling is not
deteriorated? The adaptive granulation may be a good direction to explore. In the future, we will
make more study and experiments on these issues.
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4.3 GSVM-CMW-PCA algorithm

Principle Component Analysis (PCA) is a classic technique to transform the d-dimensional
original input space to another d-dimensional “principle components space”, in which features
(called “principle components”) are linear combinations of original input features and are
orthogonal to each other [44]. The advantage of PCA is that the features are ranked based on the
data’s projection variance on them. The larger the projection variance is, the more useful the
feature is expected to be for discriminating the classes. That means PCA could serve as a feature
selection technique to ease a high-dimensional data classification problem.
For granular computing, what is interested is the first principle component. Because the first
principle component captures the largest projection variance in the data, it is reasonable to expect
that a partition along its orthogonal direction could be helpful to quickly find suitable
information granules.
A simple but fast modeling algorithm, named GSVM-CMW-PCA, is proposed for building a
GSVM in the top-down way. The hyperplane used to split the feature space is decided by
statistical principle component analysis and margin maximization principle. The algorithm is
similar to GSVM-CMW. The only difference is that we equally select m constants
c1 , c2 ,K, cm ∈ ( pc1_min, pc1_max) for the first principle component pc1 , where pc1_min is the

minimum value of pc1 in the training data, while pc1_max the maximum value. As a result,
there are altogether m hyperplane candidates. The hyperplane with the largest CMW value will
be selected as the splitting hyperplane. If there are more than one hyperplanes with the largest
CMW value, the hyperplane with the largest training accuracy is selected because we can expect

the better accuracy could be generalized to new unseen dataset.
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4.4 GSVM-CMW-PCA simulation
4.4.1 Data Preprocessing

Two public medical datasets from UCI data mining repository [68] listed in Table 4.1 are used
for comparison. One is Wisconsin Breast Cancer dataset; another is Cleveland heart-disease
dataset. Firstly, we scale and normalize the input features to [-0.9, 0.9]. Our preliminary results
show that the scaling does not deteriorate the performance of classifiers but speed up the training
and testing process much more.
Secondly, we make PCA for the two datasets, here we will remove all d input features and keep
all d principle components. That means the data is transferred from original d-dimensional input
feature space to d-dimensional principle component space.
Thirdly, we randomly split the data into training data and testing data with the conditions in
Equations 4.4-4.6. We make 21 trials for each dataset.
4.4.2 Modeling

Two models are created for performance comparison. The first one is building a general SVM
with RBF kernel in the whole space (called RBF-SVM). The RBF kernel parameters (γ , C ) are
optimized by grid search heuristic in the solution space defined in Equations 4.7-4.8.

γ ∈ {2-16 ,2-14 ,2-12 ,2-10 ,2-8 ,2-6 ,2-4 ,2-2 ,20 ,22 ,24 }

(4.7)

C ∈ {2-6 ,2-4 ,2-2 ,20 ,22 ,24 ,26 ,28 ,210 }

(4.8)

The best parameter pair is selected by leave-one-out cross-validation.
The second model is our linear GSVM-CMW-PCA. Here we only split the whole space to two
information granules. The splitting hyperplane has the format pc1 = c , where pc1 is the first
principle component. It means we only search the hyperplanes orthogonal to the first principle
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component. And then one linear SVM with regulation parameter C ≡ 1 is built for each
information granule.
4.4.3 Result

The first two columns in Table 4.8 and Table 4.9 show that linear GSVM-CMW-PCA is
competitive to RBF-SVM in terms of testing accuracy. For the Wisconsin Breast Cancer dataset,
the performance of linear GSVM is even better than RBF-SVM. More interestingly, as showed
in Table 4.10 and Table 4.11, the modeling time (training time plus testing time) of linear GSVM
is significantly shorter than the modeling time of RBF-SVM. The reason is that RBF-SVM need
leave-one-out cross-validation but linear GSVM’s parameter is decided by maximal CMW
calculated in Eq. 4.1. As Table 4.1 shows, the two datasets used for experiments are small-sized
(only several hundreds samples with about ten features). Thus we can expect the efficiency
difference will be more significant for a real-world classification problem with larger size.
As we know, one disadvantage of SVM with some kernel function is that it is sensitive to the
parameters. For example, if we use RBF kernel to model a SVM, slimly different values for
parameters (γ , C ) will result in significantly different testing accuracy, which is showed in the
first column of Table 4.12 and Table 4.13.
For comparison, we also tried to use grid search plus leave-one-out to optimize linear GSVM.
The regulation parameter C is selected from Eq. 4.9.
C ∈ {2 -7 ,2 -6 ,2 -5 ,2 -4 ,2 -3 ,2 -2 ,2 -1 ,2 0 ,21 ,2 2 ,2 3 ,2 4 ,2 5 ,2 6 }

(4.9)

By comparing the results in the third columns of Table 4.8 and Table 4.9 to the second columns,
we can know that linear GSVM-CMW-PCA performs almost the same with or without grid
search, that means linear GSVM-CMW-PCA is stable to the regulation parameter C. It implies
that we can replace time-consuming grid search or other search algorithms which are targeted on
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maximizing leave-one-out (or more general, k-folds cross-validation) validation accuracy with
fast PCA-based information granulation method by extending margin maximization principle.
TABLE 4.8
TESTING ACCURACY COMPARISON ON WISCONSIN BREAST CANCER DATASET

Trial

RBF-SVM

linear GSVM

0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
average

0.9649
0.9649
0.9430
0.9605
0.9561
0.9781
0.9868
0.9605
0.9474
0.9649
0.9737
0.9693
0.9737
0.9561
0.9561
0.9781
0.9605
0.9781
0.9825
0.9605
0.9559
0.9653

0.9693
0.9781
0.9649
0.9605
0.9605
0.9781
0.9825
0.9737
0.9781
0.9737
0.9825
0.9825
0.9781
0.9693
0.9649
0.9825
0.9649
0.9825
0.9781
0.9649
0.9780
0.9737

linear GSVM
after grid search
0.9693
0.9781
0.9649
0.9605
0.9605
0.9781
0.9825
0.9737
0.9781
0.9737
0.9825
0.9825
0.9781
0.9693
0.9649
0.9825
0.9649
0.9825
0.9781
0.9649
0.9692
0.9733

TABLE 4.9
TESTING ACCURACY COMPARISON ON CLEVELAND HEART-DISEASE DATASET

Trial
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
average

RBF-SVM
0.7700
0.8900
0.8800
0.8000
0.8300
0.7800
0.8800
0.8700
0.8300
0.8500
0.8200
0.8200
0.8400
0.8400
0.7900
0.8500
0.8300
0.8800
0.8000
0.8700
0.8571
0.8370

linear GSVM
0.7700
0.8400
0.8900
0.8100
0.7800
0.8400
0.8800
0.8600
0.8300
0.8300
0.8400
0.8200
0.8300
0.8500
0.8200
0.8400
0.8200
0.9000
0.8000
0.8500
0.8776
0.8370

linear GSVM
after grid search
0.7800
0.8700
0.8900
0.8000
0.7900
0.7900
0.8700
0.8200
0.8300
0.8400
0.8500
0.8200
0.8400
0.8300
0.8100
0.8500
0.8200
0.9100
0.8000
0.8600
0.8673
0.8351
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TABLE 4.10
MODELING TIME COMPARISON ON WISCONSIN BREAST CANCER DATASET

Trial
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
average

RBF-SVM (seconds)

linear GSVM (seconds)

2387
2343
2331
2399
2324
2407
2432
2410
2350
2387
2402
2431
2387
2326
2351
2418
2370
2416
2469
2381
2410
2387.2

≈1
≈1
≈1
≈1
≈1
≈1
≈1
≈1
≈1
≈1
≈1
≈1
≈1
≈1
≈1
≈1
≈1
≈1
≈1
≈1
≈1
≈1

TABLE 4.11
MODELING TIME COMPARISON ON CLEVELAND HEART-DISEASE DATASET

Trial
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
average

RBF-SVM (seconds)

linear GSVM (seconds)

495
530
530
488
490
447
466
455
440
452
436
431
443
442
435
451
447
464
442
453
461
461.8

≈1
≈1
≈1
≈1
≈1
≈1
≈1
≈1
≈1
≈1
≈1
≈1
≈1
≈1
≈1
≈1
≈1
≈1
≈1
≈1
≈1
≈1
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TABLE 4.12
STANDARD DEVIATION OF TESTING ACCURACY ON WISCONSIN BREAST CANCER DATASET WITH DIFFERENT MODEL PARAMETERS

TRIAL
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
average

RBF-SVM WITH DIFFERENT
GAMMA AND C FROM EQ. 1112
0.1324
0.1340
0.1267
0.1314
0.1274
0.1380
0.1387
0.1337
0.1278
0.1329
0.1374
0.1341
0.1337
0.1284
0.1302
0.1374
0.1307
0.1357
0.1365
0.1325
0.1317
0.1329

LINEAR GSVM WITH
DIFFERENT C FROM EQ. 13

0.0018
0.0072
0.0110
0.0040
0.0054
0.0018
0.0000
0.0061
0.0126
0.0018
0.0018
0.0011
0.0049
0.0037
0.0000
0.0015
0.0000
0.0037
0.0049
0.0000
0.0155
0.0042

TABLE 4.13
STANDARD DEVIATION OF TESTING ACCURACY ON CLEVELAND HEART-DISEASE DATASET WITH DIFFERENT MODEL PARAMETERS

Trial
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
average

RBF-SVM with different
Gamma and C from Eq. 11-12
0.1138
0.1414
0.1576
0.1254
0.1279
0.1195
0.1586
0.1336
0.1260
0.1414
0.1294
0.1308
0.1406
0.1341
0.1268
0.1474
0.1258
0.1636
0.1200
0.1451
0.1442
0.1359

linear GSVM with
different C from Eq. 13
0.0062
0.0183
0.0247
0.0074
0.0079
0.0302
0.0116
0.0107
0.0058
0.0156
0.0237
0.0051
0.0149
0.0141
0.0108
0.0151
0.0072
0.0243
0.0072
0.0131
0.0102
0.0135
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TABLE 4.14
RELATIONSHIP BETWEEN VALIDATION ACCURACY AND TESTING ACCURACY OF RBF-SVM ON WISCONSIN BREAST CANCER DATASET

Trial
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
average

HIGHEST
VALIDATION
ACCURACY

0.9758
0.9714
0.9802
0.9758
0.9802
0.9692
0.9626
0.9758
0.9780
0.9714
0.9670
0.9670
0.9692
0.9758
0.9780
0.9648
0.9780
0.9670
0.9670
0.9736
0.9737
0.9725

CORRESPONDING
TESTING
ACCURACY

0.9649
0.9649
0.9430
0.9605
0.9561
0.9781
0.9868
0.9605
0.9474
0.9649
0.9737
0.9693
0.9737
0.9561
0.9561
0.9781
0.9605
0.9781
0.9825
0.9605
0.9559
0.9653

HIGHEST TESTING
ACCURACY

0.9737
0.9825
0.9605
0.9737
0.9605
0.9825
0.9912
0.9825
0.9605
0.9737
0.9825
0.9781
0.9781
0.9649
0.9605
0.9868
0.9649
0.9825
0.9825
0.9737
0.9780
0.9749

TABLE 4.15
RELATIONSHIP BETWEEN VALIDATION ACCURACY AND TESTING ACCURACY OF RBF-SVM ON CLEVELAND HEART-DISEASE DATASET

Trial
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
average

HIGHEST
VALIDATION
ACCURACY

0.8782
0.8376
0.8223
0.8579
0.8579
0.8376
0.8173
0.8376
0.8477
0.8325
0.8528
0.8528
0.8376
0.8426
0.8477
0.8426
0.8579
0.8173
0.8629
0.8173
0.8241
0.8420

CORRESPONDING
TESTING
ACCURACY

0.7700
0.8900
0.8800
0.8000
0.8300
0.7800
0.8800
0.8700
0.8300
0.8500
0.8200
0.8200
0.8400
0.8400
0.7900
0.8500
0.8300
0.8800
0.8000
0.8700
0.8571
0.8370

HIGHEST TESTING
ACCURACY

0.8200
0.9100
0.9000
0.8300
0.8600
0.8400
0.8900
0.8700
0.8400
0.8600
0.8600
0.8500
0.8600
0.8500
0.8200
0.8700
0.8300
0.9200
0.8200
0.8800
0.8878
0.8604

As showed in Table 4.14 and Table 4.15, for RBF-SVM optimized by grid search based on
leave-one-out cross-validation, the testing accuracy is not the highest when the validation
accuracy is the highest. The phenomenon means there are some noises in the data. As a result,

34
the assumption of cross-validation, the data comes from the same implicit statistical distribution,
does not hold any more. However, linear GSVM-CMW-PCA modeling algorithm extends
maximal margin principle so that it does not need cross-validation, and thus could overcome
noise problem. That means linear GSVM-CMW-PCA is robust to the noise.
4.5 Discussion

In this chapter, we present GSVM-CMW, an implementation method for modeling a GSVM by
building information granules in the top-down way. The hyperplane used to split the feature
space is selected by extending statistical margin maximization principle. The simulation results
on three medical binary classification problems show that finding the splitting hyperplane is not
a trivial task and GSVM does show some improvement on testing accuracy compared to building
one single SVM in the whole feature space. More importantly and more interestingly, GSVM
provides a new mechanism to address complex classification problems, which are common in
medical or biological information processing applications. The modeling method for a GSVM is
just the first step into this interesting research topic. In the future, we will try to find more
appropriate modeling methods for GSVM and compare it to kernel-based SVM such as RBFSVM.
We also explore to utilize PCA technology in this chapter for fast modeling a GSVM by building
information granules in the top-down way. The hyperplane used to split the feature space is
decided by applying extended statistical margin maximization principle on the first principle
component. In this way, a GSVM could be modeled much faster while still remaining high
accuracy. The experimental results on two medical datasets show that finding the splitting
hyperplane is not a trivial task and linear GSVM is competitive to the well-known RBF kernel
with optimal parameters in terms of testing accuracy, but linear GSVM could be modeled in
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much shorter time and performs more stable (non-sensitive to parameters) and more robust (antinoise due to extended margin maximization principle). More importantly and more interestingly,
GSVM provides a new mechanism, which is competitive to kernel mapping method, to address
complex classification problems with high accuracy and high speed.
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CHAPTER 5
GSVM-AR
5.1 Association rules

Many previous works have reported that the frequent patterns occurred in the training dataset of
a complex and huge classification problem could lead to measured improvement on testing
accuracy [90,111,45]. The idea was named "association classification" [111].
For a binary classification problem with continuous features, an association rule is usually
formed as:
if a1 ∈ [v11 , v12 ] and a2 ∈ [v21 , v22 ] and ... an ∈ [vn1 , vn 2 ], then y = 1 (or - 1) (5.1)

The support and confidence of an association rule for a binary classification problem are defined
in Equations 5.2-5.3:
SUP( AR) = S PG / SW

(5.2)

COF ( AR ) = S PG / SG

(5.3)

where SW is the size of training data with the same class label as the THEN-part of the
association rule, SG is the size of training data that satisfy the IF-part, while S PG is the size of
training data correctly classified by the association rule. Notice that SW is defined in such a way
that the support and confidence of an association rule are calculated based on a single class. As a
result, the association rule mining will not be biased for major class in an unbalanced binary
classification problem.
From Eq. 5.1, an association rule (or a set of association rules combined disjunctively) could be
used to partition the feature space to find an information granule. So association rules mining is a
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possible solution for granulation. The realization of a successful "association granulation"
depends on the following two issues:
An association rule with high enough confidence could deduce a "pure" granule, in which it is
unnecessary to build a classifier because of its high purity. If its support is also high, it could
significantly simplify and speed up classification because it decreases the size of the training
dataset.
A more general association rule with a shorter IF-part should be more possible to avoid
overfitting training dataset. A short IF-part means a low model complication, which in turn
means a good generalization possibility.
5.2 Algorithm

This chapter proposes to take advantage of association rules mining for modeling a GSVM in the
top-down way. The hyperplane used to split the feature space is selected according to mined
association rules with high confidence and significant support. Confidence of a good association
rule should be as high as possible (should be at least higher than the validation accuracy of the
best SVM in the whole space), while its support can not be too small, otherwise it is not useful
(in other words, the support should be significant). Fig. 5.1 describes the GSVM-AR modeling
algorithm. The basic idea is to extend “Positive Pure Granule” (PPG) and “Negative Pure
Granule” (NPG) iteratively until GSVM-AR gets the best validation performance. If necessary,
the cross-validation method could be used. Notice the support threshold is provided as an input,
and the confidence threshold is set to be the validation accuracy of the general SVM in the whole
feature space. For each feature, at most two association rules are mined. Therefore, if the time
complexity for modeling a general SVM is O(l 2 d ) , the time complexity for modeling a GSVM
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is O(l 2 d 2 ) and dominated by the while loop to find a GSVM with the best validation
performance. Notice the time complexity of MiningOneFeatureARs is O(ld ) .
5.3 Simulation
5.3.1 Data description

Protein homology prediction between protein sequences is one of critical problems in
computational biology. Protein sequences are very difficult to understand and model due to their
complex random length nature. The sequential similarity measurement is believed to be useful to
predict the structural or functional similarity of proteins and thus it is helpful to group proteins
with similar function together. Due to this reason, it is a hot research topic for computational
biologists and computer scientists in recent years. Various algorithms have been developed to
measure the sequential similarity between two proteins [74,88]. From the viewpoint of data
mining, protein homology prediction could be viewed as a predictive data mining task [44]
because the goal is to predict the unknown value of a variable of interest given known values of
other variables. More specifically, it could be modeled as a binary classification problem. If a
protein sequence is homologous to a pre-specified protein sequence, it is classified to be a
positive case and 1 is output, otherwise it is negative and -1 is output.
KDDCUP04 protein homology prediction task at http://kodiak.cs.cornell.edu/kddcup/index.html
is used for experiment. The detailed characteristics of the dataset are listed in Table 5.1. From
the table, we can see that the task could be modeled as a binary classification or a binary ranking
problem: Given a protein sequence, the task is to predict whether it is homologous to the
corresponding native sequence or not. There are 153 native sequences in the training dataset and
150 native sequences in the testing dataset. For each native sequence, there is a block of
approximately 1000 protein sequences with class label (1 means homologous and 0 means non-
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homologous). The class labels of protein sequences in testing dataset are unknown. 74 features
are provided to describe the match (e.g. the score of a sequence alignment) between the native
protein sequence and the sequence that is tested for homology. We can also see that the problem
is highly unbalanced: there are only 1296 homologous protein sequences from altogether 145751
ones in the training dataset.
Four metrics are used for performance measures:
•

TOP1: fraction of blocks with a homologous sequence ranked top 1 (maximize)

•

RKL: average rank of the lowest ranked homologous sequence (minimize)

•

RMS: root mean squared error averaged on blocks (minimize)

•

APR: average of the average precision in each block. For a single block, APR could be
approximately described as the area of precision-recall curves. (maximize)

RMS is a metric for accuracy evaluation, but is easier to show the differences between models
than directly using error values. The other 3 metrics are rank-based, which means that the 3
metrics’ values are decided by the order of ranking list, and the absolute values of predictions do
not affect the performances. The four metrics are precisely defined in perf [20]. In our
experiment, we use the corresponding code to calculate the four metrics.

TABLE 5.1
CHARACTERISTICS OF KDDCUP04 PROTEIN HOMOLOGY PREDICTION
DATASETS

Dataset
Training
Testing

Block
153
150

Size
≈1000
≈1000

Attr

Class

74
74

2
2

Ratio
1296 / 144455
N/A

Note 1:
Block = # of blocks, Size = # of protein sequences in each
block, Attr = # of input features, Class = # of classes, Ratio = # of
homologous sequences / # of non-homologous sequences.
Note 2:
The data is without missing data.
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MiningOneFeatureARs(TrainingData T, SupportThreshold Sth, ConfidenceThreshold Cth)
{
y = the class label vector in T;
WAR = empty set;
for each input feature x
{
PR = {r | r is an association rule with the format "if x0<x<x1,then y=1", support>=Sth, and confidence >=Cth in T};
R = {r | r is the rule with the highest confidence in PR};
WAR = WAR + {r | r is the rule with the highest support in R};
NR = {r | r is an association rule with the format "if x0<x<x1,then y=-1", support>=Sth, and confidence >=Cth in T};
R = {r | r is the rule with the highest confidence in NR};
WAR = WAR + {r | r is the rule with the highest support in R};
}
return WAR;
}
GSVM-AR(TrainingData T, SupportThreshold Sth)
{
MG = WFS = the whole feature space on T;
PPG = NPG = empty set;
MG_SVM = the SVM modeled on the training data in MG optimized by grid search heuristic;
GSVM-AR = {
if a sample x in PPG, then its class label y = 1;
if a sample x in NPG, then its class label y = -1;
if a sample x in MG, then its class label y=the class label predicted by MG_SVM;
}
VP = the cross validation performance of GSVM-AR in WFS;
Cth = the cross validation accuracy of GSVM-AR in WFS;
WAR = MiningOneFeatureARs(T,Sth,Cth);
while(WAR is not empty)
{
r = the association rule in WAR such that if r is added into PPG or NPG,
the purity of PPG or NPG is the highest compared to adding any other rule in WAR;
WAR = WAR - {r};
if r is a positive rule
{
newPPG = PPG + {r};
newNPG = NPG;
}
else
{
newPPG = PPG;
newNPG = NPG + {r};
}
newMG = WFS - newPPG - newNPG;
newMG_SVM = the SVM modeled on the training data in newMG optimized by grid search heuristic;
newGSVM-AR = { if a sample x in newPPG, then its class label y = 1;
if a sample x in newNPG, then its class label y = -1;
if a sample x in newMG, then its class label y=the classlabel predicted by newMG_SVM;
}
newVP = the cross validation performance of newGSVM-AR in WFS;
if newVP is better than VP
{
PPG = newPPG;
NPG = newNPG;
MG = newMG;
GSVM-AR = newGSVM-AR;
VP = newVP;
}
}
return GSVM-AR;
}

Figure. 5.1. GSVM-AR modeling algorithm
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Because of the absent of the class label in the testing dataset, only the training dataset is used in
our experiment. And because our result is not on the original testing dataset, so it could not be
compared with the current best results on the competition. That is, our goal is not to be involved
in the competition to get the best result, but to use the data to show GSVM-AR’s superiority to
SVM.
5.3.2 Data preprocessing

Firstly, we scale and normalize the input features to [-0.9, 0.9]. The scaling is on each different
block separately. The reason is that the protein sequences in different blocks are in different
protein families, which are so remote that the similar absolute feature vectors can not mean
similar homology behaviors. However, to avoid overfitting, the association rules are mined from
non-scaled original data.
After scaling, we make five trials. In each trial, the data is randomly split into training dataset
and testing dataset with the conditions in Equations 5.4-5.6. That is, 102 blocks are used for
training and other 51 blocks used for testing.

S (training ) : S (testing ) = 2 : 1

(5.4)

S ( positive _ training ) : S ( positive _ testing ) = 2 : 1

(5.5)

S (negative _ training ) : S (negative _ testing ) = 2 : 1

(5.6)

S ( x) means the number of blocks in the dataset x.
5.3.3 Modeling

In each trial, we select just 1 block for modeling and other 101 training blocks for validation.
That is because our preliminary tests also show that it is even worse if we mix multiple blocks
together for training a model. (We also skip the details because it is out of the scope of this
chapter).
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Two models are created for performance comparison. The first one is a general SVM in the
whole space. The parameters of the SVM are optimized by grid search heuristic [46]:
In linear SVM, the regulation parameter C is optimized by grid search heuristic at Eq. 5.7.
C ∈ {2-10 ,2-9.5 ,2-9 ,2-8.5 ,2-8 ,2-7.5 ,2-7 ,2-6.5 ,
2- 6 ,2-5.5 ,2-5 , 2- 4.5 , 2- 4 ,2- 3.5 ,2- 3 ,2- 2.5 ,
-2

-1.5

-1

2 ,2 ,2 ,2

- 0.5

0

0.5

1

1.5

(5.7)

2

,2 ,2 ,2 ,2 ,2 }

The RBF kernel parameters (γ , C ) are optimized by grid search heuristic at Equations 5.8-5.9.

γ ∈ {2-26 ,2-24 ,2-22 ,2-20 ,2-18 ,2-16 ,2-14 ,2-12 ,2-10 ,2-8}

(5.8)

C ∈ {25 ,26 ,27 ,28 ,29 ,210 ,211 ,212 ,213 ,214 ,215 ,216 }

(5.9)

We repeat this modeling process for each of 102 training blocks. After that, 5 blocks with best
validation performance on a special metric are selected to build GSVM for comparison.
For GSVM-AR modeling, we mine association rules first. To avoid overfitting, the association
rules should be as simple as possible. Due to this reason, only 1-feature association rules with the
format x0<=x<x1 is mined. And only the rules with confidence higher than the general SVM’s
validation accuracy and significant support are kept as candidates.

TABLE 5.2
1-FEATURE ASSOCIATION RULES ON ORIGINAL TRAINING DATA WITH CONFIDENCE/SUPPORT IN 5 TRIALS
Rule

Trial 1

Trial 2

Trial 3

Trial 4

Trial 5

If attr5>78, then y=-1
If attr45>-4, then y=-1
If attr53<-2.06, then y=-1
If attr58<-1.53, then y=-1
If attr68<-2.21, then y=-1
If attr58>8.3, then y=1

100%/8666
100%/11642
100%/1080
100%/1714
100%/2515
99.27%/547

100%/8976
100%/11703
100%/1041
100%/1727
100%/2608
99.56%/457

100%/9141
100%/11075
100%/1060
100%/1758
100%/2610
99.35%/465

100%/8992
100%/11234
100%/987
100%/1712
100%/2404
99.42%/517

100%/8753
100%/11786
100%/1029
100%/1711
100%/2725
99.41%/510

Note:
Trial 1 (positive: negative = 879: 96055 in the training dataset).
Trial 2 (positive: negative = 909: 95911 in the training dataset).
Trial 3 (positive: negative = 810: 96139 in the training dataset).
Trial 4 (positive: negative = 886: 95580 in the training dataset).
Trial 5 (positive: negative = 919: 96892 in the training dataset).
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The mined association rules with their support and confidence are listed in Table 5.2. In the
table, the support and confidence for each rule are listed. For example, the sixth row shows a
positive association rule. In trial 1, the training dataset has 879 homologous protein sequences,
547 ones of which satisfy IF-part of the rule, and 543 ones satisfy both IF-part and THEN-part:
If attr58>8.3, then y=1 with Confidence=543/547= 99.27%,
Support= 543/879= 61.77%.
The second row shows a negative association rule. In trial 1, the training dataset has 11642
protein sequences satisfy IF-part of the rule. And all of them satisfy THEN-part too:
If attr45>-4, then y=-1 with Confidence=11642/11642=100%,
Support=11642/96055= 12.12%.
After that, we iteratively combine association rules by disjunction to find the granules that are
both pure and significant. When the process is completed, 3 granules are created: the granule
induced by negative rules is named NPG because almost all protein sequences in the granule are
non-homologous; the granule induced by positive rules is named PPG due to the similar reason;
and the remaining space is named "Mixed Granule" (MG), in which a SVM with the same kernel
as the general SVM is built. The 3 granules are decided by Equations 5.10-5.12:

PPG = U positive association rules,

(5.10)

NPG = Unegative association rules − PPG,

(5.11)

MG = WFS − PPG − NPG,

(5.12)

where WFS means the whole feature space.
Notice that the overlapping area of PPG and NPG is accounted in PPG. That means the
granulation is biased for homologous proteins to compensate for its minority.
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For the protein prediction task,
PPG is formed by
If attr58 > 8.3, then y = 1
NPG is formed by
If attr58 <= 8.3 and
(attr5 > 78 or attr45 > -4 or attr53 < -2.06 or attr58 < -1.53 or attr68 < -2.21),
Then y = -1
And then we compare two models on the top 5 blocks for the 4 metrics. For protein sequences in
the PPG and NPG, the outputs are 1s or -1s, respectively. Because SVM is originally designed
for binary classification problems, for protein sequences in MG, if a metric is rank-based, we
adopt the distance from the predicted protein sequence to the separating hyperplane (normalized
to be in [-1, 1]) as its output.
5.3.4 Result

The experimental results are reported in Tables 5.3-5.6 and Figures 5.2-5.5. In each cell of a
table, the performance of SVM is reported as the first number, while the performance of GSVMAR as the second number.
For TOP1 metric, Table 5.3 and Fig. 5.2 show that the performance of GSVM-AR is a little
better than SVM with both linear kernel (from 85.33% to 85.49% for testing data) and RBF
kernel (from 85.10% to 85.41% for testing data). For example, for testing data with linear kernel,
averagely to say, there are 51 * 85.33% = 43.52 blocks with a homologous protein sequence as
the TOP1 in the ranking list predicted by SVM, while 51 * 85.49% = 43.60 blocks by GSVMAR. The improvement is small because the protein sequences ranked as TOP1 in the lists are
easiest to be predicted. So a general SVM is good enough to predict them.
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For RKL metric, Table 5.4 and Fig. 5.3 show that GSVM-AR significantly outperform SVM.
That is, the average rank of the lowest ranked homologous sequences is decreased significantly
(from 78.02 to 71.01 for testing data with linear kernel, from 75.80 to 69.25 for testing data with
RBF kernel,). When recall is set to be 1, GSVM-AR has higher precision than SVM. As a result,
homologous sequences are clearer to be differentiated from non-homologous ones with GSVMAR than with SVM.
For RMS metric, Table 5.5 and Fig. 5.4 show that the performance of GSVM-AR is also
significantly better than SVM. That is, the average root mean squared error is decreased
significantly (from 0.0554 to 0.0441 for testing data with linear kernel, from 0.0554 to 0.0440 for
testing data with RBF kernel).

That means GSVM-AR is more accurate. For example,

approximately, for a testing block with 1000 protein sequences, 3.07 protein sequences are
misclassified by SVM with RBF kernel, while only 1.94 ones are misclassified by GSVM-AR
with RBF kernel.

TABLE 5.3
TOP1 ON VALIDATION/TEST SET IN 5 TRIALS
(MEAN ± STANDARD DEVIATION FROM BEST 5 BLOCKS)

Trial
1
2
3
4
5

Validation data with
Linear kernel (%)
91.09±0.00/91.09±0.00
85.55±0.54/85.55±0.54
86.14±0.00/86.14±0.00
87.72±0.54/87.72±0.54
90.50±0.54/90.69±0.54

Testing data with Linear
kernel (%)
78.82±2.56/79.61±2.23
90.98±1.07/90.98±1.07
89.42±1.75/89.42±1.75
85.88±3.22/85.88±3.22
81.57±1.07/81.57±1.07

Note:
Best 5 blocks in trial 1 are 210, 103, 73, 69, and 16.
Best 5 blocks in trial 2 are 170, 65, 274, 255, and 236.
Best 5 blocks in trial 3 are 210, 162, 144, 65, and 64.
Best 5 blocks in trial 4 are 170, 65, 16, 289, and 274.
Best 5 blocks in trial 5 are 73, 16, 261, 255, and 252.

Validation data with
RBF kernel (%)
91.09±0.70/91.09±0.70
85.55±0.54/85.55±0.54
86.14±0.70/86.14±0.70
87.53±0.54/87.53±0.54
90.30±0.44/90.50±0.54

Testing data with RBF
kernel (%)
78.82±2.56/79.61±2.23
90.59±1.64/90.59±1.64
89.02±1.07/89.02±1.07
85.49±4.07/85.88±3.22
81.57±1.07/81.96±0.88
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TABLE 5.4
RKL ON VALIDATION/TEST SET IN 5 TRIALS
(MEAN ± STANDARD DEVIATION FROM BEST 5 BLOCKS)

Validation data with
Linear kernel
67.69±2.38/62.63±1.48
91.33±6.01/83.73±4.45
71.39±2.99/64.80±3.33
73.53±6.81/68.05±5.82
71.64±1.71/65.60±2.31

Trial
1
2
3
4
5

Testing data with Linear
kernel
93.62±17.23/85.00±14.44
41.29±8.46/35.94±7.35
88.05±8.97/81.84±7.80
80.02±10.45/73.42±8.59
87.11±6.97/78.83±5.55

Validation data with
RBF kernel
66.88±2.48/61.79±1.61
87.60±5.97/81.16±5.08
66.34±5.15/61.17±5.05
72.42±6.15/67.27±5.33
68.91±4.20/63.70±4.02

Testing data with RBF
kernel
92.21±16.92/83.67±13.93
35.41±7.48/31.06±5.85
90.99±6.77/84.51±5.66
78.11±8.61/71.91±7.40
82.29±8.57/75.11±6.96

Note:
Best 5 blocks in trial 1 are 55, 164, 303, 135, and 266.
Best 5 blocks in trial 2 are 55, 110, 13, 69, and 73.
Best 5 blocks in trial 3 are 289, 110, 2, 164, and 69.
Best 5 blocks in trial 4 are 55, 289, 164, 25, and 65.
Best 5 blocks in trial 5 are 13, 110, 73, 164, and 16.

TABLE 5.5
RMS ON VALIDATION/TEST SET IN 5 TRIALS
(MEAN ± STANDARD DEVIATION FROM BEST 5 BLOCKS)

Trial
1
2
3
4
5

Validation data with
Linear kernel (%)
5.33±0.03/3.87±0.21
5.79±0.04/4.66±0.09
5.32±0.06/4.05±0.09
5.49±0.05/4.19±0.06
5.57±0.02/4.22±0.14

Testing data with Linear
kernel (%)
5.90±0.09/5.24±0.20
4.98±0.14/3.46±0.09
5.95±0.07/4.63±0.08
5.47±0.09/4.49±0.08
5.40±0.07/4.20±0.02

Validation data with
RBF kernel (%)
5.31±0.03/3.87±0.23
5.79±0.04/4.66±0.09
5.31±0.05/4.05±0.09
5.49±0.05/4.13±0.02
5.62±0.12/4.21±0.15

Testing data with RBF
kernel (%)
5.88±0.06/5.25±0.20
4.98±0.14/3.46±0.09
5.95±0.07/4.63±0.07
5.45±0.09/4.44±0.11
5.45±0.09/4.21±0.04

Note:
Best 5 blocks in trial 1 are 256, 103, 277, 271, and 212.
Best 5 blocks in trial 2 are 73, 48, 238, 256, and 277.
Best 5 blocks in trial 3 are 103, 212, 60, 7, and 48.
Best 5 blocks in trial 4 are 256, 231, 73, 277, and 103.
Best 5 blocks in trial 5 are 60, 16, 103, 7, and 48.
TABLE 5.6
APR ON VALIDATION/TEST SET IN 5 TRIALS
(MEAN ± STANDARD DEVIATION FROM BEST 5 BLOCKS)

Trial
1
2
3
4
5

Validation data with
Linear kernel (%)
83.30±0.47/83.53±0.57
77.61±0.24/77.77±0.21
78.39±0.86/78.68±0.87
81.45±0.36/81.66±0.45
83.39±0.44/83.63±0.45

Testing data with Linear
kernel (%)
75.78±1.23/76.38±0.86
86.19±1.22/86.47±1.20
82.92±0.84/83.01±0.85
79.39±1.36/79.72±1.41
76.03±0.55/76.28±0.56

Note:
Best 5 blocks in trial 1 are 16, 27, 73, 255, and 103.
Best 5 blocks in trial 2 are 55, 73, 163, 256, and 170.
Best 5 blocks in trial 3 are 103, 64, 60, 274, and 243.
Best 5 blocks in trial 4 are 16, 27, 73, 170, and 274.
Best 5 blocks in trial 5 are 16, 73, 163, 103, and 170.

Validation data with
RBF kernel (%)
83.28±0.52/83.49±0.60
77.52±0.26/77.77±0.15
78.36±0.88/78.60±0.89
81.41±0.45/81.63±0.54
83.31±0.65/83.56±0.68

Testing data with RBF
kernel (%)
75.94±1.37/76.51±0.96
86.06±1.12/86.34±1.13
83.08±1.08/83.14±1.09
79.08±1.78/79.38±1.85
76.16±0.53/76.42±0.59
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SVM/
GSVMAR
Mean
Std

Validation
data with
Linear
kernel (%)
88.20/88.24
2.32/2.36

Testing
data with
Linear
kernel (%)
85.33/85.49
5.07/4.84

Validation
data with
RBF kernel
(%)
88.12/88.16
2.32/2.37

Testing
data with
RBF kernel
(%)
85.10/85.41
5.00/4.60

Figure . 5.2. Performance comparison on TOP1 metric averaged on 5 trials. The larger TOP1 is, the
better the performance is. The results are grouped by different data/kernel pairs. In each group, the left
bar shows the result of SVM, while the right GSVM-AR. The mean and standard deviation statistics are
given in the above table. In each cell, the 1st number is the result of SVM, while the 2nd GSVM-AR.

SVM/
GSVMAR
Mean
Std

Validation
data with
Linear
kernel
75.12/68.96
9.42/8.48

Testing
data with
Linear
kernel
78.02/71.01
21.72/20.17

Validation
data with
RBF kernel

Testing
data with
RBF kernel

72.43/67.02
9.24/8.56

75.80/69.25
23.31/21.56

Figure. 5.3. Performance comparison on RKL metric averaged on 5 trials. The smaller RKL is, the
better the performance is. The results are grouped by different data/kernel pairs. In each group, the left
bar shows the result of SVM, while the right GSVM-AR. The mean and standard deviation statistics are
given in the above table. In each cell, the 1st number is the result of SVM, while the 2nd GSVM-AR.
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SVM/
GSVMAR
Mean
Std

Validation
data with
Linear
kernel (%)
5.50/4.20
0.18/0.29

Testing
data with
Linear
kernel (%)
5.54/4.41
0.37/0.60

Validation
data with
RBF kernel
(%)
5.50/4.18
0.19/0.30

Testing
data with
RBF kernel
(%)
5.54/4.40
0.37/0.60

Figure. 5.4. Performance comparison on RMS metric averaged on 5 trials. The smaller RMS is, the
better the performance is. The results are grouped by different data/kernel pairs. In each group, the left
bar shows the result of SVM, while the right GSVM-AR. The mean and standard deviation statistics
are given in the above table. In each cell, the 1st number is the result of SVM, while the 2nd GSVM-AR.

SVM/
GSVMAR
Mean
Std

Validation
data with
Linear
kernel (%)
80.83/81.06
2.52/2.53

Testing
data with
Linear
kernel (%)
80.06/80.37
4.22/4.12

Validation
data with
RBF kernel
(%)
80.78/81.01
2.54/2.54

Testing
data with
RBF kernel
(%)
80.07/80.36
4.20/4.09

Figure. 5.5. Performance comparison on APR metric averaged on 5 trials. The larger APR is, the
better the performance is. The results are grouped by different data/kernel pairs. In each group, the
left bar shows the result of SVM, while the right GSVM-AR. The mean and standard deviation
statistics are given in the above table. In each cell, the 1st number is the result of SVM, while the 2nd
GSVM-AR.
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For APR metric, Table 5.6 and Fig. 5.5 show that the performance of GSVM-AR is also better
than SVM with both linear kernel (from 80.06% to 80.37%) and RBF kernel (from 80.07% to
80.36%).
The standard deviations in these tables show that experiment results are stable and conceivable.
5.4 Discussion

In this chapter, we propose the GSVM-AR algorithm for modeling a GSVM by building
information granules in the top-down way with the aid of association rules. GSVM_AR works
by building three information granules, called Positive Pure Granule, Negative Pure Granule, and
Mixed Granule, respectively. Because of being generated from association rules with high
confidence and significant support, the PPG and NPG have high purity. Therefore we only need
to build a Support Vector Machine in MG.
The experimental results on KDDCUP04 protein homology prediction task show that finding the
splitting hyperplane is not a trivial task (We should be careful to select the association rules to
avoid overfitting) and GSVM-AR does show significant improvement compared to building one
single SVM in the whole feature space. Although the association rules are limited to be 1-feature
format (that means the splitting hyperplane is limited to be orthogonal to a single feature) and the
number of information granules is fixed to be three, GSVM-AR shows superior generalization
capability. Another advantage is that GSVM-AR is easy to be implemented.
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CHAPTER 6
GSVM-RFES
6.1 Gene selection and cancer classification on Microarray expression data
6.1.1 Biological background

Every organism is composed of cell(s). In each cell, there is a nucleus, where the genetic
material (DNA) is located. The coding segments of DNA, named “genes”, contain the sequence
information for specific proteins, which are macro-molecules that play the key roles on
biochemical and biological function, regulation and development of the organism. As a matter of
fact, all cells in the same organism have exactly the same genome. However, due to different
tissue types, different development stages, and different environmental conditions, genes from
cells in the same organism can be expressed in different combinations and/or different quantities
during the transcription process from DNA to messenger RNA (mRNA) and the translation
process from mRNA to proteins. These different gene expression patterns, including both the
combination and quantity, thus account for the huge variety of states and types of cells in the
same organism [89]. Different organisms have different genomes and different gene expression
patterns.
Very recently, DNA microarray (including cDNA microarray and GeneChip) has been
developed as a powerful technology for molecular genetics studies, which simultaneously
measures the mRNA expression levels of thousands to tens of thousands genes. A typical
microarray expression experiment monitors expression level of each gene multiple times under
different conditions or in different tissue types (for example, healthy tissue versus cancerous
tissue, one kind of cancerous tissue versus another cancerous tissue). By recording such huge
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gene expression data sets, it opens the possibility to distinguish tissue types and to identify
disease-related genes whose expression data are good diagnostic indicators [89,50,7,74,70,2,71].
From the viewpoint of data mining, it is a predictive data mining task [44] to distinguish
different tissue types because the goal is to predict the unknown value of a variable (healthy or
cancerous; if cancerous, which kind of cancer) of interest given known values of other variables
(gene expression data). More specifically, it could be modeled as a classification problem. For
example, one well-known problem by utilizing microarray gene expression data is to distinguish
between two variants of leukemia, which are Acute Myeloid Leukemia (AML) and Acute
Lymphoblastic Leukemia (ALL). The AML/ALL problem could be modeled as a binary
classification problem: if a sample is ALL, it is classified to be a negative case and -1 is output,
otherwise it is AML and 1 is output.
6.1.2 Challenges for bioinformatics scientists

A typical gene expression dataset is extremely sparse compared to a traditional classification
dataset: the data usually comes with only dozens of tissues/samples but with thousands or even
tens of thousands of genes/features. This extreme sparseness is believed to significantly
deteriorate the performance of a classifier. As a result, the ability to extract a subset of
informative genes while removing irrelevant or redundant genes is crucial for accurate
classification. Furthermore, it is also helpful for biologists to find the inherent cancer-resulting
mechanism and thus to develop better diagnostic methods or find better therapeutic treatments.
From the data mining viewpoint, this gene selection problem is essentially a feature selection or
dimensionality reduction problem. A good dimensionality reduction method should remove
irrelevant or redundant gene features for classification. After removing these “non-informative”
gene features, the inherent cancer-related data distribution pattern is expected to be more easily
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recognized in the lower-dimensioned feature space formed by remained informative or important
gene features. Consequently, a classifier modeled in the lower-dimension space can have better
performance on predicting new tissues.
For example, the AML/ALL leukemia dataset has only 72 samples (tissues) with 7129 features
(gene expression measurements). That means, without gene selection, we have to discriminate
and classify such a few samples in such a high dimensional space. It is unnecessary or even
harmful for classification because it is believed that no more than 10% of these 7129 genes are
relevant to Leukemia classification [41].
As a brief summary, there are two highly-correlated challenging tasks for bioinformatics
scientists:
•

Gene Subset Extraction: given some tissues, extract cancer-related genes while remove
irrelevant or redundant genes. Because genes should function in a complex nonindependent way, so it is desirable to extract cancer-related genes together as a group
than to extract them one by one.

•

Cancer Classification: given a new tissue, predict if it is healthy or not; or categorize it
into correct classes.

6.1.3 SVM for cancer classification

Based on [102], Support Vector Machine (SVM) is adopted for cancer classification in this work.
SVM is a new generation learning system based on recent advances in statistical learning theory
[19].
Due to extreme sparseness of microarray gene expression data, the dimension of input space is
already high enough so that the cancer classification is already as simple as a linear separable
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task [43]. It is unnecessary and even useless to transfer it to a higher implicit feature space with a
non-linear kernel. As a result, in this work we adopt linear SVM [19] as the cancer classifier.
SVM is believed to be a superior model for sparse classification problems compared to other
models [74,88,43]. However, the sparseness of microarray data is so extreme that even a SVM
classifier is unable to achieve a satisfactory performance. A preprocessing step for gene selection
can assist a SVM in finding a better separating hyperplane and thus to get more reliable
classification.
6.1.4 Correlation-based feature ranking algorithms for gene selection

Gene selection can be viewed as a feature selection or dimensionality reduction problem.
Currently, there are mainly two kinds of algorithms for gene selection:
Correlation-based feature ranking algorithms work in a forward selection way by ranking genes
individually in terms of a correlation-based metric, and then the top ranked genes are selected to
form the most informative gene subset [37,79,33].
Some commonly used ranking metrics are
Signal-to-Noise (S2N) [37]
wi =

µi ( + ) − µi ( −)
.
σ i ( + ) + σ i ( −)

(6.1)

Fisher Criterion [79]
( µi (+ ) − µi (−)) 2
wi =
.
σ i ( + ) 2 + σ i ( −) 2

(6.2)

T-Statistics [33]
wi =

µi ( + ) − µi ( −)
σ i (+) 2
n( + )

+

σ i ( −) 2
n( −)

.

(6.3)
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In Equations 6.1-6.3, µi (+ ) and µi (−) are the mean values of the ith gene’s expression data over
positive and negative samples in the training dataset, respectively. σ i (+) and σ i (−) are the
corresponding standard deviations. n(+) and n(−) denote the numbers of positive and negative
training samples, respectively. A larger wi means that the ith gene is more informative for cancer
classification.
Correlation-based algorithms are straightforward and work efficiently (linear time to the size of
the original gene set). However, a common drawback is that these algorithms implicitly assume
that genes are orthogonal to each other and thus can only detect relations between class labels
and a single gene. The mutual information such as redundancy or complementariness between
multiple genes is missed out. For example, suppose that a simple XOR relationship between
gene1 and gene2 is shown in Fig. 6.1:
If gene1 is expressed high and gene2 is expressed high, then the tissue maybe healthy.
If gene1 is expressed high and gene2 is expressed low, then the tissue maybe cancerous.
If gene1 is expressed low and gene2 is expressed high, then the tissue maybe cancerous.
If gene1 is expressed low and gene2 is expressed low, then the tissue maybe healthy.
However, this complementary relation cannot be grasped by a correlation metric because

µi (+) − µi (−) is zero.
6.1.5 SVM-RFE algorithm for gene selection

Backward elimination algorithms work by iteratively removing one “worst” gene at one time
until the predefined size of the final gene subset is reached. In each loop, the remained genes are
ranked again so that the relative rankings of genes are possible to be modified. Notice that
correlation-based metrics cannot work in a back elimination way because the ranking is never
modified.
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Figure. 6.1. XOR relationship between two genes can not be
grasped by a correlation metric

Recently, a backward elimination algorithm called Support Vector Machine–Recursive Feature
Elimination (SVM-RFE) algorithm was proposed and achieved notable performance
improvement [43]. In the SVM-RFE, the removed gene should change the objective function J
least.
2

J = w /2.

(6.4)

in which w is calculated by Eq. 2.10, because only linear SVM is adopted.
The Optimal Brain Damage (OBD) algorithm [57] approximates the change of J by removing the
ith gene by expanding J in Taylor series to second order
∆J (i ) =

∂2 J
∂J
(∆wi ) 2 .
∆wi +
2
∂wi
∂wi

(6.5)

At the optimum of J, the first order is neglected and the second order becomes
∆J (i ) = (∆wi ) 2 .

(6.6)
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Because removing the ith gene means ∆wi = wi , we can adopt wi as ranking criteria. The gene
2

2

with the smallest wi has the smallest effect on classification thus is removed.

SVM-RFE(T,F,f,s)
initialize
T := {training dataset}
F := {all input features}
f := filter_out_factor
s := the size of final informative gene subset
begin
while (the size of F > s)
Train linear SVM on T in the feature space defined by F
Rank the features of F by

wi

2

in the descending order

if f = -1
F2 := F - {the bottom ranked feature in F}
elseif f=0
F2 := F - {a number of features with largest ranks are
removed so that the size of F2 is the closest
smaller number of power of 2 }
else
F2 := F - {100f% of features in F with largest rank}
end
if the size of F2 < s
adjust F2 to be composed of s top ranked features in F
end
F = F2
end
return F
end

Figure. 6.2. the SVM-RFE algorithm

In practical, more than one gene could be removed in one step. Fig. 6.2 describes the SVM-RFE
algorithm in detail. The parameter f, here named “filter-out” factor, decides how many genes are
removed in one step. Notice if 0<f<1, 100f% of bottom-ranked genes are removed at each step;
if f=-1, only 1 gene is removed; if f=0, the least possible bottom-ranked genes are removed so
that the number of remained genes is the power of 2 at the 1st step and then half of genes are
removed at following steps. In each step, a new linear SVM is trained in a smaller feature space,

57
and thus each remained gene is assigned a new weight wi2 to be ranked again. This process is
repeated until the pre-defined number of features is remained.
Obviously, the SVM-RFE with f=-1 is most time-consuming. Suppose there are d genes, The
SVM-RFE with f=-1 works approximately in O(d2lgd) time for the ranking and the elimination
process (ranking dominates here), while other SVM-RFEs with larger f values work in O(dlgd)
time.
For example, suppose a subset of 8 genes is expected to be extracted from a set of 100 genes. If
f=-1, the SVM-RFE works in 92 steps by decreasing the size of gene set as
100 → 99 → 98 → L → 10 → 9 → 8 ; If f=0.5, the SVM-RFE works in 5 steps by decreasing

the size of gene set as 100 → 50 → 25 → 12 → 8 ; If f=0, the SVM-RFE works in 5 steps by
decreasing the size of gene set as 100 → 64 → 32 → 16 → 8 . Finally, the genes can be ranked
according to their elimination times: earlier elimination means lower rank.
6.1.6 Gene Categories

As what we estimated, there are four categories of genes in the original gene set:
•

Informative genes, which are really cancer-related;

•

Redundant genes, which are also cancer-related but there are some other informative
genes functioning similarly but more significantly for cancer classification;

•

Irrelevant genes, which are not cancer-related and their existence do not affect cancer
classification;

•

Noisy genes, which are not cancer-related but they have negative effects on cancer
classification.

A desirable algorithm should extract genes of the 1st category while eliminate genes of the last 3
categories. However, it is difficult to fully implement this goal. Firstly, the cancer-related factors
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are very possibly mixed with other non-cancer-related factors for classification. Secondly, some
non-cancer-related factors may even have more significant effects on classifying the training
dataset. It is actually the notorious “overfitting” problem. The thing comes even worse when the
training dataset is too small to embody the inherent real data distribution, which is common for
microarray gene expression data analysis. We believe that the noisy genes of the 4th category
play the key role to hide the inherent cancer-related distribution and to confuse a classifier.
Briefly to say, a noisy gene could have 3 kinds of negative effects on cancer diagnosis analysis:
•

A noisy gene is possible to individually contribute to discriminate the training samples by
some non-cancer-related factors so that it is ranked high.

•

A noisy gene or a group of noisy genes may be complementary to some redundant genes
so that these redundant genes are ranked higher.

•

A noisy gene or a group of noisy genes may conflict with some informative genes so that
these informative genes are ranked lower.

As a result, the inherent cancer-related distribution is blurred and the really informative genes are
possible to be eliminated.
6.1.7 New Metrics for Gene Selection Algorithms Evaluation

For microarray gene expression data analysis, it is more desirable to select the most informative
gene subset than to select a group of genes which are most informative individually. That is, a
group of top-ranked genes may not be the best gene subset. Although the SVM-RFE is better
than correlation-based methods because it avoids the orthogonality assumption, the preliminary
simulation shows that it is unstable.
This introduces the problem of designing a reasonable evaluation mechanism to compare
different gene selection algorithms. Currently, most relevant works are targeted to find a
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“perfect” gene subset that produces 0 validation/testing errors (in other words, 100% accuracy)
[71,41,43,37,79,33]. Because of easiness of cancer classification, if there are more than one
perfect gene subsets, the smallest one is claimed to be the best one. For example, if algorithm A
extracts a perfect gene subset with 10 genes and another algorithm B can only extract a perfect
gene subset with 15 genes, we will say “A is better than B”. This evaluation method is
meaningful in some sense. However, due to the small size of available samples and high
correlation among genes, the 15 genes extracted by algorithm B may be closer to uncover the
real cancer-resulting mechanism. That is, finding a smallest perfect gene subset alone cannot
justify a gene selection algorithm’s superiority compared to others. In our work, 3 performance
evaluation methods are adopted for different biological contexts.
•

The special performance, which is the performance on the final gene subset with a userdefined size. Suppose the size is 15, algorithm A is better than algorithm B if and only if
the SVM on the gene subset of 15 genes extracted by algorithm A has better performance
than the SVM on the gene subset of 15 genes extracted by algorithm B.

•

The best performance, which is the best performance taken on the final gene subsets
between two user-defined sizes, one of which is the largest size and another is the
smallest size. For example, if the largest size is 15 and the smallest size is 1, each
algorithm will produce 15 gene subsets that are recursively embedded. From these 15
gene subsets, the best one is taken for comparison. Algorithm A is better than algorithm
B if and only if the SVM on the best gene subset extracted by algorithm A has better
performance than the SVM on the best gene subset extracted by algorithm B. This is the
usually adopted method.
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•

The average performance, which is the performance averaged on the final gene subsets
between two user-defined sizes, one of which is the largest size and another is the
smallest size. Algorithm A is better than algorithm B if and only if the SVMs on the gene
subsets extracted by algorithm A has better average performance than the SVMs on the
gene subsets extracted by algorithm B.

These 3 performance evaluation methods evaluate a gene subset from different aspects. The
special performance is used to evaluate a model’s ability to find a high quality gene subset with
the pre-defined size, the average performance demonstrates effectiveness of a model on average,
while the best performance is used to select a best gene subset. We believe that these thorough
comparisons will be more suitable to evaluate the final gene subsets as a whole.
6.2 Two-stage SVM-RFE algorithm

The two-stage SVM-RFE algorithm is proposed to find more informative gene subsets for more
reliable cancer classification. It is designed to effectively eliminate most of irrelevant, redundant
and noisy genes while keeping information loss small at the first stage, and then finely select the
final key gene subset from survived genes at the second stage. Therefore, the two-stage SVMRFE can overcome the instability problem of the SVM-RFE algorithm to achieve better
algorithm utility. We have demonstrated that the two-stage SVM-RFE is an efficient algorithm
because its time complexity is O(d * log2d) where d is the size of the original gene set. More
importantly, the two-stage SVM-RFE is significantly more accurate and more reliable than other
gene selection methods on two gene expression datasets.
In the case of the AML/ALL dataset with 7129 gene features, compared to the “expected” SVMRFE (that has the “expected” performance averaged on multiple SVM-RFEs with different
“filter-out” factors), the two-stage SVM-RFE improves the special performance (accuracy from
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86.77% to 97.06% and AUC from 84.36% to 96.43%), improves the best performance (accuracy
from 96.18% to 100% and AUC from 96.00% to 100%), and improves the average performance
(accuracy from 88.87%±4.99% to 93.15%±5.52% and AUC from 86.94%±6.05% to
92.27%±6.51%). The improvement on the average performance is significant (at 1%) both on
accuracy and on AUC. Among the 50 genes identified by the two-stage algorithm, 30 of them
have been identified previously by other algorithms as tumor-related genes. Based on biological
experimental literatures, many of the 20 newly identified genes appear to be also tumor-related.
The two-stage SVM-RFE seems to be able to identify more tumor-related genes.
In the case of the colon cancer dataset with over 2000 gene features, compared to the “expected”
SVM-RFE, the two-stage SVM-RFE improves the special performance (accuracy from 89.84%
to 96.77% and AUC from 88.65% to 96.48%), improves the best performance (accuracy from
90.16% to 96.77% and AUC from 89.31% to 96.48%), and improves the average performance
(accuracy from 94.60%±6.23% to 97.13%±6.32% and AUC from 93.88%±6.96% to
96.70%±6.99%). The improvement on the average performance is significant (at 1%) both on
accuracy and on AUC. The two-stage SVM-RFE effectively discovers 18 genes; all of them have
been identified previously by other algorithms as tumor-related genes.
6.2.1 Instability of SVM-RFE

The reason of the good performance of the SVM-RFE is that it does not make the orthogonality
assumption and thus can handle multiple features simultaneously [43]. However, many previous
related research works make another implicit assumption on the SVM-RFE: a smaller “filter-out”
factor should result in a better gene subset. If only one gene is eliminated at each step, the final
gene subset should be the best one. Due to the efficiency reason, a larger “filter-out” factor is
adopted [43]. Intuitively, it looks reasonable because more steps are executed and the
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information loss in each step is smaller. However, a preliminary simulation on the AML/ALL
dataset shows that the assumption is not always correct.

TABLE 6.1
SVM-RFE PERFORMANCE ON AML/ALL DATA BY TRAINING ON 38 SAMPLES AND TESTING ON 34
SAMPLES

“filter-out” factor
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
-1
Mean
Std

Leave-one-out
validation accuracy
on 64 genes
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
0

100 times .632
bootstrapping
accuracy on 64 genes
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
1.0000
0

prediction accuracy
on 64 genes
0.9706
0.9412
0.8529
0.9706
0.9412
0.8529
0.8529
0.8235
0.9412
0.9118
0.8529
0.9011
0.0547

In Table 6.1, the first column is the value of “filter-out” factor f; the second column is leave-oneout validation accuracy on the training dataset with the gene subset of 64 top-ranked genes; the
third column is .632 bootstrapping accuracy [15] (with 100 times balanced random sampling
with replacement [27]) on the training dataset with the same gene subset; while the fourth
column is corresponding prediction accuracy on the testing dataset. The detailed simulation
context will be described in Section 6.3. The result shows that the assumption is not true in this
case. For example, the SVM-RFE with f=0.8 performs much better than the SVM-RFE with
f=0.2. Notice that the SVM-RFE with f=-1 is most time-consuming because only one gene is
removed at each step. However, its performance on the testing dataset is even worse than the
average performance of the 11 SVM-RFEs.
Furthermore, from Table 6.1, we notice that SVM-RFE is unstable because it is highly sensitive
to f: different f values result in significantly different gene subsets which in turns result in SVM
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classifiers with significantly different testing accuracies. For example, when the factor is 0.7, 0.3,
or -1, the testing accuracy is 85.29% for 64 genes; however, when the factor is 0.8, 0.5, or 0.1,
the testing accuracy is 94.12% for 64 genes. Cross-validation heuristic is usually adopted to
estimate the optimal value of the unknown parameters. However, Table 6.1 also shows that the
leave-one-out cross-validation accuracy is always 100%. Another common method for parameter
selection is bootstrapping. Again, Table 6.1 shows that the bootstrapping accuracy is also always
100%. In other words, neither leave-one-out cross-validation nor bootstrapping is useful to
predict the optimal f value. As a result, we doubt the utility of the SVM-RFE algorithm for
microarray gene expression data analysis. The instability of the SVM-RFE algorithm may induce
notorious overfitting phenomenon.
A careful exploration on the sensitivity of the SVM-RFE algorithm to f, the “filter-out” factor,
should be helpful to find a more reliable algorithm for gene selection and cancer classification.
Here “reliable” means “accurate and stable”. We believe that the negative effects of noisy genes
list in section 6.1.6 are the main reasons of the instability problem of the SVM-RFE algorithm.
With different f values, SVM-RFEs eliminate different numbers of “worst” genes at each step
and thus result in different gene compositions in the remaining gene set, which in turns result in
different ranking for remaining genes. In this gene elimination process, there are two kinds of
information loss. The first is caused by removing multiple genes at one step, while the second is
caused by wrongly ranking due to negative effects of noisy genes. Although a larger f value may
result in larger information loss of the first kind at each step, it may result in less information
loss of the second kind by eliminating more irrelevant, redundant and noisy genes so that
inherent cancer-related distribution is more possible to dominate in the following steps. With so
many irrelevant, redundant and noisy genes, typically the information loss induced by wrongly
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ranking is significantly larger than the information loss induced by larger f value. Therefore, a
larger f value may result in a better gene subset.
6.2.2 Two-stage SVM-RFE algorithm: Different granules with different f values

To solve the instability problem, one naive way is to try exhaustive search for the optimal f
value. However, it is extremely time-consuming. Furthermore, traditional parameter selection
heuristics such as cross validation or bootstrapping cannot select good f values from bad f values,
as demonstrated in the preliminary study on the AML/ALL dataset. And hence the new twostage SVM-RFE algorithm is proposed to overcome the instability problem and still remain
superior algorithm efficiency. To decrease the information loss induced by wrongly ranking, the
first stage is designed to specifically eliminate irrelevant, redundant and noisy genes while
keeping informative genes survived. In other words, the first stage can be viewed as a prefiltering process: multiple SVM-RFEs with different f values are executed to get multiple
different gene subsets which in turns are disjunctively combined into a “candidate gene set”. By
working multiple SVM-RFEs, a really informative gene is more possible to survive in at least
one SVM-RFE’s gene subset because the corresponding f value may eliminate noisy genes
before they function for ranking the informative gene lower. Based on the similar reason, if a
gene does not survive in any SVM-RFE’s gene subset, it is more possible to be redundant,
irrelevant, or noisy. If its size is properly selected, the candidate gene set by disjunctively
combining multiple gene subsets is much smaller than the original gene set and is mainly
composed of really informative genes.
After that, the information loss caused by wrongly ranking by SVM-RFE is relatively trivial. On
the other hand, the information loss caused by larger f value is relatively large. Therefore, at the
second stage, SVM-RFE with f=-1 is adopted to finely select the final key gene subset by
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eliminating just one gene at a time. In this way, a better final key gene subset can be extracted.
The framework of the two-stage SVM-RFE is given in Fig. 6.3.

Figure. 6.3. the two-stage SVM-RFE algorithm

If the f value of each “child” SVM-RFE at the first stage is between [0.1, 1), the two-stage SVMRFE works in O(n * d * log2d) time, where n is the number of SVM-RFEs at the first stage.
Usually n<<d, which means that it has the same efficiency as the correlation-based ranking
algorithms and the SVM-RFEs with f ≥ 0.1 and runs much faster than the SVM-RFE with f=-1
(O(d2 * log2d)).
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Figure. 6.4. One example to show the two-stage SVM-RFE will result in more accurate and more stable

For example, there are 5 genes named g1 , g 2 , g3 , g 4 , g5 . g 2 is redundant to g3 . g 4 is noisy and is
complementary to g 2 . The weights w12 > w22 > w32 > w42 > w52 for the SVM in the original 5dimension space. Notice here w22 > w32 because g 4 ’s complementary function on g 2 . Suppose the
goal is to find a gene subset of size 2, the best subset is {g1 , g3} but the result of the SVM-RFE
with f=0.6 is {g1 , g 2 } . However, if f=0.4, g 4 , g5 are eliminated and then a new SVM is modeled
with w12 > w32 > w22 in the 3-dimension space because of the elimination of g 4 , and thus the
correct subset can be found. That means the SVM-RFE cannot guarantee to get the best subset in
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this case. However, the two-stage SVM-RFE as showed in Fig. 6.4 can get the best result. The
motivation here is to coarsely eliminate most uninformative genes while keep informative genes
as many as possible at the 1st stage. And then the survived genes are finely filtered out to form
the final gene subset at the 2nd stage.
6.3 Two-stage SVM-RFE simulation
6.3.1 Data description

Two datasets are used for simulations. The 1st one is the AML/ALL leukemia dataset mentioned
above [58]. The training dataset consists of 38 samples (27 ALL and 11 AML) from bone
marrow specimens, while the testing dataset has 34 samples (20 ALL and 14 AML), which are
prepared under different experimental conditions and include 24 bone marrow and 10 blood
sample specimens. The 7129 features correspond to some normalized gene expression values
extracted from the microarray image: 6817 of them come from human genes and the other 312
come from control genes.
The colon cancer dataset is also used for comparison [58]. For the colon cancer dataset, there are
22 normal tissues and 40 colon cancer tissues. Gene expression information of colon cancer on
more than 6500 genes were measured using oligonucleotide microarray and 2000 of them with
highest minimum intensity were extracted to form a matrix of 62 tissues × 2000 gene expression
values. Similar to the AML/ALL dataset, some non-human genes are included for control.
Because there is no natural training/testing partition for the colon cancer dataset, all 62 samples
are used for training and the leave-one-out validation is used for model evaluation [43].
The characteristics of both datasets are listed in Table 6.2.
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TABLE 6.2
CHARACTERISTICS OF DATASETS USED FOR SIMULATIONS

Dataset

#samples

Ratio

#genes

AML/ALL
Colon cancer

72
62

47:25
40:22

7129
2000

6.3.2 Data preprocessing

The same as [41], the original datasets are simply normalized by decreasing the mean of
corresponding gene vector from each gene expression data and then dividing by the
corresponding standard deviation. As a result, each gene vector has 0 for mean and 1 for standard
deviation. To avoid overfitting, the mean and standard deviation are calculated by using the
training dataset. If leave-one-out validation or bootstrapping heuristic is used, the validation data
is kept out from calculating these two values.
For the AML/ALL dataset, natural training/testing partition is used.
Because there is no natural training/testing partition for the colon cancer dataset or the
lymphoma dataset, the leave-one-out validation is used [43]: in each fold, one sample is leaved
for validation and other samples are used for training. Another evaluation heuristic adopted is
balanced .632 bootstrapping [15]: random sampling with replacement is repeated for 100 times
on each of the two datasets. Each tissue sample appears exactly 100 times in the computation to
reduce variance [27].
6.3.3 Modeling

In the simulations, nine SVM-RFEs with f ∈ {0.1,0.2,0.3,0.4,0.5,0.6,0.7,0.8,0.9} are used at the
1st stage and one SVM-RFE with f=-1 is used at the 2nd stage. Fig. 6.5 shows the pseudocode of
the two-stage SVM-RFE used in the simulations. Notice each gene subset (G_i and G’) has the
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same size s. s=64 for the AML/ALL dataset, and s=4 for the colon cancer dataset. Gc is the
candidate gene set.
For fairness of comparison, the SVM-RFE with each f value is executed again to extract a gene
set with the same size as Gc firstly, and then f=-1 is used to extract the final gene subset.

Two-stage SVM-RFE(T,G,s)
initialize
T := {training dataset}
G := {all genes}
s := the size of final informative gene subset
begin
for i :=1 to 9 step by 1
G_i := SVM-RFE(T,G,0.1*i,s)
end
Gc := union of G_1, G_2, …, G_9
G’ := SVM-RFE(T,Gc,-1,s)
return G’
end

Figure. 6.5. pseudocode of the two-stage SVM-RFE algorithm

Seven different algorithms are compared:
•

The two-stage SVM-RFE.

•

Signal to Noise (S2N) correlation-based ranking algorithm with weights calculated by
Eq. 6.1.

•

Fisher Criterion (FC) correlation-based ranking algorithm with weights calculated by Eq.
6.2.

•

T-Statistics (TS) correlation-based ranking algorithm with weights calculated by Eq. 6.3.

•

“Default” SVM-RFE with f=0 which is suggest by [43] and is actually adopted by many
previous related works.

•

“Expected” SVM-RFE, the performance of which is the average performance of the 10
SVM-RFEs with different f values in the field of [0,0.9]. It is the expected performance
of SVM-RFE because of the instability of SVM-RFE.
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•

“Slowest” SVM-RFE with f=-1 which is the most time-consuming SVM-RFE.

For each of the seven algorithms, the special performance, the best performance and the average
performance defined are reported.
•

For the special performance, s = 64 for the AML/ALL dataset and s = 4 for the colon
cancer dataset.

•

For the best performance, 1 ≤ s ≤ 64 for the AML/ALL dataset and 1 ≤ s ≤ 4 for the
colon cancer dataset. (That is, for the AML/ALL dataset, there are 64 final gene subsets
whose sizes decrease one by one from 64 to 1, and the best performance of them is
reported. For the colon cancer dataset, there are 4 final gene subsets.)

•

For the average performance, 1 ≤ s ≤ 64 for the AML/ALL dataset and 1 ≤ s ≤ 18 for the
colon cancer dataset. (For the AML/ALL dataset, there are 64 final gene subsets; for the
colon cancer dataset, there are 18 final gene subsets. Notice here our goal to select more
than 4 gene subsets for the colon cancer dataset is to make the average performance
statistically significant.)

The selection of s value is based on the practical utilities of the extracted gene subsets: The
smallest number of genes is desirable for further biological study because it is very expensive or
even impractical for biologists to pursue cancer study on a large number of genes; On the other
hand, the prediction is not accurate/reliable if too few genes are selected. In previous research
works, the s value is usually decided arbitrarily or by a biologist. However, we notice that it is
difficult for biologists to decide such a value precisely. Instead of that, it is easier for biologists
to decide a field instead of a value. In this work, the lower-bound of the field is always assumed
to be 1. So the biologist only needs to decide the upper-bound.
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In the tables of the performance evaluation results, “Best” denotes the “Best Performance”,
“Mean” denotes the “Average Performance”, and “Std” denotes the standard deviation of the
“Average Performance”, respectively.
Furthermore, a paired t-test for one tailed hypothesis is conducted to demonstrate the
significance of the improvement by the two-stage SVM-RFE: “p-value” in the accuracy
evaluation tables denotes the significance level the null hypothesis µ x ≤ µ y can be rejected,
where x is the vector of the accuracy results of the two-stage SVM-RFE, and y is the vector of
the accuracy results of the compared algorithm.
6.3.4 Statistical Analysis on the AML/ALL dataset

TABLE 6.3
ACCURACY COMPARISON ON THE 7 DIFFERENT ALGORITHMS ON THE AML/ALL DATASET BY
TRAINING ON 38 SAMPLES AND TESTING ON 34 SAMPLES

models

64 genes

Best
(<=64)

Mean
(<=64)

Std
(<=64)

S2N correlation
FC correlation
TS correlation
“default” SVM-RFE
“expected” SVM-RFE
“slowest” SVM-RFE
two-stage SVM-RFE

0.9706
0.9118
0.9118
0.9118
0.8677
0.8529
0.9706

0.9706
0.9118
0.9118
0.9706
0.9618
0.9412
1.0000

0.9063
0.8465
0.8585
0.8980
0.8887
0.8768
0.9315

0.0425
0.0380
0.0370
0.0671
0.0499
0.0363
0.0552

p-value
by ttest
(<=64)
0.0010
<0.0001
<0.0001
0.0006
0.0019
<0.0001
N/A

TABLE 6.4
AREA UNDER ROC CURVE COMPARISON ON THE 7 DIFFERENT ALGORITHMS ON THE AML/ALL
DATASET BY TRAINING ON 38 SAMPLES AND TESTING ON 34 SAMPLES

models

64 genes

Best
(<=64)

Mean
(<=64)

Std
(<=64)

S2N correlation
FC correlation
TS correlation
“default” SVM-RFE
“expected” SVM-RFE
“slowest” SVM-RFE
two-stage SVM-RFE

0.9643
0.8929
0.8929
0.8929
0.8436
0.8214
0.9643

0.9643
0.8929
0.8929
0.9750
0.9600
0.9286
1.0000

0.8868
0.8183
0.8309
0.8798
0.8694
0.8525
0.9227

0.0504
0.0436
0.0427
0.0824
0.0605
0.0424
0.0651

p-value
by ttest
(<=64)
0.0001
<0.0001
<0.0001
0.0002
0.0043
<0.0001
N/A

72
For the AML/ALL dataset, the two-stage SVM-RFE extracts 169 genes for the candidate gene
set at the first stage, and then it continues to eliminate one gene at each step until final 64 genes
are selected at the second stage.
Both accuracy and AUC comparisons from Tables 6.3-6.4 show that
•

the two-stage SVM-RFE is more reliable than correlation-based methods. Compared to
S2N, the two-stage SVM-RFE has the same special performance (accuracy=97.06% and
AUC=96.43%), improves the best performance (accuracy from 97.06% to 100% and
AUC from 96.43% to 100%), and improves the average performance (accuracy from
90.63%±4.25% to 93.15%±5.52% and AUC from 88.68%±5.04% to 92.27%±6.51%).
The improvement on the average accuracy is significant (at 1%) both on accuracy and on
AUC.

•

the two-stage SVM-RFE is more reliable than the “default” SVM-RFE by improving the
special performance (accuracy from 91.18% to 97.06% and AUC from 89.29% to
96.43%), by improving the best performance (accuracy from 97.06% to 100% and AUC
from 97.50% to 100%), and by improving the average performance (accuracy from
89.80%±6.71% to 93.15%±5.52% and AUC from 87.98%±8.24% to 92.27%±6.51%).
The improvement on the average performance is significant (at 1%) both on accuracy and
on AUC.

•

the two-stage SVM-RFE is more reliable than the “expected” SVM-RFE by improving
the special performance (accuracy from 86.77% to 97.06% and AUC from 84.36% to
96.43%), by improving the best performance (accuracy from 96.18% to 100% and AUC
from 96.00% to 100%), and by improving the average performance (accuracy from
88.87%±4.99% to 93.15%±5.52% and AUC from 86.94%±6.05% to 92.27%±6.51%).
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The improvement on the average performance is significant (at 1%) both on accuracy and
on AUC.
•

the two-stage SVM-RFE is even more reliable than the “slowest” SVM-RFE by
improving the special performance (accuracy from 85.29% to 97.06% and AUC from
82.14% to 96.43%), by improving the best performance (accuracy from 94.12% to 100%
and AUC from 92.86% to 100%), and by improving the average performance (accuracy
from

87.68%±3.63%

to

93.15%±5.52%

and

AUC

from

85.25%±4.24%

to

92.27%±6.51%). The improvement on the average performance is significant (at 1%)
both on accuracy and on AUC. Moreover, two-stage SVM-RFE is significantly faster
than the “slowest” SVM-RFE as analyzed above.
The results also demonstrate that the two-stage SVM-RFE is the best algorithm in terms of
balance ability with the highest AUC values. The superior balance ability of the two-stage SVMRFE validates our estimation: the two-stage SVM-RFE eliminates irrelevant, redundant and
noisy genes more effectively because it extracts positive-related genes and negative-related
genes in balance. That means two-stage SVM-RFE takes advantage of the mutual information
between genes more effectively than other algorithms.

TABLE 6.5
ACCURACY OF TWO-STAGE SVM-RFES WITH DIFFERENT “FILTER-OUT” FACTORS AT
THE SECOND STAGE ON THE AML/ALL DATASET BY TRAINING ON 38 SAMPLES AND
TESTING ON 34 SAMPLES

“filter-out” factor

64
genes

Best
(<=64)

Mean
(<=64)

Std
(<=64)

-1
-2
-3
-4
-5
-6

0.9706
0.9412
0.8235
0.9412
0.9118
0.8824

1.0000
0.9412
0.9412
1.0000
0.9706
0.9706

0.9315
0.8493
0.8612
0.9283
0.8998
0.9007

0.0552
0.0575
0.0551
0.0497
0.0370
0.0394

p-value
by ttest
(<=64)
N/A
<0.0001
<0.0001
0.2789
0.0010
0.0014
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TABLE 6.6
AREA UNDER ROC CURVE OF TWO-STAGE SVM-RFES WITH DIFFERENT “FILTER-OUT”
FACTORS AT THE SECOND STAGE ON THE AML/ALL DATASET BY TRAINING ON 38
SAMPLES AND TESTING ON 34 SAMPLES

“filter-out” factor

64
genes

Best
(<=64)

Mean
(<=64)

Std
(<=64)

-1
-2
-3
-4
-5
-6

0.9643
0.9286
0.7964
0.9286
0.8929
0.8571

1.0000
0.9286
0.9393
1.0000
0.9643
0.9643

0.9227
0.8178
0.8425
0.9220
0.8824
0.8811

0.0651
0.0693
0.0684
0.0556
0.0420
0.0468

p-value
by ttest
(<=64)
N/A
<0.0001
<0.0001
0.4567
0.0005
0.0003

Figure. 6.6. two-stage SVM-RFE extracts most reliable gene subsets
on the AML/ALL dataset (The prediction accuracy is 100% from 47
genes to 58 genes)

To justify that the first stage effectively eliminates irrelevant, redundant and noisy genes, we also
try different f values at the second stage. Due to small number (169) of the candidate genes, at
the second stage, we try to remove 1-6 gene(s) at each step. Tables 6.5-6.6 show that the SVMRFE with f=-1 has the best performance. That means, for the AML/ALL dataset, the information
loss induced by large f values dominates while the information loss induced by wrongly ranking
is relatively trivial at the second stage.
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For the AML/ALL dataset, gene subsets with 64 genes to 1 gene are extracted. In Fig. 5.6, each
curve denotes the testing accuracy with different numbers of genes for an algorithm. As
demonstrated, no algorithm can find high quality gene subsets if the upper-bound is too small
and the extracted gene subsets are not reliable. With the increase of number of genes, two-stage
SVM-RFE can select better gene subsets for more reliable AML/ALL classification than other
algorithms.
6.3.5 Biological Analysis on the AML/ALL dataset

TABLE 6.7
PERFORMANCE OF TWO-STAGE SVM-RFE ON THE AML/ALL DATASET BY TRAINING ON 38 SAMPLES AND TESTING ON 34
SAMPLES

#genes
64
63
62
61
60
59
58
57
56
55
54
53
52
51
50
49
48
47
46
45
44
43

accuracy
0.9706
0.9706
1
0.9706
0.9706
0.9706
1
1
1
1
1
1
1
1
1
1
1
1
0.9706
0.9706
0.9412
0.9706

auc
0.9643
0.9643
1
0.9643
0.9643
0.9643
1
1
1
1
1
1
1
1
1
1
1
1
0.9643
0.9643
0.9393
0.9643

#genes
42
41
40
39
38
37
36
35
34
33
32
31
30
29
28
27
26
25
24
23
22
21

accuracy
0.9706
0.9118
0.9412
0.9412
0.9412
0.9412
0.9118
0.9412
0.9118
0.8529
0.8529
0.8529
0.8529
0.9118
0.9412
0.8824
0.9118
0.9118
0.9118
0.8824
0.8824
0.9118

auc
0.9643
0.9036
0.9393
0.9393
0.9393
0.9393
0.9036
0.9393
0.9036
0.8321
0.8321
0.8321
0.8321
0.9036
0.9393
0.8679
0.9036
0.9036
0.9036
0.8786
0.8786
0.9143

#genes
20
19
18
17
16
15
14
13
12
11
10
9
8
7
6
5
4
3
2
1

accuracy
0.9412
0.9118
0.9118
0.9412
0.9118
0.9412
0.9412
0.8529
0.7941
0.8235
0.8235
0.7941
0.8529
0.8824
0.9412
0.9706
0.9412
0.9412
0.8824
0.9412

auc
0.9393
0.9036
0.9036
0.9393
0.9036
0.9393
0.9393
0.8214
0.7500
0.7857
0.7857
0.7500
0.8214
0.8571
0.9286
0.9643
0.9393
0.9393
0.8679
0.9286
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TABLE 6.8
MOST IMPORTANT GENES SELECTED BY TWO-STAGE SVM-RFE ON THE AML/ALL DATASET (GENES WITH * ARE PREVIOUSLY IDENTIFIED
GENES)

rank
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17

GAN
M23197*
X85116*
X95735*
U22376*
D49950*
Y12670*
M37435
M24400*
U50136*
M55150*
M83652*
M29610*
M19507*
X06948*
X70297*
L08246*
U82759*

18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50

X16901*
M60298*
M62762*
U92459*
U63289*
U43292*
M96326*
J04621
M81933*
M86406*
X81479
M63138*
X13839*
M16038*
L49229*
M68891*
U25128*
M61853*
U21689*
M84526*
M20902*
X05409*
X04085*
D21851*
M98539*
M22960*
X55668*
J05500*
U37055*
M26708*
Y10207*
X58431*
X13294*

Description of Gene Function
Human differentiation antigen (CD33)
Integral membrane protein (Protein 7.2b)
Homo sapiens Zyxin
Human C-myb
Interferon-gamma inducing factor (IL-18)
Leptin receptor gene-related protein
macrophage-specific colony-stimulating factor (CSF-1)
Human chymotrypsinogen
Huaman leukotriene C4 synthase (LTC4S)
Human fumarylacetoacetate hydrolase
Complement omponent properdin
Glycophorin E
Myeloperoxidase
High affinity IgE receptor alpha-subunit (FcERI)
Nicotinic acetylcholine receptor alpha-7 subunit
Myeloid cell differentiation protein (MCL1)
Homeodomain protein HoxA9
RAP30 subunit of transcription initiation factor
RAP30/74
Erythrocyte membrane protein band 4.2 (EPB42)
Vacuolar H+ ATPase proton channel subunit
Metabotropic glutamate receptor 8
RNA-binding protein CUG-BP/hNab50 (NAB50)
MDS1B (MDS1)
Azurocidin
Heparan sulfate proteoglycan core protein
Cdc25A
Skeletal muscle alpha 2 actinin (ACTN20)
EMR1 hormone receptor
Cathepsin D (catD)
Vascular smooth muscle alpha-actin
Tyrosine kinase encoded by lyn mRNA
Retinoblastoma susceptibility protein (RB1)
GATA-binding protein (GATA2)
PTH2 parathyroid hormone receptor
Cytochrome P4502C18 (CYP2C18)
Glutathione S-transferase-P1c
Adipsin/complement factor D
Apolipoprotein C-I (VLDL)
Mitochondrial aldehyde dehydrogenase I
Catalase (EC 1.11.1.6) 5'flank and exon 1
Mitochondrial leucyl-tRNA synthetase
Prostaglandin D2 synthase
Protective protein
Proteinase 3
Beta-spectrin (SPTB)
Hepatocyte growth factor-like protein
Prothymosin alpha (ProT-alpha),
CD171 protein
Homeobox protein encoded by Hox2.2 gene
A-Myb

References
[41][11][55][76][101]
[41][11][55]
[41][43][11][17]
[41][11][17][65][78]
[11][17][40][32]
[41]
[105]
[41][11][17][55]
[41][11][17]
[41][11]
[6]
[11][55]
[72][54]
[11]
[41]
[41][43][17][55]
[4]
[18]
[41][11][17]
[64]
[17]
[34]
[41][11]
[17]
[52]
[41][11][55]
[118]
[41][11][17]
[22][66]
[9]
[69]
[55]
[87]
[41][11][55]
[55]
[53]
[41]
[51]
[84]
[11] [55]
[11]
[59]
[80][77]
[103]
[55]
[11]
[31]

Table 6.7 shows the testing performance in terms of accuracy and AUC on the AML/ALL
dataset for gene subsets with different sizes from 64 genes to 1 gene. Each gene subset is
achieved by removing one “worst” gene from its closest larger gene subset. Notice that from 63
genes to 62 genes or from 59 genes to 58 genes, the testing accuracy is improved. It shows
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maybe a noisy gene is removed here. Similarly, the testing accuracy is deteriorated from 62
genes to 61 genes or from 47 genes to 46 genes because maybe an informative gene is removed.
Because the testing accuracy for the AML/ALL dataset is 100% for the gene subsets from 58
genes to 47 genes selected by the two-stage SVM-RFE, here we select top 50 genes to analyze
their biological functions related to leukemia classification in Table 6.8. The “*” signed genes in
the case of AML/ALL are also identified by the other approaches in previous works, while the
other ones are newly found by the two-stage SVM-RFE.
Besides these common genes in the case of AML/ALL, many of the novel genes discovered by
the two-stage SVM-RFE have already been demonstrated in literatures that they are directly or
indirectly related with cancer. For instance, human chymotrypsinogen (Rank No. 8 in Table 6.8)
is one of protease proenzymes, which show remarkable selective effects that result in growth
inhibition of tumor cells with metastatic potential [75], glycophorin E (Rank No. 12 in Table 6.8)
is in glycophorin family, which is related to erythroid differentiation in the murine
erythroleukemia cell line [92], inactivation of the retinoblastoma gene (Rank No. 32 in Table
6.8) is a common event in parathyroid tumorigenesis [22,66], the hepatocyte growth factor-like
protein (Rank No. 46 in Table 6.8) interacts with RON [80], which is strongly expressed in renal
oncocytomas and renal cell carcinoma [77].
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6.3.6 Statistical Analysis on the colon cancer dataset

For the colon cancer dataset, the two-stage SVM-RFE extracts 18 genes for the candidate gene
set at the first stage, and then it continues to eliminate one gene at each step until final 4 genes
are selected at the second stage.
With leave-one-out validation, Tables 6.9-6.10 show that
•

the two-stage SVM-RFE is more reliable than correlation-based methods. Compared to
S2N, the two-stage SVM-RFE improves the special performance (accuracy from 85.48%
to 96.77% and AUC from 83.64% to 96.48%), improves the best performance (accuracy
from 85.48% to 96.77% and AUC from 83.64% to 96.48%), and improves the average
performance (accuracy from 86.11%±2.54% to 97.13%±6.32% and AUC from
84.06%±3.47% to 96.70%±6.99%). The improvement on the average performance is
significant (at 1%) both on accuracy and on AUC.

•

the two-stage SVM-RFE is more reliable than the “default” SVM-RFE by improving the
special performance (accuracy from 88.71% to 96.77% and AUC from 86.14% to
96.48%), by improving the best performance (accuracy from 91.94% to 96.77% and
AUC from 91.70% to 96.48%), and by improving the average performance (accuracy
from

95.07%±5.89%

to

97.13%±6.32%

and

AUC

from

94.19%±6.06%

to

96.70%±6.99%). The improvement on the average performance is significant (at 1%)
both on accuracy and on AUC.
•

the two-stage SVM-RFE is more reliable than the “expected” SVM-RFE by improving
the special performance (accuracy from 89.84% to 96.77% and AUC from 88.65% to
96.48%), by improving the best performance (accuracy from 90.16% to 96.77% and
AUC from 89.31% to 96.48%), and by improving the average performance (accuracy
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from

94.60%±6.23%

to

97.13%±6.32%

and

AUC

from

93.88%±6.96%

to

96.70%±6.99%). The improvement on the average performance is significant (at 1%)
both on accuracy and on AUC.
•

the two-stage SVM-RFE is even more reliable than the “slowest” SVM-RFE by
improving the special performance (accuracy from 95.16% to 96.77% and AUC from
95.23% to 96.48%), by improving the best performance (accuracy from 95.16% to
96.77% and AUC from 95.23% to 96.48%), and by improving the average performance
(accuracy from 96.06%±5.70% to 97.13%±6.32% and AUC from 95.86%±5.82% to
96.70%±6.99%). Although the improvement on the average performance is not
significant (p-value=0.0518 on accuracy and p-value=0.1494 on AUC), as we claimed
before, two-stage SVM-RFE is much faster than the “slowest” SVM-RFE.
TABLE 6.9
ACCURACY COMPARISON ON THE 7 DIFFERENT ALGORITHMS ON THE COLON CANCER
DATASET BY LEAVE-ONE-OUT VALIDATION

models
S2N correlation
FC correlation
TS correlation
“default” SVM-RFE
“expected” SVM-RFE
“slowest” SVM-RFE
two-stage SVM-RFE

Best
(<=4)

4 genes
0.8548
0.8226
0.7742
0.8871
0.8984
0.9516
0.9677

0.8548
0.8548
0.7903
0.9194
0.9016
0.9516
0.9677

Mean
(<=18)
0.8611
0.8611
0.8181
0.9507
0.9460
0.9606
0.9713

Std
(<=18)
0.0254
0.0266
0.0302
0.0589
0.0623
0.0570
0.0632

p-value
by ttest
(<=18)
<0.0001
<0.0001
<0.0001
0.0012
0.0076
0.0518
N/A

TABLE 6.10
AREA UNDER ROC CURVE COMPARISON ON THE 7 DIFFERENT ALGORITHMS ON THE COLON
CANCER DATASET BY LEAVE-ONE-OUT VALIDATION

models
S2N correlation
FC correlation
TS correlation
“default” SVM-RFE
“expected” SVM-RFE
“slowest” SVM-RFE
two-stage SVM-RFE

Best
(<=4)

4 genes
0.8364
0.7807
0.7841
0.8614
0.8865
0.9523
0.9648

0.8364
0.8261
0.7966
0.9170
0.8931
0.9523
0.9648

Mean
(<=18)
0.8406
0.8390
0.8130
0.9419
0.9388
0.9586
0.9670

Std
(<=18)
0.0347
0.0345
0.0253
0.0606
0.0696
0.0582
0.0699

p-value
by ttest
(<=18)
0.0000
<0.0001
<0.0001
0.0035
0.0087
0.1494
N/A

With balanced .632 bootstrapping (100 times random sampling with replacement), similar
improvement is observed in Tables 6.11-6.12.
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The same as the AML/ALL dataset, the results also demonstrate two-stage SVM-RFE is the best
model in terms of balance ability, while the gene subsets extracted by the original SVM-RFEs
are biased. We also try different f values at the second stage on the colon cancer dataset. Similar
result to the AML/ALL dataset is observed. Due to space limit, we skip to report the result here.
TABLE 6.11
ACCURACY COMPARISON ON THE 7 DIFFERENT ALGORITHMS ON THE COLON CANCER
DATASET BY 100 TIMES BOOTSTRAPPING

models
S2N correlation
FC correlation
TS correlation
“default” SVM-RFE
“expected” SVM-RFE
“slowest” SVM-RFE
two-stage SVM-RFE

4 genes
0.8447
0.8302
0.7609
0.8995
0.8849
0.9394
0.9588

Best
(<=4)
0.8513
0.8504
0.7714
0.8995
0.8869
0.9394
0.9588

Mean
(<=18)
0.8314
0.8312
0.8011
0.9236
0.9263
0.9487
0.9572

Std
(<=18)
0.0098
0.0101
0.0319
0.0574
0.0622
0.0633
0.0681

p-value
by ttest
(<=18)
<0.0001
<0.0001
<0.0001
<0.0001
0.0106
0.0706
N/A

TABLE 6.12
AREA UNDER ROC CURVE COMPARISON ON THE 7 DIFFERENT ALGORITHMS ON THE COLON
CANCER DATASET BY 100 TIMES BOOTSTRAPPING

models
S2N correlation
FC correlation
TS correlation
“default” SVM-RFE
“expected” SVM-RFE
“slowest” SVM-RFE
two-stage SVM-RFE

4 genes
0.8313
0.7944
0.7879
0.8997
0.8901
0.9461
0.9710

Best
(<=4)
0.8411
0.8187
0.7942
0.8997
0.8911
0.9461
0.9710

Mean
(<=18)
0.8325
0.8292
0.8218
0.9279
0.9326
0.9526
0.9589

Std
(<=18)
0.0193
0.0156
0.0319
0.0592
0.0683
0.0634
0.0719

p-value
by ttest
(<=18)
<0.0001
<0.0001
<0.0001
<0.0001
0.0083
0.1626
N/A

6.3.7 Biological Analysis on the colon cancer dataset

Similarly, with leave-one-out cross validation (Table 6.13) or .632 bootstrapping (Table 6.14),
top 18 genes selected by the two-stage SVM-RFE can induce highly accurate classification.
Therefore, we report them in Table 6.15 for biological analysis. All of the 18 genes have been
previously reported in bioinformatics literature as colon cancer-related genes. Gene No. 11
(myosin light chain gene) in Table 6.15 is an interesting example. Recent research has indicated
that tumor necrosis factor-induced cytoskeletal rearrangement driven by activity of myosin light
chain kinase (MLCK), which may affect expression of myosin light chain (MLC), is necessary
for tumor necrosis factor-dependent nuclear factor kappa-B activation and amplification of pro-
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survival signals [104], which may influence tumor growth. Therefore, the MLC gene seems to be
an informative gene on tumor development. Unlike the original SVM-RFE algorithm that
eliminates this gene from its top ranking [43], our algorithm ranks it top 11; this gene is also
ranked high by other approaches [11,86,38].

TABLE 6.13
PERFORMANCE OF TWO-STAGE SVM-RFE ON THE COLON CANCER DATASET BY LEAVE-ONE-OUT VALIDATION

#genes
18
17
16
15
14
13

accuracy
1
1
1
1
1
1

auc
1
1
1
1
1
1

#genes
12
11
10
9
8
7

accuracy
1
1
0.9839
1
1
1

auc
1
1
0.9773
1
1
1

#genes
6
5
4
3
2
1

accuracy
1
1
0.9677
0.9032
0.8548
0.7742

auc
1
1
0.9648
0.8739
0.8159
0.7739

TABLE 6.14
PERFORMANCE OF TWO-STAGE SVM-RFE ON THE COLON CANCER DATASET BY 100 TIMES BOOTSTRAPPING

#genes
18
17
16
15
14
13

accuracy
0.9675
0.9741
0.9807
0.9811
0.9882
0.9903

auc
0.9735
0.9794
0.9845
0.9858
0.9907
0.9928

#genes
12
11
10
9
8
7

accuracy
0.9952
0.9952
0.9864
0.9908
0.9930
0.9974

auc
0.9971
0.9971
0.9889
0.9925
0.9946
0.9978

#genes
6
5
4
3
2
1

accuracy
0.9789
0.9820
0.9588
0.8806
0.8574
0.7323

auc
0.9874
0.9889
0.9710
0.8706
0.8325
0.7346

TABLE 6.15
MOST IMPORTANT GENES SELECTED BY TWO-STAGE SVM-RFE ON THE COLON DATASET

Rank
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18

GAN
H08393
H64807
T57882
M92287
H55916
T62947
R88740
H01418
H49870
T79831
J02854
H16096
Z50753
J04102
H81558
R87126
M76378
U00968

Description of Source or Gene Function
Soares infant brain 1NIB
Alu repetitive element
Stratagene fetal spleen
Cyclin D3 (CCND3)
Peptidyl-prolyl cis-trans isomerase
Stratagene lung
ATP Synthase coupling Factor 6
Soares placenta Nb2HP
Soares adult brain N2b5HB55Y
Protein-tyrosine phosphatase
20-kDa myosin light chain (MLC-2)
Soares infant brain 1NIB
GCAP-II/uroguanylin precursor
Erythroblastosis virus oncogene homolog 2 (ets-2)
TAR1 repetitive element
Alu repetitive element
Cysteine-rich protein (CRP)
Srebp-1

Possible functions to colon cancer
[43][11][38]
[43][55][38]
[38]
[38]
[11][38]
[43][11][55][117][38]
[43][55][86][38]
[38]
[86][38]
[38]
[43][11][86][38]
[55][38]
[11][55][86][38]
[38]
[43][38]
[11][86][117][38]
[11][55][86][38]
[55][38]
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6.3.8 Summary on two-stage SVM-RFE simulation

•

the two-stage SVM-RFE is the best algorithm for gene selection compared to other 6
methods for three datasets in terms of accuracy. That means two-stage SVM-RFE is an
effective algorithm for cancer classification.

•

the two-stage SVM-RFE is the best algorithm for gene selection compared to other 6
methods for three datasets in term of AUC. That means the two-stage SVM-RFE
effectively takes advantage of the correlation among genes to select the informative gene
subset.

•

S2N algorithm performs well on the AML/ALL dataset but performs badly on the colon
cancer dataset. It means the correlations among gene expression data are more important
for the colon cancer diagnosis than for the AML/ALL diagnosis.

•

the “slowest” SVM-RFE performs well on the colon cancer dataset but performs badly on
the AML/ALL dataset. It once again shows that the SVM-RFE is an unstable algorithm.

If the f value of each “child” SVM-RFE in the 1st stage is between [0.1, 1), the two-stage SVMRFE works in O(d) time. That means it has the same efficiency as the S2N algorithm or the
SVM-RFEs with f>0.1 and runs much faster than the SVM-RFE with f=-1 (O(d2)).
The two-stage SVM-RFE algorithm has identified a subset of genes, which are consistent with
the genes (100% identical in the case of colon cancer and 60% identical in the case of
AML/ALL) discovered by other conventional algorithms. Many of the common genes are
directly or indirectly related to tumor activities. For instance in the case of AML/ALL, high-level
CD33 (differentiation antigen) activity is observed in AML[76,101], C-myb (a transcription
factor) is associated with cell apoptosis (programmed cell death; disruption of C-myb expression
can disrupt tumor growth [65,78]), and IL-18 (Interferon-gamma inducing factor, a cytokine
mainly produced by macrophages) affect T-cell activation [40,32], which can influence tumor
development.
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Previous works on the SVM-RFE assume that the smaller “filter-out” factor should result in the
better performance. If at each step only one gene is eliminated, the final gene subset should be
the best one. Only due to the efficiency reason, larger “filter-out” factor is adopted [43]. Our
work shows that the assumption is not always correct because the SVM-RFE with f=-1 (that is,
at each step only one “worst” gene is eliminated) cannot always achieve better performance than
SVM-RFE with a larger “filter-out” factor. Actually, it is even worse on the AML/ALL dataset.
As a result, selecting larger “filter-out” factor is not only due to efficiency reason, but even
necessary for effectiveness reason. Currently, the “filter-out” factor is decided arbitrarily [43,33].
Unfortunately, our work also shows that the SVM-RFE is unstable: SVM-RFEs with different
“filter-out” factors have significantly different performances. And there is no simple monotonic
relation between the “filter-out” factor and the performance because of the complex correlations
among genes. As a result, it is difficult for the original SVM-RFE to find the optimal “filter-out”
factor.
Therefore, to find a more informative gene subset for more reliable prediction, the two-stage
SVM-RFE algorithm is presented in this work. Firstly, the two-stage SVM-RFE algorithm
avoids the problem to select the optimal “filter-out” factor and thus overcome the instability
problem of the original SVM-RFE algorithm. Secondly, the two-stage SVM-RFE has the same
time complexity (linear to the size of the original gene set) as the correlation-based S2N ranking
algorithm and the original SVM-RFE algorithm (except the “slowest” SVM-RFE, which runs in
quadratic time). More importantly, the two-stage SVM-RFE performs much better in terms of
generalization capability (more accurate to predict new samples) on two publicly available gene
expression datasets. Because of the inherent advantage to discriminate informative features from
noisy or redundant features, we expect that this superior performance could also be true in
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processing other similar datasets with extreme sparseness such as Web text mining, image
pattern recognition, and other bioinformatics problems.
To the best of our knowledge, this is the 1st work to point out the instability problem of the
SVM-RFE algorithm resulted by choosing different “filter-out” factors. Similarly, we expect that
the same instability problem also exists in other RFE algorithms. This is another interesting
future work to explore, which may generalize the similar two-stage SVM-RFE algorithms in
other areas. By increasing stability and accuracy, this two-stage algorithm can predict and
classify tumor types or subtypes more precisely and it also has potential to identify more tumorrelated genes. In the case of AML/ALL, 50 genes are identified by the two-stage algorithm,
where 30 of them have been identified previously by other algorithms as tumor-related genes,
and many of the 20 newly identified genes appear also to be tumor-related. In the case of colon
cancer, this two-stage SVM-RFE effectively discovers 18 genes; all of them have been identified
previously by other algorithms as tumor-related genes.
In summary, the two-stage SVM-RFE has advantages over other conventional algorithms. Of
course, the newly identified genes by this algorithm need to be further confirmed experimentally,
which may generate more insights for cancer mechanism, treatment and study. Nevertheless, this
predication of these cancer-informative genes will help to stimulate and guide detailed studies on
the gene functions.
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6.4 GSVM-RFE algorithm
6.4.1 Inflexibility of current algorithms

Both correlation-based algorithms (S2N as an example) and backward elimination algorithms
(SVM-RFE as an example) are inflexible in that the same gene subset is always extracted in
multiple different runs. However, biologically, there may be multiple different gene subsets
which regulate cancer in different ways. As a result, the biological analysis on the single gene
subset extracted by these algorithms may loss other cancer-related information, especially when
some selection bias [3] is introduced in the gene selection process.
To extract multiple informative gene subsets for reliable cancer classification, the GSVM-RFE
algorithm is proposed.
6.4.2 Relevance Index

“Relevance Index” (RI) was used to measure the relevance of a feature to a cluster in [112] to
ease an unsupervised clustering process. Here the idea is extended as the first step of GSVMRFE. The point here is to pre-filtering some non-relevant genes to ease the following gene
selection and supervised classification. Because a gene is possible to be negatively expressed or
positively expressed, Equations 6.7-6.8 define the negative relevance index and the positive
relevance index to measure the negative correlation and the positive correlation of a gene with
the cancer being studied, respectively.
Ri − = 1 − σ i2− / σ i2 ,

(6.7)

Ri + = 1 − σ i2+ / σ i2 ,

(6.8)

where σ i2 , σ i2− , and σ i2+ are the variances of the projected values on the ith gene of the whole
training samples, the negative training samples, and the positive training samples, respectively. A
large negative relevance index value means the local variance among negative samples is small
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compared to the global variance among the whole samples. Fig. 6.7 shows an example how the
two relevance Index metric work.

Figure. 6.7. gene X1 is positive-related; gene X2 is negative-related; gene X3 is both positive-related
and negative-related; gene X4 is irrelevant

To apply RI metric for gene selection, a negative filtering threshold α − ∈ [0,1) and a positive
filtering threshold α + ∈ [0,1) need to be decided. The ith gene is “negative-related” if Ri − ≥ α −
because the projections of the negative samples are closer than the projections of the whole
samples on the ith gene. Similarly, it is “positive-related” if Ri + ≥ α + . If Ri − < α − and Ri + < α + ,
it is “non-related”. A gene may be both negative-related and positive-related. These two filtering
thresholds should be selected carefully: firstly, they can not be too large, otherwise the
information loss may happen because some cancer-related genes are wrongly eliminated;
secondly, they should be selected “in balance”, which means negative-related genes and positiverelated genes should be selected in balance, otherwise the minor genes are possible to be totally
eliminated to result in performance degradation, especially when negative-related genes are
significantly larger than positive-related genes in the original dataset or visa versa.
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6.4.3 Fuzzy C-Means clustering

RI metric alone can not extract good gene subsets. The shortcoming of RI is that it assumes the
independence between different genes. As we know, the assumption is not true for microarray
gene expression data. If the filtering thresholds are too large, many informative genes will be
wrongly eliminated.
Some genes may be similarly regulated and similarly expressed. And hence these genes may
play a similar role in cancer classification. As a result, if genes with similar expression patterns
are grouped together into clusters, a few typical genes in a cluster may be selected and other
genes in the cluster may be safely eliminated without significant loss of information. On the
other hand, an informative gene may contribute to cancer classification with complex
correlations with multiple different clusters. Therefore, after the pre-filtering by RI metric, Fuzzy
C-Means [12] is adopted to group genes into different function clusters.
The Fuzzy C-Means clustering algorithm groups genes into K clusters with centers
c1 , L ck ,L cK in the training samples space. (That is, each training sample is a dimension of the
space). Fuzzy C-Means assigns a real-valued vector U i = {µ1i ,L µ ki ,L, µ Ki } to each gene.

µ ki ∈ [0,1] is the membership value of the ith gene in the kth cluster. The larger membership value
indicates the stronger association of the gene to the cluster. Membership vector values µ ki and
cluster centers ck can be obtained by minimizing
K N

J ( K , m) = ∑ ∑ ( µ ki ) m d 2 ( xi , ck ) ,

(6.9)

d 2 ( xi , ck ) = ( xi − ck )T Ak ( xi − ck ) ,

(6.10)

k =1i =1
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K

N

k =1

i =1

∑ µ ki = 1 , 0 < ∑ µ ki < N ,

(6.11)

where 1 ≤ i ≤ N and 1 ≤ k ≤ K [12].
In Eq. 6.9, K and N are the number of clusters and the number of genes in the dataset,
respectively. m > 1 is a real-valued number which controls the ‘fuzziness’ of the resulting
clusters, µ ki is the degree of membership of the ith gene in the kth cluster, and d 2 ( xi , ck ) is the
square of distance from ith gene to the center of the kth cluster. In Eq. 6.10, Ak is a symmetric and
positive definite matrix. If Ak is the identity matrix, d 2 ( xi , ck ) corresponds to the square of the
Euclidian distance. Eq. 6.11 indicates that empty clusters are not allowed.
6.4.4 GSVM-RFE algorithm

The new GSVM-RFE algorithm is proposed in this work for more reliable gene selection. It
works in three stages. Fig. 6.8 shows a sketch of the GSVM-RFE algorithm.
At the first stage, RI metric is used to coarsely group genes into two granules: “relevant granule”
and “irrelevant granule”. The relevant granule consists of negative-related genes and positiverelated genes, while the irrelevant granule is comprised of irrelevant genes (genes with small RI+
values and small RI- values). Only genes in the relevant granule are survived for the following
stages. The assumption is that irrelevant genes are not so useful for cancer classification or even
possible to correlate other genes in some unknown complex ways to confuse Fuzzy C-Means to
get good clustering results or confuse SVMs to get good classification results. This pre-filtering
process can dramatically decrease the number of candidate genes on which Fuzzy C-Means
works. Therefore, it can improve both the efficiency and the effectiveness of the following stages
of GSVM-RFE.
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At the second stage, in each step survived genes are clustered by Fuzzy C-Means into several
“function granules”. In each function granule, a linear SVM is modeled and genes in the function
granule are ranked by their wi2 value in Eq. 6.6 in the descending order.

Figure. 6.8. GSVM-RFE algorithm
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The higher-ranked genes are selected as new survived genes, and then all survived genes in these
function granules are combined disjunctively into the next step. This process is repeated until the
number of survived genes is less than or equal to a pre-specified threshold Nmp. By using the
Fuzzy C-Means clustering algorithm, GSVM-RFE explicitly groups genes with similar
expression patterns into clusters and then the lower-ranked genes in each cluster could be safely
removed because the more significant genes with similar functions will survive. Furthermore,
due to complex correlation between genes, the similarity is by no means a “crisp” concept. Fuzzy
C-Means deals with complex correlation between genes by assigning a gene into several clusters
with different membership values. Therefore, a really informative gene achieves more than one
opportunities to survive.
At the third stage, SVM-RFE with f=0 is used to finely select the final “most informative” gene
subsets.
The filter-out factor f>0 in the second stage. As a result, GSVM-RFE is a O(d2) algorithm
because the clustering process dominates. In practice, because the pre-filtering stage by RI
metric eliminates most of genes, the expected time is much faster.
Because different runs of Fuzzy C-means generate different clusters, different runs of GSVMRFE should extract different gene subsets in general. This flexibility makes GSVM-RFE more
suitable for gene selection than traditional methods. In a gene regulation network, many different
gene subsets may regulate cancer in different ways. These multiple different gene subsets may be
more helpful for cancer study by minimizing information loss. Moreover, the genes that survive
in multiple subsets deserve higher priority for biological study.
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6.5 GSVM-RFE simulation
6.5.1 Modeling

The same as [41], the original dataset is simply normalized so that each gene vector has 0 for
mean and 1 for standard deviation. To avoid overfitting, for testing accuracy evaluation, the
mean and standard deviation are calculated on the training dataset; while for leave-one-out
validation accuracy evaluation on the training dataset, the validation sample is kept out from
calculating these two values.
The regulation parameter C ≡ 1 for the linear SVMs. For the SVM-RFE algorithm, the filter-out
factor f = 0.5 is used at the first stage to coarsely select a set of Nmp genes. At the second
stage, f = 0 is used to finely select the final “most informative” gene subsets. The performances
of the linear SVMs on the gene subsets between Nfu genes and Nfl genes are reported for
comparison.
For the Fuzzy C-Means algorithm, the “fuzziness degree” m = 1.15 , the maximal iteration
number is 100, and the minimal improvement ε = 10−5 . For the GSVM-RFE algorithm, at the
second stage, in each step survived genes are grouped into 5 clusters, in each of which one linear
SVM is modeled to select genes with the filter-out factor f = 0.5 , and then all of the 5 subsets of
survived genes are combined disjunctively into the next step.
Notice in each step, the fuzzy membership values are defuzzified in such a way that a gene is
always grouped into the cluster with the largest membership value and the cluster with the
second largest membership value. The assumption is that different gene function groups are
clustered based on their expression strengths. Some genes whose expression strengths are
between two groups may be better to be clustered into the two groups at the same time. This
way, each gene achieves two opportunities to survive at the following selection process.
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This recursive process is repeated until the number of survived genes is less than or equal to Nmp.
The third stage of GSVM-RFE is the same as the second stage of the above SVM-RFE
algorithm.
In the following, a gene subset is referred to be a “perfect” gene subset if the SVM modeled in
the gene subset space achieves 100% leave-one-out cross-validation accuracy on the training
dataset and also 100% prediction accuracy on the testing dataset.
6.5.2 Data description on the prostate cancer dataset

The first set of experiments is on the prostate cancer dataset for tumor versus normal
classification [58]. The training dataset consists of 102 prostate samples (52 with tumors and 50
without tumors); while the testing dataset has 34 samples (25 with tumors and 9 without tumors).
The two datasets are prepared under different biological experimental contexts. There is a nearly
10-fold difference in overall microarray intensity between them [58]. The 12600 features
correspond to some normalized gene expression values extracted from the microarray image.
Here negatives are defined to be the normal prostate samples without tumor, while positives are
the tumor samples. The genes distribution in the prostate cancer dataset is highly imbalanced
between negative-related genes and positive-related genes. If α + = α − = 0.5 , 4761 positiverelated genes and only 110 negative-related genes are survived. To alleviate the imbalance,

α + = 0.75 and α − = 0.5 are used to select 721 positive-related genes and 110 negative-related
genes. There is no overlapping between positive-related genes and negative-related genes. At the
following stages, Nmp=64, Nfu=10, Nfl=1.
We run GSVM-RFE 20 times. For each run, 10 stratified gene subsets are extracted with 10, 9,
…, 1 gene(s). The testing accuracies of the linear SVMs on the 10 gene subsets are recorded. The
highest one is called “best accuracy” and the mean of them is called “average accuracy”.
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6.5.3 Statistical Analysis on the prostate cancer dataset

Table 6.16 shows that GSVM-RFE significantly improves accuracy compared with S2N and
SVM-RFE. The best accuracy (the first column) of the “expected” GSVM-RFE averaged on the
20 runs is 99.71% and the average accuracy (the second column) is 90.18%.
TABLE 6.16
TESTING ACCURACY ON THE PROSTATE CANCER DATASET

model
S2N
SVM-RFE
expected GSVM-RFE

Best
(<=10)
0.9118
0.9412
0.9971

Mean
(<=10)
0.7941
0.8177
0.9018

Std
(<=10)
0.0832
0.0818
0.0803

TABLE 6.17
TESTING AUC ON THE PROSTATE CANCER DATASET

model
S2N
SVM-RFE
expected GSVM-RFE

Best
(<=10)
0.8333
0.9244
0.9962

Mean
(<=10)
0.6111
0.6804
0.8394

Std
(<=10)
0.1571
0.1811
0.1478

Table 6.17 demonstrates that GSVM-RFE has good average performance (83.94%) while S2N
and SVM-RFE have poor average performances (61.11% and 68.04%) in terms of the AUC
metric. In other words, GSVM-RFE is much better than S2N and SVM-RFE with higher AUC
values.
TABLE 6.18
TESTING SENSITIVITY ON THE PROSTATE CANCER DATASET

model
S2N
SVM-RFE
expected GSVM-RFE

Best
(<=10)
1.0000
1.0000
1.0000

Mean
(<=10)
1
0.9720
0.9720

Std
(<=10)
0
0.0329
0.0562

TABLE 6.19
TESTING SPECIFICITY ON THE PROSTATE CANCER DATASET

model
S2N
SVM-RFE
expected GSVM-RFE

Best
(<=10)
0.8929
0.9600
0.9980

Mean
(<=10)
0.7872
0.8282
0.9125

Std
(<=10)
0.0743
0.0988
0.0833
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Furthermore, Table 6.18 and Table 6.19 compare sensitivity and specificity among the three
algorithms. As shown in the results, only GSVM-RFE demonstrates superior balance ability
between the negative class and the positive class (tumor prostate) with both high average
sensitivity (97.20%) and also high average specificity (91.25%). Firstly, Relevance Index-based
pre-filtering selects positive-related genes and negative-related genes in balance. Secondly, FCM
explicitly groups genes into different clusters based on their expression patterns so that
informative genes from different function granules (clusters) are selected in balance.
Fig. 6.9 visualizes the average performance comparison among S2N, SVM-RFE and expected
GSVM-RFE. The goal of such an average performance comparison is to verify that the
performance gain of GSVM-RFE is statistically significant. However, in practice, biologists do
not care about the average performance but the best gene subset(s). As a result, we will only
submit the gene subsets extracted by the runs with good performance while discarding the gene
subsets from the runs with bad performance.

Figure 6.9. average performance comparison on the prostate cancer dataset
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More importantly, a perfect gene subset is extracted in 18 runs of GSVM-RFE. To the best of the
authors’ knowledge, it is the first time that such a perfect gene subset is reported for the prostate
cancer dataset. Interestingly, 18 runs of GSVM-RFE extract the exactly the same perfect gene
subset with 8 genes. Although these 18 runs produce different clusters, the same 8 genes can
always be extracted. It strongly convinces us the 8 genes are critical for prostate cancer. The
other two perfect gene subsets with 15 and 17 genes, respectively, are also extracted by other
runs of GSVM-RFE. Due to the length limit, we have to skip them here.
6.5.4 Biological Analysis on the prostate cancer dataset
TABLE 6.20
A PERFECT GENE SUBSET ON THE PROSTATE CANCER DATASET

rank/
index
1/6185
2/4649
3/5821
4/5045
5/10537
6/6368
7/11818
8/5402

GAN
X07732*
M16942
AF044311
AL080150
AF045229*
AB017363
M21535
W27944

Description of Gene Function
hepatoma mRNA for serine protease hepsin

References
[110]

[110]
erg protein (ets-related gene)
39g8 retina

Table 6.20 lists the perfect subset of 8 genes. The “*” signed genes have been already identified
by other approaches in previous works, while the other ones are newly found by GSVM-RFE.
6.5.5 Statistical Analysis on the AML/ALL dataset

The AML/ALL leukemia dataset [58] mentioned above is also used in the experiments. Here
negatives are defined to be the ALL samples, while positives are AML samples. At the first
stage, α + = 0.5 and α − = 0.5 are adopted to extract 1685 positive-related genes and 432
negative-related genes. Only the 2020th gene (GAN: M55150) is both negative-related and
positive-related. Nmp=169, Nfu=64, Nfl=1. We run GSVM-RFE 20 times.
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Table 6.21 shows that GSVM-RFE is most accurate compared to S2N and SVM-RFE. The best
accuracy of the “expected” GSVM-RFE averaged on the 20 runs is 96.91% and the average
accuracy is 91.75%.
Table 6.22 demonstrates that GSVM-RFE has excellent average performance (90.64%), S2N
has good average performance (86.54%), while SVM-RFE has fair average performances
(76.29%) in terms of the AUC metric. In other words, GSVM-RFE is better than S2N and SVMRFE with higher AUC values.
TABLE 6.21
TESTING ACCURACY ON THE AML/ALL DATASET

model
S2N
SVM-RFE
expected GSVM-RFE

Best
(<=20)
0.9412
0.9412
0.9691

Mean
(<=20)
0.8883
0.8029
0.9175

Std
(<=20)
0.0537
0.0541
0.0370

TABLE 6.22
TESTING AUC ON THE AML/ALL DATASET

model
S2N
SVM-RFE
expected GSVM-RFE

Best
(<=20)
0.9286
0.9286
0.9668

Mean
(<=20)
0.8654
0.7629
0.9064

Std
(<=20)
0.0632
0.0666
0.0423

TABLE 6.23
TESTING SENSITIVITY ON THE AML/ALL DATASET

model
S2N
SVM-RFE
expected GSVM-RFE

Best
(<=20)
1.0000
1.0000
0.9975

Mean
(<=20)
0.9950
0.9900
0.9695

Std
(<=20)
0.0154
0.0205
0.0330

TABLE 6.24
TESTING SPECIFICITY ON THE AML/ALL DATASET

model
S2N
SVM-RFE
expected GSVM-RFE

Best
(<=20)
0.9091
0.9091
0.9681

Mean
(<=20)
0.8466
0.7575
0.9017

Std
(<=20)
0.0554
0.0611
0.0455
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Figure 6.10. average performance comparison on the AML/ALL dataset

Furthermore, Table 6.23 and Table 6.24 compare sensitivity and specificity among the three
algorithms. Only GSVM-RFE demonstrates excellent balance ability between the negative class
and the positive class (AML) with both high average sensitivity (96.95%) and also high average
specificity (90.17%). Once again, it proves that GSVM-RFE can extract positive-related genes
and negative-related genes in balance.
Fig. 6.10 visualizes the average performance comparison among S2N, SVM-RFE and expected
GSVM-RFE.
6.5.6 Biological Analysis on the AML/ALL dataset

TABLE 6.25
A PERFECT GENE SUBSET ON THE AML/ALL DATASET

rank/
index
1/1834
2/6539
3/2020
4/4535
5/461
6/4847
7/3221
8/5950
9/6169

GAN
M23197*
X85116*
M55150*
X74262*
D49950*
X95735*
U43885
M29610*
M13690*

Description of Gene Function
Human differentiation antigen (CD33)
Integral membrane protein (Protein 7.2b)
Human fumarylacetoacetate hydrolase
RETINOBLASTOMA BINDING PROTEIN P48
Interferon-gamma inducing factor (IL-18)
Homo sapiens Zyxin
Grb2-associated binder-1 mRNA
Glycophorin E
C1NH Complement component 1 inhibitor

References
[41][11][55][76][101]
[41][11][55]
[41][11][17]
[41][11][17]
[11][17][40][32]
[41][37][11][17]
[6]
[55]
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Table 6.25 lists a perfect subset with 9 genes to analyze their biological functions related to
leukemia classification. Notice in Table 6.25, M55150, the only gene both negative-related and
positive-related, is extracted and ranked at the third place. The “*” signed genes have been
already identified to be cancer-related in previous works, while the other ones are newly
identified by GSVM-RFE. The other two perfect gene subsets with 8 and 16 genes (not reported
here), respectively, are also extracted by other runs of GSVM-RFE.
Many genes in these perfect gene subsets have already been reported to be directly or indirectly
related to tumor activities. For instance, high-level CD33 (differentiation antigen) activity is
observed in AML [76,101], IL-18 (Interferon-gamma inducing factor, a cytokine mainly
produced by macrophages) affect T-cell activation [40,32], which can influence tumor
development.
Besides, the novel genes discovered by this new GSVM-RFE algorithm may also be directly
or indirectly related with cancer. Furthermore, GSVM-RFE extracts genes together as a group.
For example, 8 from 9 genes in Table 6.25 have been reported to be cancer-related in different
biological or bioinformatics literature. However, it is novel for GSVM-RFE to extract them
together. In this way, the inherent regulation mechanism and correlations among these genes
may be explored more effectively and more efficiently.
6.6 Discussion
6.6.1 Natural training/testing partition

One challenge of cancer classification on microarray gene expression data is that the data is
generally not independent and identically distributed (i.i.d.) as traditional data mining models
assume. Experiments under different experimental conditions (or even the same experimental
conditions but at different time) produce different expression data. As a result, an ideal algorithm
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should be able to model a classifier from the dataset under one experimental condition and
generalize it well onto other datasets under different experimental conditions. To this end, a
classifier should discriminate the samples not by the experimental condition related factors but
by the cancer-related factors.
For the AML/ALL dataset, some previous works [43,37,33] combined the training dataset and
the testing dataset together into one whole dataset on which leave-one-out validation heuristic
was used for model evaluation. However, in each fold of leave-one-out validation, many training
samples come from the same biological condition as the validation sample. As a result, it is
easier to model a classifier to correctly classify the validation sample under the help of some
factors that are experimental condition-related but possibly not cancer-related. That is, the leaveone-out validation is prone to model a classifier overfitting the biological experiment conditionrelated factors. And hence really informative gene subsets may not be extracted. As a result, this
work still adopts the original training/testing partition. With this “natural” partition, a classifier is
expected to be dominated by really cancer-related factors if both high validation accuracy on the
training dataset and high prediction accuracy on the testing dataset are observed.
To justify this idea, we also try leave-one-out validation on the whole AML/ALL dataset to run
GSVM-RFE for gene selection. The results (not reported here due to length limit) show that
almost all runs of GSVM-RFE can extract a small subset with only 5 or 7 genes with 100%
leave-one-out accuracy. However, based on these gene subsets, a SVM built on the training
dataset performs not well on the testing dataset.
The similar overfitting happens in the experiments on the prostate cancer dataset. Some previous
research work [110] adopted leave-one-out validation on the 102 training samples. However, our
experiments show that a lot of gene subsets have 100% leave-one-out validation accuracy but
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very low prediction accuracy on the 34 testing samples. Therefore, leave-one-out validation
accuracy is not a convincible criterion for gene selection because of the strong negative effects of
biological experiment condition-related factors.
6.6.2 Size of the final gene subsets

The size is decided according to practical utilities of the extracted gene subsets: A small number
of genes are desirable for further biological study because it is very expensive or even
impractical to conduct biological experiments on a large number of genes; On the other hand, the
prediction is not accurate if too few genes are selected. In previous research works, the size is
usually decided arbitrarily by a biologist. However, we notice that it is difficult for a biologist to
decide such a value precisely. It is more reasonable for him or her to decide a field instead of a
value. In this work, the lower-bound of the field is always assumed to be 1. So the biologist only
needs to decide the upper-bound. For the prostate cancer dataset, performance on the 10 stratified
subsets with 10 genes to 1 gene is reported. For the AML/ALL dataset, performance on the 20
stratified subsets with 20 genes to 1 gene is reported.
6.6.3 RI pre-filtering

Another group of experiments show that performance of GSVM-RFE is deteriorated without RI
pre-filtering (not shown here). This result verifies our assumption that RI pre-filtering not only
can speed up the running of GSVM-RFE, but also can decrease noise between irrelevant genes
and noisy genes. As a result, the following stages of GSVM-RFE work more effectively and
more efficiently to extract informative cancer-related gene subsets.
6.6.4 Number of clusters and membership of clusters

For complex gene selection problems, selection from multiple granules is better than selection
from one single granule without clustering. By explicitly clustering genes into different function
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granules based on their expression strength patterns, redundant genes can be identified and
removed. Furthermore, genes that regulate cancers in different ways can be extracted in balance.
It should be even better if a gene can be grouped into more than one granule. By being clustered
into multiple function granules, an important cancer-related gene may be ranked low in some
granules but ranked high in other granules, and hence gains more opportunities to be extracted.
FCM has the inherent advantage to be applied for gene selection compared to other crisp
clustering algorithms such as self-organizing map, k-means, or hierarchical clustering.
On the other hand, too many clusters make clustering trivial. In the second stage of GSVM-RFE,
5 clusters are generated at each step. That is, genes are approximately grouped into “strong
negative-related cluster”, “weak negative-related cluster”, “neutral cluster”, “weak positiverelated cluster”, and “strong positive-related cluster”. Notice that at the second stage, the
clustering is recursively executed on the smaller and smaller survived gene subset at each step.
The number 5 may be not the best. However, the contribution here is to prove multiple granules
can improve the performance by decreasing noise and selecting genes in balance.
6.6.5 Extract gene subsets in balance
TABLE 6.26
UNBIASED PERFORMANCE COMPARISON ON THE PROSTATE CANCER DATASET

models
No selection
S2N
SVM-RFE
GSVM-RFE

accuracy

auc

sensitivity

specificity

0.3235
0.7941
0.8177
0.9018

0.5400
0.6111
0.6804
0.8394

1.0000
1.0000
0.9720
0.9720

0.0800
0.7872
0.8282
0.9125

TABLE 6.27
UNBIASED PERFORMANCE COMPARISON ON THE AML/ALL DATASET

models
No selection
S2N
SVM-RFE
GSVM-RFE

accuracy

auc

sensitivity

specificity

0.9118
0.8883
0.8029
0.9175

0.8929
0.8654
0.7629
0.9064

1.0000
0.9950
0.9900
0.9695

0.8696
0.8466
0.7575
0.9017
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Without gene selection, classification performance of linear SVMs is not reliable, as shown in
the first row of Table 6.26 for the prostate cancer dataset and the first row of Table 6.27 for the
AML/ALL dataset. Obviously, the classifiers are prone to the negative class with low AUC
values (or high sensitivity and low specificity).
S2N and SVM-RFE do not alleviate the imbalance too much. Linear SVMs modeled on the gene
subsets extracted by both of them are still prone to the negative class (the second rows and the
third rows in the Tables, the average performance is reported).
Due to the explicit granulation with clustering, the minor genes may form a “pure granule” (a
cluster) so that at least some of them can be extracted. The balance ability is demonstrated to be
critical for the superior performance of GSVM-RFE (the fourth rows in the Tables, the average
performance is reported).
The results also show that the prostate cancer dataset is much more noisy and imbalanced than
the AML/ALL dataset. The fact that the performance improvement gained by GSVM-RFE is
more significant in the first dataset demonstrates that GSVM-RFE improves the cancer
classification mainly due to noise elimination and balanced gene selection.
6.6.6 Selection bias

Ambroise et al demonstrated that selection bias is introduced because the testing dataset or the
validation dataset is involved in gene selection [3]. As a result, the testing or validation accuracy
can not be confidently generalized to new samples. In our experiments, the best accuracy is in
this case. However, in practice we can expect that the size of a gene subset is randomly selected
in the field [Nfl, Nfu] and one special run of the Fuzzy C-Mean clustering for GSVM-RFE is
randomly picked up. In this way, the testing dataset is leaved out from gene selection and
classifier modeling. As a result, the average accuracy is an unbiased estimation of generalized
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prediction accuracy. Actually, the average accuracy is even a pessimistic estimation because a
biologist does not expect to select too few genes with too much information loss. Consequently,
the improvement of GSVM-RFE is reliable. The unbiased average testing accuracy on the two
datasets are reported in the first columns of Table XII and Table XIII. Notice that in Table XIII,
the unbiased accuracy of S2N or SVM-RFE is even lower than the accuracy without gene
selection so that the extracted gene subsets are not reliable.
Furthermore, due to existence of selection bias, it is helpful or even necessary to provide
multiple gene subsets other than just one single “most informative” gene subset to avoid
information loss. Therefore, the flexibility of clustering makes GSVM-RFE more suitable for
gene selection than traditional algorithms.
6.6.7 Time Complexity

Correlation-based algorithms are straightforward to understand and work efficiently. If there are
d genes originally, the ranking process takes O(dlgd) time.
Because the ranking process dominates the SVM-RFE algorithm, the SVM-RFE (which remove
50% lower-ranked genes in each step) works in O(dlgd) time.
GSVM-RFE is a O(d2) algorithm because the clustering process dominates. In practice, because
the pre-filtering stage by RI metrics eliminates most of genes, the expected time is much shorter.
6.7 Summary on GSVM-RFE simulation

To find most informative gene subsets for reliable cancer classification, the GSVM-RFE
algorithm is proposed in this chapter. Firstly, GSVM-RFE utilizes Relevance Index metric for
gene pre-filtering to improve the algorithm efficiency and effectiveness at the same time.
Secondly, GSVM-RFE explicitly groups genes with similar expression patterns into clusters.
Therefore, the lower-ranked genes in each cluster can be safely removed because the more
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significant genes with similar functions will survive. Finally, GSVM-RFE deals with complex
correlation between genes by assigning a gene into several clusters with different membership
values so that a really informative gene is more possible to survive.
GSVM-RFE is more reliable to predict unseen testing samples, as demonstrated in the
experiments on the two microarray gene expression datasets. More importantly, GSVM-RFE can
find multiple compact cancer-related gene subsets on each of which a SVM with 100%
prediction accuracy can be modeled. Due to the selection bias in each single gene subset, the
multiple “perfect gene subsets” are believed to be more helpful for biologists to uncover the
inherent cancer-resulting mechanism.
In summary, GSVM-RFE has advantages over traditional algorithms. Of course, the newly
identified genes by this algorithm need to be further confirmed biologically, which may generate
more insights for cancer mechanism, treatment and study. Nevertheless, the extraction of these
cancer-related gene subsets may help to stimulate and guide detailed cancer studies on the gene
functions.
As a general feature selection algorithm, because of the inherent advantage to eliminate
irrelevant or redundant features while select really informative features, we expect that this
superior performance can also be true in processing other similar datasets with extreme
sparseness such as biomedical text mining, biomedical image pattern recognition, and other
bioinformatics problems. This is an interesting future work.
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CHAPTER 7
GSVM-DC
7.1 Algorithm

Usually, grid search heuristic [46] is adopted for SVM modeling. The basic idea is to try
different parameter grids to find which one is the best. It is time-consuming due to large
parameter space, especially for very large datasets.
To improve efficiency, it is natural to try to decrease the size of the training dataset. The
elimination of some samples from the training dataset may have two results: 1 information loss
by eliminating informative or useful samples to deteriorate the performance of a classifier; and 2
data cleaning by eliminating the irrelevant or redundant or noisy samples to improve the
performance of a classifier. Our goal is to minimize the first negative effect (information loss)
while to maximize the second positive effect (data cleaning). If the original training dataset is
viewed as a single granule, the problem is, how to adjust the size of the granule to achieve the
optimal classification performance.
For a biomedical problem, usually much more than need data is accumulated. There are many
redundant or even noisy data. In this case, too many training data is unnecessary or even
harmful. The SVM algorithm tells us that only SVs are needed and other samples can be safely
removed without affecting classification (Fig. 7.1). The advantage motivates us to explore the
potentiality to utilize SVM as a data cleaning tool.
However, different kernels and/or different parameter values may extract different SVs. Which
one should be extracted?
SVM tries to find the optimal decision boundary by trade-off between the margin width and the
training accuracy. There is a regulation parameter C for misclassification errors penalty. For

106
complex datasets, if C is increased, the SVM algorithm is forced to decrease misclassification
errors by decreasing the margin width. As a result, less SVs are extracted. It motivates us to build
a linear SVM with a very small C value and the extracted SVs can be used as the new
compressed training dataset, which is expected to include most, if not all, important and useful
samples.

Figure. 7.1. A SVM with maximal margin. Except Support
Vectors, the other samples can be safely removed

However, information loss may still happen because a linear SVM is still possible to loss some
important samples. As a result, it is not a good idea to extract SVs directly from the whole
training dataset. The other disadvantage by extracting the “global” SVs is overfitting: when we
use grid search and cross validation heuristics to optimize the parameters, overfitting may
happen because the validation samples were already used to extract the “global” SVs.
A natural way is to split the training samples into different granules. The samples in one granule
could be leaved for validation and other samples could be used to extract SVs. In [36], authors
won the ACM KDDCUP04 protein homology task mainly by taking advantage of the natural
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granules splitting (blocks decided by native protein sequences) to undersample the training
dataset with SVMs in each block. However, it is still unexplored how to do undersampling (SVs
extraction) for a general dataset without any prior knowledge for granulation.
Our solution is to build multiple granules in a bagging-similar way. Fig. 7.2 sketches the
algorithm, named Granular Support Vector Machines with Data Cleaning (GSVM-DC). Each
granule is composed of the training samples in each fold of the k-fold cross validation. There are
altogether k granules, where k is the number of the folds of cross validation.
The granulation is highly overlapping (each training sample appears in k-1 granules) so that each
training sample gets k-1 opportunities to be extracted as a SV. In each granule, a SVM with a
very small C value is modeled and the corresponding SVs are extracted to form the “Local
Support Vector set” (LSVs) to “clean” the granule. With the very small C value and highly
overlapping granulation, it is expected to minimize information loss caused by missing some
important samples.
After LSVs are extracted, k-fold cross validation is executed to optimize SVM parameters. In the
ith fold, the training dataset is LSVi, the validation dataset is the (k-i+1)th subset of the original
training dataset.
Finally, LSVs are disjunctively combined to form a compressed training dataset, on which a
SVM with the optimal parameters is modeled for classification.
Suppose there are g ∈ N groups of parameters for grid search with k-fold cross validation. In
each fold, there are n training samples, and m LSVs, averaged on all k folds. If SVM modeling
takes O( g * k * n 2 ) time, GSVM-DC needs O(k * n 2 + g * k * m 2 ) . Because usually the size of
LSVs is much less than the size of the original training dataset (m << n) and g>>1, the tuning
by grid search can be greatly speed up.
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Figure. 7.2. GSVM-DC algorithm

7.2 Simulation

GSVM-DC proposed in this chapter is compared with the original SVM algorithm. We try linear
kernel and RBF kernel for SVM. Correspondingly, the final SVM in GSVM-DC also adopts
linear kernel and RBF kernel, respectively, for comparison. Notice that the SVMs used to select
LSVs in GSVM-DC are always linear SVMs.
7.2.1 Datasets

Six life science binary classification data from UCI data mining repository [68] are used for
comparison. The detailed characteristics of datasets are listed in Table 7.1.
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TABLE 7.1
CHARACTERISTICS OF DATASETS USED FOR EXPERIMENTS

Dataset
1 Pima Indians Diabetes
1 Wisconsin Breast Cancer
1 Cleveland heart-disease
1 Postoperative Patient
2 Abalone
2 Protein Localization Sites

Size

Attr

Ratio

768
683
297
90
4177
1484

8
9
13
8
8
8

500:268
444: 239
160:137
66:24
4145:32
1433:51

Note 1:
Size = # of cases after removing cases with missing data, Attr =
# of input features, Ratio = # of negative cases : # of positive cases.
Note 2:
16 cases in Wisconsin Breast Cancer dataset and 6 cases in
Cleveland heart-disease dataset with missing values were removed.
Note 3: Class “S” in Postoperative Patient dataset was defined as positive.
Class “19” in Abalone dataset was defined as positive. Class “ME2” in
Protein Localization Sites dataset was defined as positive.

7.2.2 Metrics

Two sets of experiments, on balanced datasets and imbalanced datasets, separately, are designed
and performed.
For balanced datasets, misclassification error, defined in Eq. 1.1, is used to evaluate performance
of the two algorithms. The top 4 datasets in Table 7.1 are used in the first set of experiments.
g − means =

TN
TP
×
TN + FP TP + FN

.

(7.1)

For imbalanced datasets, misclassification error is virtually useless to evaluate a classifier’s
performance. [56] proposed g-means as defined in Eq. 7.1. This metric has been broadly used by
many researchers to evaluate performance of classifiers on imbalanced datasets. We also adopt
g-means here. The last 2 datasets in Table 7.1 are used in the second set of experiments.
7.2.3 Modeling

Each dataset is split into 5 equal size subsets. Each subset is leaved for testing in turn and other 4
subsets are combined and used for training. The split is executed in a stratified way so that

S (training ) : S (testing ) = 4 : 1 ,
S ( positive _ training ) : S ( positive _ testing ) = 4 : 1 ,
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S (negative _ training ) : S (negative _ testing ) = 4 : 1 ,
where S (x) means the size of the dataset x.
For each training/testing process, firstly the data is normalized so that each input feature has 0
mean and 1 standard deviation on the training dataset; then two models are built: the first model
is a general SVM, whose parameters (γ , C ) are optimized by grid search and 4-fold inner cross
validation. (For linear kernel, only C is optimized.) The second model is a GSVM-DC: Local
Support Vectors are extracted by a linear SVM with C = 2 −10 in each granule that consists of the
training samples in each fold. Because there are 4 granules, 4 sets of LSVs are extracted. And
then the parameters are optimized in the similar way to SVM but on the smaller training dataset
that is only composed of the LSVs. Finally performance on the 5 training/testing processes is
aggregated (for misclassification errors) or averaged (for g-means values) for comparison.
The above mentioned 5-fold outer cross validation is executed 5 times for 5 different random
splitting on each dataset.
For linear kernel, the grid search scope is limited in
C ∈{2-10 ,2-9 ,2-8 ,2-7 ,2-6 ,2-5 ,2-4 ,2-3 ,2-2 ,2-1 ,20 ,21 ,22 ,23 ,2 4 ,25 }.
For RBF kernel, the grid search scope is limited in

γ ∈ {2-16 ,2-14 ,2-12 ,2-10 ,2-8 ,2-6 ,2-4 ,2-2 ,20 ,2 2 ,2 4 } ,
C ∈ {2-6 ,2-4 ,2-2 ,20 ,2 2 ,2 4 ,26 ,28 ,210 } .
7.2.4 Results analysis on balanced datasets

Tables 7.2-7.4 show the results on the first set of experiments. For linear kernel, performance of
the two algorithms is almost the same. However, as we analyzed above, GSVM-DC is much
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faster than SVM. That means GSVM-DC works both efficiently and effectively. Due to the small
size of these datasets, the time differences are not significant so we don’t report them here.
For RBF kernel, GSVM-DC is even a little more accurate than SVM with fewer errors. The
results demonstrate that GSVM-DC can effectively clean the training dataset and avoid
information loss at the same time, at least on the 4 datasets. For example, Table 7.2 shows that
GSVM-DC (average test errors=175.2 with RBF kernel) is more accurate than SVM (average
test errors=178.6 with RBF kernel) on Pima Indians Diabetes dataset.

TABLE 7.2
VALIDATION/TEST ERRORS ON PIMA INDIANS DIABETES DATASET

Trial
1
2
3
4
5
Mean
Std

linear SVM
173/176
175/178
176/177
173/176
176/178
174.6/177
1.52/1

linear
GSVM
173/172
174/176
176/176
172/176
176/177
174.2/175.4
1.79/1.95

RBF SVM
170/178
172/177
172/182
169/175
173/181
171.2/178.6
1.64/2.88

RBF
GSVM
170/175
170/172
174/180
170/170
173/179
171.4/175.2
1.95/4.32

TABLE 7.3
VALIDATION/TEST ERRORS ON WISCONSIN BREAST CANCER DATASET

Trial
1
2
3
4
5
Mean
Std

linear SVM
22/23
20/20
21/21
21/22
20/22
20.8/21.6
0.84/1.14

linear
GSVM
22/23
20/20
21/21
21/22
20/22
20.8/21.6
0.84/1.14

RBF SVM
21/26
18/21
20/24
18/28
20/23
19.4/24.4
1.34/2.70

RBF
GSVM
21/24
18/22
20/21
18/28
20/21
19.4/23.2
1.34/2.95

TABLE 7.4
VALIDATION/TEST ERRORS ON CLEVELAND HEART-DISEASE DATASET

Trial
1
2
3
4
5
Mean
Std

linear SVM
48/50
46/45
45/47
47/47
46/45
46.4/46.8
1.14/2.05

linear
GSVM
48/50
46/45
45/47
47/47
46/45
46.4/46.8
1.14/2.05

RBF SVM
45/49
46/45
45/46
46/49
44/45
45.2/46.8
0.84/2.05

RBF
GSVM
45/49
46/45
45/46
46/48
44/45
45.2/46.6
0.84/1.82
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TABLE 7.5
VALIDATION/TEST ERRORS ON POSTOPERATIVE PATIENT DATASET

Trial
1
2
3
4
5
Mean
Std

linear SVM
25/24
25/24
25/24
25/24
25/24
25/24
0/0

linear
GSVM
25/24
25/24
25/24
25/24
25/24
25/24
0/0

RBF SVM
24/27
24/25
25/24
25/26
25/25
24.6/25.4
0.55/1.14

RBF
GSVM
25/26
25/24
25/24
24/24
25/24
24.8/24.4
0.45/0.89

It seems that GSVM-DC is more possible to improve performance on RBF kernel than on linear
kernel. One possible reason is that RBF kernel is more complex than linear kernel. Therefore,
SVM with RBF kernel is more sensitive to redundant or noisy samples. Modeling only on LSVs
eliminates the negative effect and hence improves performance of GSVM-DC.
7.2.5 Results analysis on imbalanced datasets

Tables 7.6 and 7.8 compare performance of two algorithms on the second group of datasets.
Linear SVM and linear GSVM-DC are totally ineffective because both of them have 0 g-means
values. The reason is that they classify every sample as negative so that TP is 0.
For RBF kernel, GSVM-DC greatly improves performance on the imbalanced datasets. For
Abalone dataset, the g-means value of GSVM-DC is 0.6030, averaged on 5 trials, which is much
higher than SVM whose average g-means value is 0.0804. For Protein Localization Sites dataset,
GSVM-DC (with g-means value=0.6138, average on 5 trials) is also significantly better than
SVM (with average g-means=0.5393). Interestingly, SVM has higher validation g-means value
but lower test g-means value than GSVM-DC. Once again, it shows that modeling only on LSVs
eliminates the negative effect of redundant or noisy samples and hence improves classification
performance.
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TABLE 7.6
VALIDATION/TEST G-MEANS ON ABALONE DATASET

Trial
1
2
3
4
5
Mean
Std

linear SVM
(%)
0/0
0/0
0/0
0/0
0/0
0/0
0/0

linear
GSVM (%)
21.59/0
19.63/0
23.87/0
31.87/0
21.63/0
23.72/0
4.80/0

RBF SVM
(%)
20.87/16.43
9.86/8.14
15.64/8.13
16.29/7.50
10.02/0
14.54/8.04
4.65/5.82

RBF
GSVM (%)
61.54/64.06
62.53/59.94
62.78/58.01
61.13/59.48
62.84/60.02
62.16/60.30
0.78/2.25

TABLE 7.7
TIME(S)/AVGTRAINSIZE G-MEANS ON ABALONE DATASET

Trial

RBF SVM

RBF GSVM

1
2
3
4
5
Mean
Std

1909/3342
1902/3342
2005/3342
2012/3342
1985/3342
1963/3342
53.12/0

51/69
50/70
55/68
53/70
54/65
52.6/68.4
2.07/2.07

TABLE 7.8
VALIDATION/TEST G-MEANS ON PROTEIN LOCALIZATION SITES DATASET

Trial
1
2
3
4
5
Mean
Std

linear SVM
(%)
0/0
1.58/0
0/0
0/0
2.13/0
0.74/0
1.03/0

linear
GSVM (%)
35.30/0
25.38/0
23.63/0
22.72/0
17.73/0
24.95/0
6.45/0

RBF SVM
(%)
58.77/53.29
61.33/56.56
59.37/54.65
65.22/49.03
61.77/56.10
61.29/53.93
2.54/3.02

RBF
GSVM (%)
62.19/59.04
59.24/59.23
58.04/60.11
61.26/62.72
59.33/65.82
60.01/61.38
1.68/2.88

TABLE 7.9
TIME(S)/AVGTRAINSIZE G-MEANS ON PROTEIN LOCALIZATION SITES
DATASET

Trial

RBF SVM

RBF GSVM

1
2
3
4
5
Mean
Std

430/1187
478/1187
472/1187
458/1187
457/1187
459/1187
18.55/0

27/91
30/91
29/92
27/90
29/91
28.4/91
1.34/0.71
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Moreover, Tables 7.7 and 7.9 show that GSVM-DC with RBF kernel is also much faster than
SVM with RBF kernel. For Abalone dataset, GSVM-DC averagely runs 52.6 seconds, while
SVM needs 1963 seconds. The reason is that GSVM-DC greatly decreases the size of the
training dataset from 3342 to 68.4, averagely. For Protein Localization Sites dataset, GSVM-DC
averagely takes 28.4 seconds with the average training size 91, while SVM takes 459 seconds
with the training size 1187.
7.3 Discussion

In this chapter, a new GSVM modeling algorithm, named GSVM-DC, is presented. It works by
building a sequence of information granules and then extracting informative samples as Local
Support Vectors while eliminating redundant samples in each granule. Finally, the LSVs are
disjunctively combined to model a final SVM. In this way, the local significance of each granule
and global correlation among different granules are elegantly trade-off. As a result, an accurate
and fast classifier can be modeled.
GSVM-DC is inherently an undersampling technology. The improvement on effectiveness for
imbalanced datasets is expected to be more significant if we combine GSVM-DC with some
oversampling technologies, such as SMOTE [24]. Algorithm design and simulations on larger
and more complex datasets are currently in processing.
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CHAPTER 8
GSVM-RU

Highly imbalanced classification is important and increasingly common with emergence of new
machine intelligence application domains including biomedical informatics. In order to solve this
challenging class imbalance problem, a novel Granular Support Vector Machines - Repetitive
Undersampling algorithm (GSVM-RU) is designed in this work. GSVM-RU creatively utilizes
Support Vector Machines (SVM) themselves for undersampling to minimize the negative effect
of information loss while maximizing the positive effect of data cleaning in the undersampling
process. Consequently, an accurate and fast classifier can be modeled. The empirical study on
four benchmark imbalanced datasets demonstrates that GSVM-RU is both effective and efficient.
Specifically, for the extremely imbalanced abalone dataset, GSVM-RU achieves 73.4±1.6% gmeans value, which is much higher than the best known result 57.8±5.4%. Another encouraging
result is that GSVM-RU leads the extremely imbalanced KDDCUP 2004 protein homology
prediction competition as of July/19/2005.
8.1 Introduction
8.1.1 Class Imbalance Problem

Highly skewed data distribution induces the class imbalance problem that happens, in its
simplest form, when there are significantly more negative samples than positive samples for a
binary classification problem. (In this chapter, the majority class is always assumed to be
negative and the minority class is positive.) The class imbalance problem is ubiquitous in
machine intelligence applications, such as protein homology prediction, diagnosing medical
diseases, credit card fraud detection, intrusion detection for national security, etc. Usually, for an
imbalanced classification problem, it is of primary interest to find rare samples.
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8.1.2 Traditional Algorithms

Many methods have been proposed for imbalanced classification and some good results have
been reported [25]. These methods can be categorized into three different classes: weightadjusting, boundary alignment, and sampling. Sampling can be further categorized into two
subclasses: oversampling the minority class, or undersampling the majority class. Interested
readers may refer to [106] for a good survey. However, the class imbalance problem is still not
thoroughly investigated yet:
•

Most of current methods use Decision Trees (DT) as the basic classifier [48]. Although
there are already some works on SVM for imbalanced classification [1,85,107], the
application of SVM for undersampling is still unexplored. Because SVM decides the
class label of a sample only based on Support Vectors (SVs), which are the training
samples close to the decision boundary, the modeling effectiveness and efficiency may be
improved for imbalanced classification in a SVs-based undersampling way.

•

From the viewpoint of granular computing, most of current methods, including costsensitive boosting, bagging, undersampling the majority class, or oversampling the
minority class, actually can be viewed as granular-computing-based because all of them
try to form multiple information granules with suitable numbers and suitable sizes (See
Section 2 for a brief introduction of granular computing). It is interesting to try to solve
the class imbalance problem systematically in the framework of granular computing.

8.1.3 SVM for Imbalanced Classification

SVM embodies the Structural Risk Minimization (SRM) principle to minimize an upper bound
on the expected risk [102,19]. Because structural risk is a reasonable trade-off between the
training error and the modeling complication, SVM has a great generalization capability.
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Geometrically, the SVM modeling algorithm works by constructing a separating hyperplane with
the maximal margin.
Compared with other standard classifiers, SVM performs better on moderately imbalanced
datasets. The reason is that only SVs are used for classification and many negative samples
which are far from the decision boundary can be removed without affecting classification [1].
However, performance of SVM is significantly deteriorated on the highly imbalanced datasets.
For this kind of datasets, the SRM principle becomes unsuitable because it is prone to find the
simplest model that best fits the training dataset. Unfortunately, the simplest model is exactly the
naive classifier that classifies all samples as negative.
Another disadvantage of SVM is that it is an expensive O(n 2 ) algorithm. Usually, the grid search
heuristic [46] is used to find optimal SVM parameters. For large datasets, it is very timeconsuming, especially when some non-linear kernel (for example, Radial Basis Function kernel)
is applied.
There are already some works that are targeted at improving effectiveness of SVM for highly
imbalanced classification:
Akbani et al proposed the SMOTE with Different Costs algorithm (SDC) [1]. SDC oversamples
the minority class by applying Synthetic Minority Over-sampling TEchnique (SMOTE) [24], a
popular oversampling algorithm, with different error costs. As a result, the boundary of the
learned SVM can be better defined and far away from the minority class.
Raskutti et al explored effects of different imbalanced compensation techniques on SVM [85].
They demonstrated that a one-class SVM learned only from the minority class sometimes can
perform better than a SVM modeled from two classes.
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Wu et al proposed the Kernel Boundary Alignment algorithm (KBA) which adjusts the boundary
toward the majority class by directly modifying the kernel matrix [107]. In this way, the
boundary is expected to be closer to the “ideal” boundary.
8.1.4 GSVM-RU for Imbalanced Classification

In this chapter, we creatively utilize the advantage of SVs-based classification to design a novel
Granular Support Vector Machines–Repetitive Undersampling algorithm (GSVM-RU) under the
principle of granular computing.
As above-mentioned, only SVs of a SVM classifier are related to classification. So the intuitive
idea is to extract SVs as the new training dataset while eliminating the non-SVs samples for
undersampling. However, information loss may happen by extracting SVs only once. Firstly,
whether a sample is extracted to be a SV is sensitive to SVM parameters. Secondly, the highly
skewed data distribution pushes the boundary toward the minority class [107]. As a result, some
informative samples may be lost.
GSVM-RU extracts SVs multiple times to build multiple information granules, and then the
information in these granules is fused in a data-dependant way for classification. Our theoretical
and empirical studies below show that GSVM-RU can achieve better data distribution with much
fewer training samples than the original dataset. Consequently classification performance can be
improved in terms of both effectiveness and efficiency.
The rest of the chapter is organized as follows. In Section 8.2, GSVM-RU is presented in detail.
Section 8.3 evaluates performance of GSVM-RU on three highly imbalanced life science
datasets. Section 8.4 reports performance of GSVM-RU on the KDDCUP04 protein homology
prediction task. Finally, Section 8.5 concludes the chapter.
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8.2 GSVM-RU algorithm

Under the framework of GSVM, GSVM-RU is designed to attack highly imbalanced
classification problems.
8.2.1 GSVM-RU

Usually, the grid search heuristic [46] is adopted for SVM modeling: different parameter grids
are tried to find which one has the best training (or validation) performance. It is time-consuming
due to usually large datasets and the large parameter space.
To improve efficiency, it is natural to decrease the size of the training dataset. In this sense,
undersampling is by nature more suitable to model a SVM for imbalanced classification than
other approaches.
However, elimination of some samples from the training dataset may have two effects:
•

information loss: due to elimination of informative or useful samples, classification
performance is deteriorated;

•

data cleaning: because of elimination of irrelevant or redundant or noisy samples,
classification performance is improved.

Our goal is to minimize the negative effect of information loss and to maximize the positive
effect of data cleaning.
For a highly imbalanced dataset, it is expected that there are many redundant or even noisy
negative samples. Random undersampling is the most common undersampling approach for
rebalancing the dataset to achieve better data distribution. However, random undersampling
suffers from information loss. As Fig. 8.1(a) shows, although random undersampling makes the
distance of the learned boundary close to the distance of the ideal boundary, the cues about the
orientation of the ideal boundary may be lost [1].
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In this work, we creatively utilize SVM itself for undersampling. The idea is based on the wellknown fact about SVM: only SVs are necessary and other samples can be safely removed
without affecting classification. This fact motivates us to explore the potentiality to utilize SVM
for data cleaning/undersampling.
Unfortunately, due to the highly skewed data distribution, the SVM modeled on the original
training dataset is prone to classify every sample to be negative. As a result, a single SVM
cannot guarantee to extract all informative samples as SVs, no matter which kernel and which
parameters are used.
We believe that GSVM is a promising way to reduce information loss. The assumption is that
although a single SVM is not enough to extract all informative samples, it does be able to extract
a part of them. Under this assumption, multiple information granules with different informative
samples can be formed by the following granulation operations: Firstly, we assume that all
positive samples are informative to form a positive information granule. Secondly, negative
samples extracted by a SVM as SVs are also possibly informative so that they form a negative
information granule. Here we call these negative samples as Negative Local Support Vectors
(NLSVs). And then the NLSVs are removed from the original training dataset to produce a
smaller training dataset, on which a new SVM is modeled to extract another group of NLSVs.
This process is repeated several times to form multiple negative information granules.
After that, an aggregation operation is executed to selectively aggregate the samples in these
negative information granules with all positive samples to complete the undersampling process.
Finally, a SVM is modeled on the aggregated dataset for classification. Fig. 8.2 sketches the
GSVM-RU algorithm.
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Ideal

Ideal
Learned

Learned
Original

Original

(a) randomly undersampling

(b) GSVM-RU undersampling

the dot line - the ideal boundary
the dash line - the boundary learned from the original dataset
the solid line - the boundary learned from the undersampling dataset
Figure. 8.1. GSVM-RU can still give good cues on the orientation of the ideal boundary while
make the distance close to the ideal one.

Figure. 8.2. GSVM-RU algorithm
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As demonstrated in Fig. 8.1(b), because only the circled negative samples are removed from the
original dataset, GSVM-RU undersampling can still give good cues about the orientation of the
ideal boundary, and hence can overcome the shortcoming of random undersampling as
mentioned earlier.
To make GSVM-RU an utilizable algorithm, there are still three problems: (1) how to select
kernels and parameters to extract NLSVs? (2) how many negative information granules should
be formed? and (3) how to aggregate the samples in these information granules?
In this work, linear SVMs are adopted for undersampling. The obvious advantage by using linear
SVMs is the efficiency reason: for a linear SVM, only the regulation parameter C needs to be
tuned so that the parameter space for grid search is much smaller. (As a comparison, two
parameters (γ , C ) need to be tuned for a SVM with the RBF kernel). As a result, a linear SVM is
easier and faster to be modeled than a non-linear kernel SVM. Furthermore, although a single
linear SVM may lose information, running it multiple times based on the above-mentioned
granulation idea can extract most, if not all, informative samples. (Actually, the RBF SVM is
also used for undersampling in our simulations. However, no obvious performance gain is
observed.)
As we know, SVM tries to find the optimal decision boundary by trade-off between the margin
width and the training accuracy. The regulation parameter C is used for misclassification errors
penalty. Different C values result in different SVs. So we can adjust C to control the information
extracted for one granule. The optimal C value is data-dependant and can be searched by cross
validation.
For the similar reason to reduce information loss, more negative information granules are
preferred than less negative information granules. However, some non-informative samples may
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also be extracted as NLSVs. As a result, some granules which are not really informative should
be eliminated from the final aggregated dataset. In GSVM-RU, the granulation operation and the
aggregation operation are executed iteratively. The undersampling process is stopped if
classification performance cannot be further improved when a new negative granule is extracted
and the corresponding NLSVs are aggregated into the final dataset.
In general, if g ∈ N granules are extracted, there are 2g possible aggregation ways. For simplicity
and efficiency, two special aggregation operations are adopted in this work:
•

The first aggregation operation is called “discard”: when a new negative granule is
extracted, only negative samples in this granule are aggregated into the new aggregation
dataset and all samples in old negative granules are discarded. This operation is based on
an assumption mentioned in [1,107]: for a highly imbalanced classification problem, the
majority class pushes the “ideal” decision boundary toward the minority class. So if old
NLSVs are discarded, the decision boundary is expected to be closer to the ideal one. The
repetitive undersampling process is stopped when the new extracted granule alone cannot
further improve classification performance.

•

The second aggregation operation is called “combine”: when a new granule is extracted,
it is combined with all old granules to form a new aggregation dataset. The assumption is
that not all informative samples can be extracted as NLSVs in one granule. As a result, it
is expected to reduce information loss by extracting NLSVs multiple times. The
repetitive undersampling process is stopped when the new extracted granule cannot
further improve classification performance if joint with old granules.
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8.2.2 Time Complexity Analysis

In grid search, suppose there are d1 ∈ N groups of parameters on the SVM for undersampling and
d 2 ∈ N groups

of parameters on the SVM for classification; Suppose also there are n ∈ N training

samples in the original training dataset and m ∈ N informative samples in the aggregated dataset
after g times undersampling. If SVM modeling needs O(d 2 * n 2 ) time, GSVM-RU approximately
takes O(d1 * g * n 2 + d 2 * m 2 ) . If the number of informative samples is much less than the size of the
original training dataset (m << n) and the parameter space for GSVM-RU is smaller than the
parameter space for the classification SVM (d1 * g < d 2 ) (which is true here because the linear
SVM is used for undersampling and the RBF SVM is used for classification), the modeling time
can be reduced compared with directly modeling a SVM on the original training dataset for
classification.
8.3 Simulations on the First Group of Datasets

The hardware used in the simulations is a laptop with centrino-1.6MHz CPU and 1024M
memory. The software is based on OSU SVM Classifier Matlab Toolbox [67], which
implements a Matlab interface to LIBSVM [23].
8.3.1 Evaluation Metric and Datasets

For highly imbalanced datasets, accuracy is virtually useless to evaluate a classifier’s
performance. Kubat et al [56] proposed g-means as defined in Eq. 1 and Fig. 3, which is the
geometric mean of classification accuracy on negative samples and classification accuracy on
positive samples. This metric has been broadly used by many researchers to evaluate
classification performance on imbalanced datasets. We also adopt g-means here. The three
datasets in Table I are used in our simulations.
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g − means =

TN
TP
×
.
TN + FP TP + FN

(8.1)

8.3.2 Data Modeling

We run GSVM-RU on each dataset for 7 times.
For the yeast dataset and the abalone dataset, in each run, the original dataset is randomly split
into 7 equal-sized subsets in a stratified way so that the majority/minority ratio is the same for
each subset.
After that, each subset is left for testing in turn and other 6 subsets are combined for training. For
each training/testing process, firstly the data is normalized so that each input feature has 0 mean
and 1 standard deviation on the training dataset; then GSVM-RU is executed on the normalized
training dataset: the model parameters are optimized by grid search with 6-fold inner cross
validation. (Notice that SVMs used for undersampling are with the linear kernel, and SVMs used
for classification are with the RBF kernel.) Finally each sample is used for testing one and only
one time, and thus the testing performance is calculated and reported. The validation
performance averaged on the 7 training/testing processes is also reported.
For the mammography dataset, the original dataset is randomly split into 10 equal-sized subsets
in the stratified way and 9-fold inner cross validation is used to optimize the model parameters in
each training/testing process.
The GSVM-RU undersampling process is repeated until classification performance cannot be
improved by aggregating the latest NLSVs.
As mention in Section 2, to some extent, the regulation parameter C of a linear SVM can be
adjusted to control how many informative samples are extracted to form an information granule.
In our preliminary simulations, we validate this idea: for the yeast dataset and the abalone
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dataset, more SVs can be extracted with the increase of the C value (Fig. 8.4 and Fig. 8.5); while
for the mammography dataset, less SVs are extracted with the increase of the C value (Fig. 8.6).
8.3.3 Result Analysis

For the yeast dataset, the best validation performance is observed when the “discard” aggregation
operation is adopted and the 7th granule is used as the final aggregation dataset. The result
indicates that the first assumption (the decision boundary is pushed toward the minority class) is
reasonable on the yeast dataset. When the NLSVs in the old granules are discarded, the decision
boundary gradually goes back to the “ideal” one and thus classification performance is improved
(Fig. 8.7). After the 8th granule is extracted, too many informative samples are discarded so that
classification performance is deteriorated. And hence the repetitive undersampling process is
stopped.
For the abalone dataset, the best validation performance is observed when the “combine”
aggregation operation is adopted and the first 5 granules are combined to form the final
aggregation dataset. The result indicates that the second assumption (a part but not all of
informative samples can be extracted in one granule) is reasonable on the abalone dataset. When
more and more informative samples are combined into the aggregated dataset, information loss is
less and less so that better performance can be achieved (Fig. 8.8). However, when the 6th
granule is extracted and combined into the aggregation dataset, the validation performance can
not be improved. The reason is that the new extracted samples are too far from the “ideal”
boundary so that they are prone to be redundant or irrelevant other than informative. And hence
the repetitive undersampling process is stopped.
For the mammography dataset, the best validation performance is observed when the first
granule is used as the final aggregation dataset. Both the “discard” operation and the “combine”
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operation are not effective to improve classification performance further (the results are not
shown here). One possible reason is that enough informative samples have been extracted in the
first granule. Another possible reason is that the aggregation operations used here are not general
enough. It is an interesting future work to try more general aggregation operations. For example,
maybe classification performance can be improved by discarding the 2nd granule and combining
the 1st one and the 3rd one.
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real
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predicted
negatives
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Figure. 8.3. the confusion matrix

TABLE 8.1
CHARACTERISTICS OF DATASETS USED FOR SIMULATIONS

Dataset

Attr

Size

#positive
(positive%)
51 (3.44%)
32 (0.77%)
260 (2.32%)

Yeast 0
8
1484
Abalone 0
8
4177
Mammography
6
11183
Error! Reference
source not found.
Note 1:
Attr = # of input features, Size = # of cases.
Note 2:
Class “ME2” in the yeast dataset is defined as
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Figure. 8.4. a larger C value results in more Support Vectors
on the yeast dataset

Figure. 8.5. a larger C value results in more Support Vectors
on the abalone dataset

Figure. 8.6. a larger C value results in less Support Vectors
on the mammography dataset
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Figure. 8.7. results of different granules for the yeast dataset with the
“discard” operation averaged on the 7 runs

Figure. 8.8. results of different granules for the abalone dataset with the
“combine” operation averaged on the 7 runs
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TABLE 8.2
VALIDATION/TEST G-MEANS ON YEAST DATASET (THE 7TH
GRANULE, 7-6-FOLDS DOUBLE CV)

Trial

Validation

Test

1
2
3
4
5
6
7
GSVM-RU
KBA 0

84.37
84.28
84.77
84.20
85.18
84.43
85.48
84.7±0.5
N/A

83.94
83.11
84.93
84.04
84.01
84.04
85.06
84.2±0.7
82.2±7.1

TABLE 8.3
VALIDATION/TEST G-MEANS ON ABALONE DATASET (THE FIRST 5
GRANULES, 7-6-FOLDS DOUBLE CV)

Trial

Validation

Test

1
2
3
4
5
6
7
GSVM-RU
KBA 0

76.04
75.76
74.97
75.45
74.40
74.74
76.57
75.4±0.8
N/A

75.01
73.55
70.15
74.81
73.23
73.57
73.50
73.4±1.6
57.8±5.4

TABLE 8.4
VALIDATION/TEST G-MEANS ON MAMMOGRAPHY DATASET (THE
FIRST GRANULE, 10-9-FOLDS DOUBLE CV)

Trial

Validation (%)

Test (%)

1
2
3
4
5
6
7
GSVM-RU

83.16
83.93
83.20
82.27
84.05
83.91
83.98
83.5±0.7

83.83
83.63
83.63
83.33
84.75
84.50
83.42
83.9±0.6
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Table 8.2 and Table 8.3 compare GSVM-RU with KBA [107] in terms of the g-means
metric on the yeast dataset and the abalone dataset, respectively. The g-means value is
increased from

82.2±7.1% to 84.2±0.7% for the highly imbalanced yeast dataset, and

significantly increased from

57.8±5.4% to 73.4±1.6% for the extremely highly

imbalanced abalone dataset. Notice that in Wu’s work [107], for each random splitting,
only one subset is used for testing and other six subsets are combined for training; in our
work, every subset is used for testing in turn. So the performance improvement is
statistically more reliable.
To our best knowledge, no results on the g-means metric have been reported for the
mammography dataset in the literature. Table 8.4 reports performance of GSVM-RU and
the result (83.9±0.6%) is quite promising.
Moreover, Table 8.5 compares the modeling time between GSVM-RU and a RBF SVM
optimized by grid search. For the yeast dataset, GSVM-RU averagely takes 37 seconds,
while SVM takes 643 seconds. For the abalone dataset, GSVM-RU averagely runs 447
seconds, while SVM needs 2748 seconds. The higher speed of GSVM-RU is due to the
significantly smaller training size by undersampling the majority class. As a comparison,
KBA even needs more time than SVM [107].
8.4 Simulations on the KDDCUP 2004 Protein Homology Prediction Dataset

The same hardware and software as the first group of simulations are adopted.
8.4.1 Granular Computing and GSVM Dataset and Evaluation Metrics

The

KDDCUP

2004

protein

homology

prediction

task

at

http://kodiak.cs.cornell.edu/kddcup/index.html is used in the second group of
simulations. The detailed characteristics of the dataset are listed in Table 8.6. The task
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can be modeled as a binary classification problem: Given a protein sequence, the task is
to predict whether it is homologous to the corresponding native sequence or not. There
are 153 native sequences in the training dataset and 150 native sequences in the testing
dataset. For each native sequence, there is a block of approximately 1000 protein
sequences with class label (1 means homologous and 0 means non-homologous). The
class labels of protein sequences in the testing dataset are kept secret. 74 features are
provided to describe the match (e.g. the score of a sequence alignment) between the
native protein sequence and the sequence that is tested for homology. The problem is
extremely highly imbalanced: there are only 1296 homologous protein sequences from
altogether 145751 ones in the training dataset.
Four metrics are used for performance measures:
•

TOP1: fraction of blocks with a homologous sequence ranked top 1 (maximize)

•

RMSE: root mean squared error averaged on blocks (minimize)

•

RKL: average rank of the lowest ranked homologous sequence (minimize)

•

APR: average of the average precision in each block. For a single block, APR
could be approximately described as the area of precision-recall curves.
(maximize)

RMSE is a metric for accuracy evaluation and is easier to show the differences between
models than directly using accuracy. The other 3 metrics are rank-based, which means
that the 3 metrics’ values are decided by the order of ranking list, and the absolute values
of predictions do not affect the performances. The four metrics are precisely defined in
perf [20]. In the simulation, we use the corresponding code to calculate the four metrics.
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8.4.2 Data Modeling

Firstly the data is normalized so that each input feature has 0 mean and 1 standard
deviation in each block. The reason for normalizing in each different block separately is
that protein sequences in different blocks are in different protein families, which may be
remote so that similar absolute feature vectors are not necessary to mean similar
homology behaviors.
Similar to [36], GSVM-RU is tuned by grid search with 153-folds cross validation: each
block is left for validation in turn and other 152 blocks are used for training. In each
training/validation process, linear SVMs are modeled on each training block for
undersampling and then all extracted informative samples are aggregated to model a RBF
SVM for prediction.
GSVM-RU is tuned for each of the four metrics separately. Finally, the model parameters
with the best validation performance are used to retrain a GSVM on all of the 153 blocks.
The GSVM is used to make prediction on the testing dataset.
The GSVM-RU undersampling process is repeated until the validation performance
cannot be improved by aggregating the latest NLSVs. Due to the efficiency issue, the
regulation parameter C of linear SVMs for undersampling is fixed to be 1, and only the
“discard” operation is adopted for aggregation.

TABLE 8.5
MODELING TIME COMPARISON AVERAGED ON 7 RUNS
BETWEEN SVM AND GSVM-RU

Yeast
Abalone

RBF-SVM
(seconds)
643±26
2748±74

GSVM-RU
(seconds)
37±3
447±18
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TABLE 8.6
CHARACTERISTICS OF KDDCUP04 PROTEIN HOMOLOGY PREDICTION DATASETS

Dataset

Block

Size

Attr

#positive (positive%)

Training

153

145751

74

1296 (0.89%)

Testing

150

139658

74

N/A

Note:

Block = # of blocks, Size = # of protein sequences, Attr = # of input features.

TABLE 8.7
VALIDATION/TEST PERFORMANCE ON KDDCUP04 PROTEIN HOMOLOGY PREDICTION TASK (153-FOLDS CV) AS OF 07/19/2005

validation
test
rank

TOP1
(maximize)
0.9020
0.9000
6.5

RMSE
(minimize)
0.03553
0.03529
2

RKL
(minimize)
40.54
45.88
2

APR
(maximize)
0.84723
0.84184
2

average
N/A
N/A

3.125 (the best)

8.4.3 Result Analysis

Our solution has the best average rank over the four metrics in the ongoing KDDCUP
2004

protein

homology

prediction

contest

as

of

07/19/2005

at

http://kodiak.cs.cornell.edu/cgi-bin/newtable.pl?prob=bio. Table 8.7 summarizes the
result.
For the TOP1 metric, the best validation performance 0.9020 is achieved when the 1st
granule is used as the final aggregation dataset. The testing performance is 0.9000, which
ranks 6.5th.
For the RMSE metric, the best validation performance 0.03553 is achieved when the 1st
granule is used as the final aggregation dataset. The testing performance is 0.03529,
which ranks 2nd.
For the RKL metric, the best validation performance 40.54 is achieved when the 7th
granule is used as the final aggregation dataset. The testing performance is 45.88, which
ranks 2nd.
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For the APR metric, the best validation performance 0.84723 is achieved when the 10th
granule is used as the final aggregation dataset. The testing performance is 0.84184,
which ranks 2nd.
The results demonstrate that the first assumption (the decision boundary is pushed toward
the minority class) is reasonable for RKL and APR metrics. When the NLSVs in the old
granules are discarded, the decision boundary gradually goes back to the “ideal” one and
thus prediction performance is improved.
For TOP1 and RMSE metrics, the “discard” operation is not effective to improve
prediction performance further. One possible reason is that enough informative samples
have been extracted from the first granule. Another possible reason is that the “discard”
operation is not the most suitable aggregation operation. We have not tried other more
expensive operations due to the huge size of the KDDCUP 2004 protein homology
prediction dataset.
8.5 Summary

A new learning model called Granular Support Vector Machines is proposed in this work.
GSVM systematically and formally combines the methodologies from statistical learning
theory and granular computing theory. In this work, a new GSVM modeling algorithm,
named GSVM-RU, is designed specifically for highly imbalanced classification
problems. GSVM-RU builds a sequence of information granules by repetitively
extracting informative samples as SVs. Finally, the samples in these granules are
selectively aggregated to model a SVM for final classification. In this way, the local
significance of each granule and global correlation among different granules are elegantly
trade-off. GSVM-RU is efficient because of usually much smaller size of the after-
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undersampling aggregation dataset compared to the original training dataset. It is also
effective due to
•

reservation of informative samples which are essential for classification and

•

elimination of large quantities of redundant or even noisy samples which may
confuse a classifier to find the optimal decision boundary.

GSVM-RU is inherently an undersampling algorithm. The improvement on effectiveness
seems more significant if the imbalance degree is higher. As two benchmarks, GSVMRU greatly improves the g-means value on extremely imbalanced abalone dataset (the
positive ratio is 0.77%) and leads the ongoing KDDCUP 2004 protein homology
prediction contest (the positive ratio is 0.89%).
The performance is expected to be improved further if we combine GSVM-RU with
some oversampling approaches, such as SMOTE [24], or boosting meta-learning
techniques, such as SMOTEBoost [26]. Algorithm design and simulations on larger and
more complex datasets are currently in processing. In the future, parallel GSVM-RU will
also be investigated to speed up learning significantly.
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CHAPTER 9
CONCLUSIONS AND FUTURE WORKS
9.1 Conclusion

A classification problem is a predictive data mining problem where the unknown variable
is categorical. Samples of different classes are accumulated, on which a classifier is
trained to predict future samples. With emergence of E-business, Web intelligence and
biomedical informatics, new challenges are coming. Among them, noise, non i.i.d., high
dimensionality and imbalance are four especially interesting ones due to their
pervasiveness in datasets from these application domains.
In this work, a framework named Granular Support Vector Machines (GSVM) is
proposed to systematically and formally combine statistical learning theory, granular
computing theory and soft computing theory to enhance effectiveness, efficiency and/or
interpretability of classification on complex datasets [93-100]. In general, GSVM works
by building a sequence of information granules and then modeling Support Vector
Machines (SVM) in some of these information granules when necessary. A good
granulation method to find suitable granules is crucial for modeling a GSVM with good
performance.
Under this framework, many algorithms have been proposed to build a GSVM model for
classification problems with different characteristics. Specifically, GSVM-RFE
(recursive feature elimination) algorithm was proposed for high-dimensional cancer
classification. The empirical study demonstrates that GSVM-RFE can make much more
reliable prediction on microarray expression data compared to previous approaches.
Another GSVM-RU (repetitive undersampling) algorithm was proposed for highly
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imbalanced classification. GSVM-RU ranks as one of the best solutions in ACM
KDDCUP04 competition for protein homology prediction and ranks #1 in the US in
DMC05 competition for customers’ online shopping behavior prediction.
9.2 Long vision

A lot of data mining algorithms have been proposed by scientists from different research
communities such as database, machine learning, statistics, soft computing, etc. Each
algorithm has its own advantages and also its own disadvantages. For a specific data
mining task, which algorithm is the best is highly data dependant. That means, before we
touch the data, we can not know which algorithm is the most suitable for the problem at
hand. As a result, it is desirable to design a hybrid and adaptive data mining system.

Machine
Learning

Computational
Intelligence

Granulation

Statistical
Learning

Granular
Computing

Graph
Theory

Subproblems
conquer

Aggregation
Data
Warehouse

Language
Theory

Figure. 9.1. GrC-PDM

Our long term research goal is to build a hybrid intelligent predictive data modeling
framework with the ideas of granular computing (named GrC-PDM). With GrC-PDM
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framework, we can build adaptive knowledge discovery and data mining systems to
provide effective and efficient decision support for drug design, disease diagnosis, credit
card fraudulent detection, spam filtering, and many other applications. This dissertation
work can be viewed as one preliminary step toward the goal.
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